KURA episode 20260825_KURA_MIDDAY
Public episode JSON embedded as readable text for automated access.
{
"schema_version": "tryding-agent-episode.v1",
"episode_id": "20260825_KURA_MIDDAY",
"episode_url": "https://trydingday.com/data/agents/v1/episodes/20260825_KURA_MIDDAY.html",
"public_page_url": "https://trydingday.com/coverage/kura/2026-08-25/midday/",
"published_at": "2026-08-25T18:53:12.207658Z",
"updated_at": "2026-09-16T22:16:11.325459Z",
"lifecycle": {
"tracking_status": "closed",
"active_for_tracking": false,
"stage": "closed"
},
"instrument": {
"type": "equity",
"symbol": "KURA",
"exchange": "NASDAQ",
"name": "Kura Oncology, Inc."
},
"technical_reference": {
"status": "ok",
"reference_price": 13.79,
"model_downside_reference": 12.57,
"model_upside_scenario_1": 15,
"model_upside_scenario_2": 16.22,
"atr_14": 0.81,
"method": "reference_price_plus_minus_atr14"
},
"public_content": {
"date": "August 25, 2026",
"generated_at": "2026-08-25T18:53:12.207658Z",
"original_published_at": null,
"session_tag": "midday",
"label": "Market coverage",
"try_label": "Try of the Day",
"public_status": "Try of the Day",
"why_today": "The panel selected Kura Oncology as the Try of the Day after comparing the corrected 27-name field. Its insider purchase, reported treatment demand and above-VWAP structure provide the clearest prospective case, while the stretched move and wide quoted spread keep the thesis conditional.",
"entry_reasoning": "Panel thesis: KURA's prospective thesis is that the company-specific treatment-adoption signal can support continued relative strength over the next 15 market sessions if follow-through remains visible in price and participation. Invalidation boundary: A sustained loss of that structure with fading participation, or evidence that the insider purchase and demand signal do not carry forward, would falsify the continuation thesis.",
"reference_price": 13.79,
"scanner": {
"price": 13.79,
"reference": 13.79,
"score": 5,
"score_version": "v0_legacy_reconstructed",
"change": 11.21,
"volume": 2515089,
"average_volume": 1770666,
"volume_ratio": 1.42,
"rsi": 86.86,
"ema_trend": "11.99 > 11.15 > 10.55",
"position_52w": 99.7,
"atr_14": 0.81,
"vwap": 13.37,
"vwap_state": "above",
"vwap_distance_pct": 3.14,
"vwap_reading": {
"price": 13.37,
"state": "above",
"distance_pct": 3.14
},
"range_position": 0.998,
"gap_pct": 0,
"relative_strength": {
"excess_pct": 10.76,
"index": "QQQ",
"index_chg_pct": 0.45,
"status": "normal"
},
"volume_percentile": {
"median_vol": 1529300,
"percentile": 85.7,
"status": "elevated",
"today_vol": 2515089
},
"extension": {
"atr": 0.81,
"dist_atr": 3.26,
"ema_ref": 11.15,
"status": "healthy"
},
"atr_move_signal": {
"atr_pct": 5.87,
"status": "normal",
"z": 1.91
},
"sector_breadth": {
"chg_pct": 0.45,
"etf": "XLV",
"status": "neutral"
},
"sentiment": null,
"sentiment_score": null,
"earnings_warning": {
"days_away": null,
"earnings_date": null,
"has_earnings_soon": false,
"status": "clear"
},
"options_snapshot": null,
"extended_hours": {
"ext_pct": null,
"market_state": "REGULAR",
"phase": "regular",
"post_market_pct": null,
"pre_market_pct": null,
"status": "none"
},
"coiled_spring": {
"component_count": 0,
"components": {},
"count": 0,
"detector_version": "coiled-compression-ohlc.v1",
"reason": "coiled_ohlc_detector_runs_on_research_and_known_ticker_rails",
"schema_version": "coiled-features.v1",
"status": "not_evaluated"
},
"short_pct_float": 15.22,
"days_to_cover": 9.11,
"catalyst": "Kura Oncology Shares Jump After CEO Buys $1.24 Million of Stock",
"sector": "Healthcare",
"exchange": "NASDAQ",
"sec_signal": "INSIDER_NET_BUY (P/S)"
},
"levels": {
"reference": 13.79,
"downside": 12.57,
"upside_1": 15,
"upside_2": 16.22
},
"review": {
"score": 5,
"status": "Majority with dissent",
"summary": "The panel selected Kura Oncology as the Try of the Day after comparing the corrected 27-name field. Its insider purchase, reported treatment demand and above-VWAP structure provide the clearest prospective case, while the stretched move and wide quoted spread keep the thesis conditional.",
"views": [
{
"name": "Nate Brooks",
"role": "market structure and timing analyst",
"icon": "📈",
"view": "The first cut is structure. CRML and GENB have louder raw tape, but KURA is above VWAP and up with a near-top range position and meaningful relative strength. I am not calling that proof. I am asking whether we prefer active participation with extension or cleaner structure with less participation.",
"reasoning": "LEU remains the credible alternative because its structure is nearly as high in the range and its options are more usable, but the 0.29x volume ratio matters. RKT has a concrete settlement and reopening mechanism, yet its tape is flat and quiet. KURA is the better comparative answer because it has enough participation to make the next structural check meaningful."
},
{
"name": "Marcus Feld",
"role": "information, fundamentals and catalyst analyst",
"icon": "🦊",
"view": "KURA has the cleaner mechanism than CRML. The CEO purchase and the treatment-demand figures point to a company-specific reason for attention. But I want to know whether those facts are enough for a forward thesis, because CRML's move is stronger even though its merger story is unverified.",
"reasoning": "I concede there is no fresh direct proof that demand will continue after this snapshot. I still support the Try label because the evidence is current enough to define a test, and the thesis is now narrow: treatment adoption and company-specific demand, not a sector-wide biotech lift. If the next data point only repeats a headline without demand evidence, I would withdraw support."
},
{
"name": "Elena Vartanyan",
"role": "independent statistical auditor",
"icon": "🎯",
"view": "KURA's structure is undeniable, but it is also an 86.86 RSI reading, 3.26 ATR above the EMA reference and 99.7% of the 52-week high. LEU has a cleaner extension profile, yet its volume ratio is only 0.29x. Neither gets a free continuation claim. We need to say exactly what would make the next observation informative.",
"reasoning": "The quiet names with strong sealed forward outputs are a useful warning: FHN and ESQ cannot be promoted on that basis while their current tape is weak. I now support a majority KURA resolution. My qualification is unchanged: the case is prospective and conditional, and the missing EOD layer limits what we can say about market-wide confirmation."
},
{
"name": "Priya Nandakumar",
"role": "institutional risk and execution manager",
"icon": "🛡️",
"view": "The cost side is not decorative. KURA's options snapshot is complete, but the median quoted spread is 103.469602% and trade pressure is negative. CRML carries 29.37% short interest and a 1.98 ATR extension. LEU has a much tighter 11.36% spread and 26.68% short interest. KURA may be the best case, but it is not the easiest case to carry through a reversal.",
"reasoning": "I remain the dissent on risk language. I will not call a near-high move with a wide spread confirmed continuation. I accept the majority Try of the Day because KURA has a concrete mechanism, a next check and a falsifier, and because the alternatives have sharper attribution or participation defects. The persistent objection is that failure can be fast and expensive in a stretched structure."
},
{
"name": "Kenji Osei",
"role": "AI Systems & Market Data Integrity Analyst",
"icon": "🧠",
"view": "Lineage separates them further. KURA has two primary 8-K records in the sealed packet, with the commercial figures carried by supporting news. CRML has one 6-K and no company announcement for the merger chatter. LEU has three primary SEC records and a traceable energy-security context, but its current catalyst is more indirect. I will not turn source count into a score, but the attribution quality favors KURA over CRML.",
"reasoning": "One more constraint: the sealed breadth cut is complete for 300 fresh quotes, with 153 advancers and 146 decliners, but the EOD layer is unavailable. There is no direct issuer evidence tying the intraday move to the CEO purchase itself. That is a persistent provenance objection. It does not disqualify KURA, but it prevents us from describing the catalyst as fully validated by the session tape."
}
],
"conviction": {
"status_phrase": "majority-with-dissent",
"basis": "Support — KURA combines 11.21% relative strength, 1.42x volume and a company-specific demand signal; Counter-case — the move is extended and the options snapshot shows a 103.469602% median spread with negative trade pressure; Unresolved — follow-through above the captured VWAP must remain supported by participation and company evidence.",
"risk": "KURA is near its 52-week high with RSI 86.86 and 3.26 ATR extension. The complete options snapshot still showed a 103.469602% median quoted spread and negative trade pressure.",
"resolution_pct": 61.0,
"counter_case_pct": 24.0,
"unresolved_pct": 15.0
},
"context_roundtable": {
"mode": "coffee",
"status": "complete",
"consulted_voice_ids": [
"elena",
"marcus",
"kenji",
"priya",
"nate"
],
"summary": "The session was broad but uneven: falling oil and lower yields eased macro pressure, while sanctions and Hormuz risk stayed live. Breadth was mildly positive, but leadership rotated toward healthcare, energy and materials as technology and industrials cooled. The room's conclusion is a selective, event-sensitive tape, not a clean risk-on trend.",
"long_read": "The broad backdrop improved at the margin as oil prices eased and Treasury yields moved lower, reducing immediate pressure on both inflation-sensitive assets and duration-sensitive equities. That relief was incomplete because sanctions and possible shipping disruption kept an active geopolitical channel open. A calmer oil tape therefore reduced one source of stress without removing the possibility of a sharp reversal.\n\nMarket structure was mildly positive rather than universally strong. The sealed breadth snapshot showed more advancers than decliners, while external rotation measures pointed toward relatively firmer healthcare, energy and materials and softer technology and industrials. Those signals agree on selectivity, but their universes differ, so they are useful for context and not a substitute for the sealed candidate evidence.\n\nThe X thread used for context added a similar caution: the advance was described as complicated, with leadership and a line of defense still needing confirmation. That is consistent with a prospective case that has a clear next check but remains exposed to fast changes in participation. The selected healthcare thesis can fit a firmer sector backdrop without becoming a sector-wide claim.\n\nThe practical synthesis is unchanged: a company-specific signal may earn attention in a selective tape, but continuation must be demonstrated through structure, participation and fresh company evidence. Macro relief is supportive context; policy risk, crowded extension and liquidity remain the counter-case.",
"transcript": [
{
"speaker_id": "elena",
"text": "The day-level backdrop was less hostile after oil fell and the 10-year Treasury yield eased to 4.64% from 4.70%. That relieved one macro pressure, but it is not the same as a clean risk-on signal.",
"source_urls": [
"https://apnews.com/article/f17fc8cfc61f40114eb7246701b4695d"
]
},
{
"speaker_id": "priya",
"text": "The relief has a live counterweight. Sanctions, tanker risk and the Strait of Hormuz remain capable of repricing energy and transport quickly, so lower oil cannot be treated as a safety certificate.",
"source_urls": [
"https://apnews.com/article/1a4fa2e3812c458a25a561b38dc89f09",
"https://apnews.com/article/e367634d8853c8fa4a341132cd577f31",
"https://currently.att.yahoo.com/att/iran-vows-to-resist-widened-us-sanctions-says-washington-seeks-talks-125959732.html"
]
},
{
"speaker_id": "kenji",
"text": "The sealed breadth cut was mildly positive at 153 advancers versus 146 decliners across 300 fresh quotes. External sector breadth pages use different universes and timestamps, so I will treat them as directional context, not as a replacement for the sealed market cut.",
"source_urls": [
"https://pro.stockalarm.io/market/breadth"
]
},
{
"speaker_id": "nate",
"text": "The rotation is not uniform. Technology and industrials were cooling while healthcare and energy were relatively firmer. That fits a selective tape. The current Mark Minervini thread also describes an advance that is still testing its line of defense, which matches the need for follow-through.",
"source_urls": [
"https://investinglive.com/stocks/stock-market-sector-rotation-update-industrials-join-technology-in-cooling-off/",
"https://currentlogic.substack.com/p/weekly-dispersion-brief-aug-17-aug",
"https://x.com/markminervini/status/2091896760637550952"
]
},
{
"speaker_id": "marcus",
"text": "The sanctions story is a slow-burn policy risk rather than a single headline impulse. It can matter through counterparties, shipping and energy costs, but it does not become a catalyst for every company that happens to trade well today.",
"source_urls": [
"https://apnews.com/article/e367634d8853c8fa4a341132cd577f31",
"https://currently.att.yahoo.com/att/iran-vows-to-resist-widened-us-sanctions-says-washington-seeks-talks-125959732.html"
]
},
{
"speaker_id": "priya",
"text": "Exactly. If shipping disruption returns to the tape, the first-order effect may be oil and rates, while the second-order effect is dispersion between sectors. A selective healthcare case can survive that only if its own evidence stays stronger than the macro shock.",
"source_urls": [
"https://apnews.com/article/1a4fa2e3812c458a25a561b38dc89f09",
"https://currently.att.yahoo.com/att/iran-vows-to-resist-widened-us-sanctions-says-washington-seeks-talks-125959732.html"
]
},
{
"speaker_id": "elena",
"text": "Lower yields are helpful for duration-sensitive assets, but the market reaction remains conditional on policy and inflation expectations. The day is better described as pressure easing in places, not as confirmation of a durable advance.",
"source_urls": [
"https://apnews.com/article/f17fc8cfc61f40114eb7246701b4695d"
]
},
{
"speaker_id": "nate",
"text": "The Mark Minervini thread is useful precisely because it stays cautious: a complicated advance and a line of defense that still has to hold. That is the same structural question we left on the selected case. No second vote is needed; the context simply keeps the test honest.",
"source_urls": [
"https://x.com/markminervini/status/2091896760637550952",
"https://x.com/markminervini/status/2091888323551789435"
]
},
{
"speaker_id": "marcus",
"text": "Meb Faber's reminder that the market tells its own story is the right discipline here. We can use the tape to challenge the narrative, but we should not turn a broad market post into issuer evidence. The selected company still stands or falls on its own next check.",
"source_urls": [
"https://x.com/MebFaber/status/2092205407825498347"
]
},
{
"speaker_id": "kenji",
"text": "The sector reports point in the same broad direction often enough to be useful, but their different universes and definitions matter. Healthcare and energy leadership is a context signal; it is not proof that a particular healthcare name will carry forward.",
"source_urls": [
"https://currentlogic.substack.com/p/weekly-dispersion-brief-aug-17-aug",
"https://pro.stockalarm.io/market/breadth"
]
},
{
"speaker_id": "marcus",
"text": "That distinction protects the causal chain. Iran policy can explain why energy and shipping are sensitive, and rotation can explain why healthcare is receiving attention, but neither substitutes for the company-specific treatment-demand evidence already used in the sealed resolution.",
"source_urls": [
"https://apnews.com/article/e367634d8853c8fa4a341132cd577f31",
"https://investinglive.com/stocks/stock-market-sector-rotation-update-industrials-join-technology-in-cooling-off/"
]
},
{
"speaker_id": "priya",
"text": "The unresolved risk is still asymmetrical in time: wide quoted spreads and stretched structures can move before the story has time to update. The public context therefore supports a conditional continuation thesis only, with the structural check and falsifier left intact.",
"source_urls": [
"https://apnews.com/article/f17fc8cfc61f40114eb7246701b4695d",
"https://investinglive.com/stocks/stock-market-sector-rotation-update-industrials-join-technology-in-cooling-off/"
]
},
{
"speaker_id": "elena",
"text": "I can reconcile the two layers. Selective healthcare leadership and a company-specific demand signal can coexist with a fragile, policy-sensitive market. That strengthens the relevance of the selected case without changing its resolution or confidence.",
"source_urls": [
"https://investinglive.com/stocks/stock-market-sector-rotation-update-industrials-join-technology-in-cooling-off/",
"https://currentlogic.substack.com/p/weekly-dispersion-brief-aug-17-aug"
]
},
{
"speaker_id": "nate",
"text": "The final read is selective follow-through, not a clean market-wide trend: easing oil and yields help, sanctions keep a live shock channel, and rotation rewards relative strength while punishing weak participation. The original KURA resolution remains sealed; the context layer adds conditions, not a new selection.",
"source_urls": [
"https://apnews.com/article/f17fc8cfc61f40114eb7246701b4695d",
"https://apnews.com/article/1a4fa2e3812c458a25a561b38dc89f09",
"https://x.com/markminervini/status/2091896760637550952"
]
}
],
"source_urls": [
"https://apnews.com/article/f17fc8cfc61f40114eb7246701b4695d",
"https://apnews.com/article/1a4fa2e3812c458a25a561b38dc89f09",
"https://apnews.com/article/e367634d8853c8fa4a341132cd577f31",
"https://currently.att.yahoo.com/att/iran-vows-to-resist-widened-us-sanctions-says-washington-seeks-talks-125959732.html",
"https://investinglive.com/stocks/stock-market-sector-rotation-update-industrials-join-technology-in-cooling-off/",
"https://currentlogic.substack.com/p/weekly-dispersion-brief-aug-17-aug",
"https://pro.stockalarm.io/market/breadth",
"https://x.com/markminervini/status/2091896760637550952",
"https://x.com/markminervini/status/2091888323551789435",
"https://x.com/MebFaber/status/2092205407825498347"
]
},
"context_roundtable_sources": [
{
"event_id": "coffee_kura_20260825_ap_01",
"headline": "Oil prices ease as sanctions and shipping risk remain in focus",
"url": "https://apnews.com/article/f17fc8cfc61f40114eb7246701b4695d",
"publisher": "AP News",
"source_quality": "market_context",
"public_safe": true,
"published_at": null,
"available_at": null
},
{
"event_id": "coffee_kura_20260825_ap_02",
"headline": "Iran resists widened US sanctions as Washington signals talks",
"url": "https://apnews.com/article/1a4fa2e3812c458a25a561b38dc89f09",
"publisher": "AP News",
"source_quality": "market_context",
"public_safe": true,
"published_at": null,
"available_at": null
},
{
"event_id": "coffee_kura_20260825_ap_03",
"headline": "Sanctions and Hormuz risk remain a live policy channel",
"url": "https://apnews.com/article/e367634d8853c8fa4a341132cd577f31",
"publisher": "AP News",
"source_quality": "market_context",
"public_safe": true,
"published_at": null,
"available_at": null
},
{
"event_id": "coffee_kura_20260825_yahoo_01",
"headline": "Iran vows to resist widened US sanctions, says Washington seeks talks",
"url": "https://currently.att.yahoo.com/att/iran-vows-to-resist-widened-us-sanctions-says-washington-seeks-talks-125959732.html",
"publisher": "Yahoo News",
"source_quality": "market_context",
"public_safe": true,
"published_at": null,
"available_at": null
},
{
"event_id": "coffee_kura_20260825_investinglive_01",
"headline": "Stock market sector rotation update: Industrials join technology in cooling off",
"url": "https://investinglive.com/stocks/stock-market-sector-rotation-update-industrials-join-technology-in-cooling-off/",
"publisher": "InvestingLive",
"source_quality": "market_context",
"public_safe": true,
"published_at": null,
"available_at": null
},
{
"event_id": "coffee_kura_20260825_currentlogic_01",
"headline": "Weekly dispersion brief: market leadership remains uneven",
"url": "https://currentlogic.substack.com/p/weekly-dispersion-brief-aug-17-aug",
"publisher": "Current Logic",
"source_quality": "market_context",
"public_safe": true,
"published_at": null,
"available_at": null
},
{
"event_id": "coffee_kura_20260825_stockalarm_01",
"headline": "Stock market breadth and statistics — August 2026",
"url": "https://pro.stockalarm.io/market/breadth",
"publisher": "Stock Alarm Pro",
"source_quality": "market_context",
"public_safe": true,
"published_at": null,
"available_at": null
},
{
"event_id": "coffee_kura_20260825_minervini_01",
"headline": "A complicated advance still needs its line of defense to hold",
"url": "https://x.com/markminervini/status/2091896760637550952",
"publisher": "Mark Minervini (X)",
"source_quality": "market_context",
"public_safe": true,
"published_at": null,
"available_at": null
},
{
"event_id": "coffee_kura_20260825_minervini_02",
"headline": "The market advance remains conditional on structural follow-through",
"url": "https://x.com/markminervini/status/2091888323551789435",
"publisher": "Mark Minervini (X)",
"source_quality": "market_context",
"public_safe": true,
"published_at": null,
"available_at": null
},
{
"event_id": "coffee_kura_20260825_mebfaber_01",
"headline": "The market tells its own story",
"url": "https://x.com/MebFaber/status/2092205407825498347",
"publisher": "Meb Faber (X)",
"source_quality": "market_context",
"public_safe": true,
"published_at": null,
"available_at": null
}
]
},
"updates": [
{
"day": 15,
"timestamp": "2026-09-16T22:16:11.325459Z",
"date": "Session 15 · Sep 16, 2026 · 18:16 NASDAQ",
"text": "KURA's 15-session tracking closes at -19.02% from the $13.79 entry price. The path reached -1.23% at best and -20.28% at worst. Fresh closure evidence records an $11.20 provider price and an $11.25 post-market quote with a reported extended-hours change of +0.45%; traded volume is 0.99 times average. Current session-average price, RSI, EMA trend and 52-week position readings are unavailable. The treatment-adoption and insider-purchase signals remain company-specific context, not proof that they sustained demand. The published follow-through condition was not confirmed across the full horizon, so public tracking ends.",
"price": 11.24,
"pct": -18.73,
"return_vs_entry_pct": -18.49,
"return_vs_base_pct": -18.49,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": -0.43,
"session_day": 15,
"reference_price": 13.79,
"reference_text": "$11.24 · -18.49% from $13.79 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": true,
"active_relevant": false,
"terminal_closure": true,
"transcript_anchor": "transcript-entry-18fca94a00c2f6334a246c6a4987b6ee3443c3c10daf7b31c7491137ea89966c",
"price_as_of": "2026-08-25T21:18:04Z",
"vwap_as_of": null
},
{
"day": 14,
"timestamp": "2026-09-15T21:47:08.562235Z",
"date": "Session 14 · Sep 15, 2026 · 17:47 NASDAQ",
"text": "KURA recovered 0.73 points from the previous public note, but the tracked return remains -18.29% after a 2.25% decline to USD 11.30. Price is only modestly above VWAP with no confirmed structure, so the treatment-demand and insider-purchase thesis remains a company-specific question rather than evidence of renewed continuation.",
"price": 11.3,
"pct": -18.29,
"return_vs_entry_pct": -18.06,
"return_vs_base_pct": -18.06,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": -0.04,
"session_day": 14,
"reference_price": 13.79,
"reference_text": "$11.30 · -18.06% from $13.79 base",
"timing": "",
"market_marker": {
"phase": "post",
"text": "Aftermarket update: $11.43 (+1.19% vs regular close) · Sep 15, 2026 · 17:34 NASDAQ"
},
"extended_hours": {
"phase": "post",
"price": 11.43,
"ext_pct": 1.19,
"as_of": "2026-09-15T21:34:25Z",
"persisted": false
},
"relevant": false,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "",
"price_as_of": "2026-09-15T21:34:25Z",
"vwap_as_of": null
},
{
"day": 14,
"timestamp": "2026-09-15T19:27:19.871047Z",
"date": "Session 14 · Sep 15, 2026 · 15:27 NASDAQ",
"text": "KURA's current tape points to deterioration: it moved -2,21% to $11,30, with VWAP at 11,22 and volume at 0,70 times its three-month average. The tracked return is -19,02%, versus 0,24 points since the previous public note; Healthcare-relative wording remains supportive with a -0,06 point gap versus Healthcare, so the published thesis is not upgraded beyond what this move supports.",
"price": 11.305,
"pct": -19.02,
"return_vs_entry_pct": -18.02,
"return_vs_base_pct": -18.02,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": 1.23,
"session_day": 14,
"reference_price": 13.79,
"reference_text": "$11.30 · -18.02% from $13.79 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": false,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "",
"price_as_of": "2026-09-15T19:21:00.581079Z",
"vwap_as_of": null
},
{
"day": 14,
"timestamp": "2026-09-15T16:22:18.081027Z",
"date": "Session 14 · Sep 15, 2026 · 12:22 NASDAQ",
"text": "KURA tracked loss widened 2.85 points to -19.26% as the current capture fell 3.68% to $11.14, 0.31% below VWAP on 0.35 times average volume near the lower part of its range. Healthcare-relative context remains comparatively supportive, but distribution, no confirmed structure and a weaker twenty-session return than the sector leave the treatment-demand and insider-purchase thesis without clear follow-through.",
"price": 11.135,
"pct": -19.26,
"return_vs_entry_pct": -19.25,
"return_vs_base_pct": -19.25,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": -3.08,
"session_day": 14,
"reference_price": 13.79,
"reference_text": "$11.13 · -19.25% from $13.79 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": false,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "",
"price_as_of": "2026-09-15T15:52:36.865021Z",
"vwap_as_of": null
},
{
"day": 13,
"timestamp": "2026-09-14T23:32:40.210908Z",
"date": "Session 13 · Sep 14, 2026 · 19:32 NASDAQ",
"text": "KURA's tracked loss narrowed to -16.41% as the latest capture rose 1.49% to $11.56, almost at but just below VWAP on fading participation. Healthcare relative strength keeps the treatment-demand question alive, yet no structure or sustained volume has appeared, so the insider-purchase and follow-through thesis remains unconfirmed.",
"price": 11.56,
"pct": -16.41,
"return_vs_entry_pct": -16.17,
"return_vs_base_pct": -16.17,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": 0.0,
"session_day": 13,
"reference_price": 13.79,
"reference_text": "$11.56 · -16.17% from $13.79 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": false,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "",
"price_as_of": "2026-09-14T22:47:52Z",
"vwap_as_of": null
},
{
"day": 13,
"timestamp": "2026-09-14T22:40:30.492295Z",
"date": "Session 13 · Sep 14, 2026 · 18:40 NASDAQ",
"text": "KURA improved 0.73 points to -16.41% as the latest capture rose 1.49% to $11.56, 0.35% above VWAP on 0.79x average volume. Healthcare relative strength remains supportive, but fading participation and no confirmed structure leave the treatment-demand and insider-purchase thesis without clear follow-through.",
"price": 11.56,
"pct": -16.41,
"return_vs_entry_pct": -16.17,
"return_vs_base_pct": -16.17,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": 0.73,
"session_day": 13,
"reference_price": 13.79,
"reference_text": "$11.56 · -16.17% from $13.79 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": false,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "",
"price_as_of": "2026-09-14T20:06:30Z",
"vwap_as_of": null
},
{
"day": 13,
"timestamp": "2026-09-14T14:56:59.079441Z",
"date": "Session 13 · Sep 14, 2026 · 10:56 NASDAQ",
"text": "KURA tracked loss narrowed 0.50 points to -17.14% as the current capture rose 0.61% to $11.46, 0.61% above VWAP on only 0.09 times average volume. Healthcare-relative strength remains supportive and the price sits high in the range, but no structure is confirmed and fading participation leaves the treatment-demand and insider-purchase thesis without clear follow-through.",
"price": 11.46,
"pct": -17.14,
"return_vs_entry_pct": -16.9,
"return_vs_base_pct": -16.9,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": 0.5,
"session_day": 13,
"reference_price": 13.79,
"reference_text": "$11.46 · -16.90% from $13.79 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": false,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "",
"price_as_of": "2026-09-14T14:05:55.081234Z",
"vwap_as_of": null
},
{
"day": 12,
"timestamp": "2026-09-11T21:54:40.336253Z",
"date": "Session 12 · Sep 11, 2026 · 17:54 NASDAQ",
"text": "KURA tracked loss widened 1.08 points to -17.64% as the latest capture fell 1.56% to USD 11.39 with no confirmed structure and participation at 1.19 times its three-month average. The treatment-demand and insider-purchase case remains company-specific, but the current tape has not rebuilt follow-through; longer-window Healthcare strength keeps the question open without restoring the published continuation thesis.",
"price": 11.39,
"pct": -17.64,
"return_vs_entry_pct": -17.4,
"return_vs_base_pct": -17.4,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": -0.9,
"session_day": 12,
"reference_price": 13.79,
"reference_text": "$11.39 · -17.40% from $13.79 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": true,
"active_relevant": true,
"terminal_closure": false,
"transcript_anchor": "transcript-entry-b22b4c340b3d669aeae655053ba31516bf5e5aad35d28d7289d627c3ff7337ac",
"price_as_of": "2026-09-11T21:21:06Z",
"vwap_as_of": null
},
{
"day": 12,
"timestamp": "2026-09-11T19:50:39.116519Z",
"date": "Session 12 · Sep 11, 2026 · 15:50 NASDAQ",
"text": "KURA's tracked loss narrowed 0.22 points to -16.56% as the stock slipped 0.48% to $11.52 and held above VWAP in the middle of its range. The change is too small to call a repair: volume was 0.63 times average, no structure is confirmed and the treatment-demand case remains under pressure despite longer-window healthcare relative strength.",
"price": 11.515,
"pct": -16.56,
"return_vs_entry_pct": -16.5,
"return_vs_base_pct": -16.5,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": -0.18,
"session_day": 12,
"reference_price": 13.79,
"reference_text": "$11.52 · -16.50% from $13.79 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": false,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "",
"price_as_of": "2026-09-11T19:21:33.380908Z",
"vwap_as_of": null
},
{
"day": 12,
"timestamp": "2026-09-11T14:46:30.825300Z",
"date": "Session 12 · Sep 11, 2026 · 10:46 NASDAQ",
"text": "KURA tracked loss widened 0.44 points to -16.78% as the stock slipped 0.26% to $11.54, finished 0.83% below VWAP at the session low and traded at only 0.08 times average volume. Longer-window Healthcare outperformance remains, but the treatment-demand case has not repaired: the current capture shows no structure and no renewed participation.",
"price": 11.54,
"pct": -16.78,
"return_vs_entry_pct": -16.32,
"return_vs_base_pct": -16.32,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": -0.22,
"session_day": 12,
"reference_price": 13.79,
"reference_text": "$11.54 · -16.32% from $13.79 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": false,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "",
"price_as_of": "2026-09-11T14:06:25.411176Z",
"vwap_as_of": null
},
{
"day": 11,
"timestamp": "2026-09-10T21:44:28.957516Z",
"date": "Session 11 · Sep 10, 2026 · 17:44 NASDAQ",
"text": "KURA's tracked loss was essentially unchanged, narrowing 0.04 points to -16.34%. The stock fell 4.30% to USD 11.57, 1.15% below VWAP near the bottom of its range on 1.01 times average volume, with no confirmed structure; longer-term Healthcare-relative strength remains positive, but the treatment-demand case is under renewed pressure.",
"price": 11.57,
"pct": -16.34,
"return_vs_entry_pct": -16.1,
"return_vs_base_pct": -16.1,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": 0.32,
"session_day": 11,
"reference_price": 13.79,
"reference_text": "$11.57 · -16.10% from $13.79 base",
"timing": "",
"market_marker": {
"phase": "post",
"text": "Aftermarket update: $11.58 (+0.09% vs regular close) · Sep 10, 2026 · 17:21 NASDAQ"
},
"extended_hours": {
"phase": "post",
"price": 11.58,
"ext_pct": 0.09,
"as_of": "2026-09-10T21:21:35Z",
"persisted": false
},
"relevant": false,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "",
"price_as_of": "2026-09-10T21:21:35Z",
"vwap_as_of": null
},
{
"day": 11,
"timestamp": "2026-09-10T20:00:18.313110Z",
"date": "Session 11 · Sep 10, 2026 · 16:00 NASDAQ",
"text": "KURA's tracked loss widened 1.77 points to -16.38% since the previous public note. The latest capture fell 4.67% to USD 11.53, 1.15% below VWAP near the bottom of its range on 0.62 times average volume; Healthcare-relative strength remains positive over twenty sessions, but the treatment-demand case is facing renewed weakness without confirmed structure.",
"price": 11.525,
"pct": -16.38,
"return_vs_entry_pct": -16.42,
"return_vs_base_pct": -16.42,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": -1.84,
"session_day": 11,
"reference_price": 13.79,
"reference_text": "$11.53 · -16.42% from $13.79 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": false,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "",
"price_as_of": "2026-09-10T19:21:10.275300Z",
"vwap_as_of": null
},
{
"day": 11,
"timestamp": "2026-09-10T14:36:25.701868Z",
"date": "Session 11 · Sep 10, 2026 · 10:36 NASDAQ",
"text": "KURA's tracked loss widened 2.03 points to -14.61% since the last public note. The latest capture fell 2.56% to .78, 0.40% below VWAP in the lower part of its range on 0.12 times average volume, with decelerating participation and no confirmed structure. The treatment-demand and insider-purchase case still has longer-window Healthcare-relative support, but current tape shows no renewed follow-through.",
"price": 11.78,
"pct": -14.61,
"return_vs_entry_pct": -14.58,
"return_vs_base_pct": -14.58,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": -2.25,
"session_day": 11,
"reference_price": 13.79,
"reference_text": "$11.78 · -14.58% from $13.79 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": true,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "transcript-entry-fb36814eb372c3dd46029fa76f64c95aa06a8dd21476666cba1ef273ac940623",
"price_as_of": "2026-09-10T14:06:15.609526Z",
"vwap_as_of": null
},
{
"day": 10,
"timestamp": "2026-09-09T22:21:24.090061Z",
"date": "Session 10 · Sep 9, 2026 · 18:21 NASDAQ",
"text": "KURA's tracked loss narrowed from -13.05% to -12.58% since the last public note, even as the latest capture fell 3.43% to .09, below VWAP near the bottom of its range on 1.37x average volume. Its Healthcare-relative lead remains substantial, but accelerating weakness and no confirmed structure leave the treatment-demand thesis without renewed follow-through.",
"price": 12.09,
"pct": -12.58,
"return_vs_entry_pct": -12.33,
"return_vs_base_pct": -12.33,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": 0.4,
"session_day": 10,
"reference_price": 13.79,
"reference_text": "$12.09 · -12.33% from $13.79 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": false,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "",
"price_as_of": "2026-09-09T21:28:21Z",
"vwap_as_of": null
},
{
"day": 10,
"timestamp": "2026-09-09T20:21:12.674492Z",
"date": "Session 10 · Sep 9, 2026 · 16:21 NASDAQ",
"text": "KURA's tracked loss widened 2.06 points to -13.05% as the latest capture fell 3.87% to USD 12.04, 1.42% below VWAP on 0.82x average volume. Its 20-session Healthcare lead remains 21.86 points, but accelerating weakness and no confirmed structure leave the treatment-demand thesis without renewed follow-through.",
"price": 12.035,
"pct": -13.05,
"return_vs_entry_pct": -12.73,
"return_vs_base_pct": -12.73,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": -3.09,
"session_day": 10,
"reference_price": 13.79,
"reference_text": "$12.04 · -12.73% from $13.79 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": false,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "",
"price_as_of": "2026-09-09T19:21:49.561649Z",
"vwap_as_of": null
},
{
"day": 10,
"timestamp": "2026-09-09T14:34:38.262426Z",
"date": "Session 10 · Sep 9, 2026 · 10:34 NASDAQ",
"text": "KURA's tracked loss widened 1.52 points to -10.99% as the latest capture slipped 0.48% to USD 12.46, 0.16% below VWAP on 0.14x average volume, with no confirmed structure. KURA still leads Healthcare by 26.33 points over 20 sessions, keeping the treatment-demand and insider-purchase case specific, but the present tape shows no renewed demand; the continuation thesis remains unproven.",
"price": 12.46,
"pct": -10.99,
"return_vs_entry_pct": -9.64,
"return_vs_base_pct": -9.64,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": -0.43,
"session_day": 10,
"reference_price": 13.79,
"reference_text": "$12.46 · -9.64% from $13.79 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": true,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "transcript-entry-18b2d9479daf01bbfbafa1cc990cb110dcdcd2f3dd3febff528a81de724e2dea",
"price_as_of": "2026-09-09T14:06:47.281893Z",
"vwap_as_of": null
},
{
"day": 9,
"timestamp": "2026-09-08T22:00:29.448100Z",
"date": "Session 9 · Sep 8, 2026 · 18:00 NASDAQ",
"text": "KURA's tracked loss widened 0.72 points to -9.47% as price fell 5.51% to $12.52, moved 1.07% below VWAP and traded at 0.84x average volume. Strong Healthcare-relative performance keeps the treatment-demand question specific, but no confirmed structure or renewed follow-through is visible.",
"price": 12.52,
"pct": -9.47,
"return_vs_entry_pct": -9.21,
"return_vs_base_pct": -9.21,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": -0.76,
"session_day": 9,
"reference_price": 13.79,
"reference_text": "$12.52 · -9.21% from $13.79 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": false,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "",
"price_as_of": "2026-09-08T21:13:23Z",
"vwap_as_of": null
},
{
"day": 9,
"timestamp": "2026-09-08T19:47:47.440697Z",
"date": "Session 9 · Sep 8, 2026 · 15:47 NASDAQ",
"text": "KURA's tracked loss widened 1.05 points to -8.75% as price fell 4.72% to $12.63 and slipped 1.07% below VWAP. Twenty-session Healthcare-relative strength remains +28.67 points, but 0.61x volume, decelerating activity and no confirmed structure leave the treatment-demand case without renewed follow-through.",
"price": 12.625,
"pct": -8.75,
"return_vs_entry_pct": -8.45,
"return_vs_base_pct": -8.45,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": -0.98,
"session_day": 9,
"reference_price": 13.79,
"reference_text": "$12.62 · -8.45% from $13.79 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": false,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "",
"price_as_of": "2026-09-08T19:22:03.550453Z",
"vwap_as_of": null
},
{
"day": 9,
"timestamp": "2026-09-08T14:32:56.297090Z",
"date": "Session 9 · Sep 8, 2026 · 10:32 NASDAQ",
"text": "KURA tracked loss widened 3.51 points to -7.70% at session 9 after the latest capture fell 3.70% to $12.76. Price is only 0.08% above VWAP, while volume is 0.14 times average, dollar volume is 0.11 of its 20-day average and no structure is confirmed; strong twenty-session Healthcare-relative performance keeps the treatment-demand case specific, but this tape shows no renewed demand.",
"price": 12.76,
"pct": -7.7,
"return_vs_entry_pct": -7.47,
"return_vs_base_pct": -7.47,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": -3.55,
"session_day": 9,
"reference_price": 13.79,
"reference_text": "$12.76 · -7.47% from $13.79 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": true,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "transcript-entry-c01e0ddfa072fcd24bb0f9c36d5867f0b6735027f85c7195768a3cdc57e301e1",
"price_as_of": "2026-09-08T14:06:19.550837Z",
"vwap_as_of": null
},
{
"day": 8,
"timestamp": "2026-09-04T22:02:21.741193Z",
"date": "Session 8 · Sep 4, 2026 · 18:02 NASDAQ",
"text": "KURA tracked loss narrowed 0.22 points to -4.19% as the latest capture rose 0.76% to $13.25 and held 1.22% above VWAP near the top of its range. Healthcare-relative strength keeps the treatment-adoption question alive, but 0.72 times average volume and no confirmed structure mean the improvement is not yet continuation.",
"price": 13.25,
"pct": -4.19,
"return_vs_entry_pct": -3.92,
"return_vs_base_pct": -3.92,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": 0.22,
"session_day": 8,
"reference_price": 13.79,
"reference_text": "$13.25 · -3.92% from $13.79 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": false,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "",
"price_as_of": "2026-09-04T21:27:38Z",
"vwap_as_of": null
},
{
"day": 8,
"timestamp": "2026-09-04T20:02:39.091485Z",
"date": "Session 8 · Sep 4, 2026 · 16:02 NASDAQ",
"text": "KURA tracked loss narrowed 0.95 points to -4.41% as the latest capture rose 0.52% to $13.22 and held 0.98% above VWAP near the top of its range. Strong Healthcare-relative performance keeps the treatment-adoption question alive, but volume is 0.47 times average, money flow is neutral and no confirmed structure is recorded; continuation remains unproven.",
"price": 13.2185,
"pct": -4.41,
"return_vs_entry_pct": -4.14,
"return_vs_base_pct": -4.14,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": 1.19,
"session_day": 8,
"reference_price": 13.79,
"reference_text": "$13.22 · -4.14% from $13.79 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": false,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "",
"price_as_of": "2026-09-04T19:21:46.989147Z",
"vwap_as_of": null
},
{
"day": 8,
"timestamp": "2026-09-04T14:53:58.205607Z",
"date": "Session 8 · Sep 4, 2026 · 10:53 NASDAQ",
"text": "KURA's tracked loss narrowed 0.42 points to -5.36% even as the latest capture slipped 0.72% to $13.06; it remains 0.50% above VWAP around 65% of the range, but volume is only 0.10 times average. Strong Healthcare-relative performance keeps the treatment-adoption question alive, yet the absence of participation and confirmed structure leaves continuation unproven.",
"price": 13.055,
"pct": -5.36,
"return_vs_entry_pct": -5.33,
"return_vs_base_pct": -5.33,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": 0.11,
"session_day": 8,
"reference_price": 13.79,
"reference_text": "$13.05 · -5.33% from $13.79 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": false,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "",
"price_as_of": "2026-09-04T14:06:17.385242Z",
"vwap_as_of": null
},
{
"day": 7,
"timestamp": "2026-09-03T20:16:41.591302Z",
"date": "Session 7 · Sep 3, 2026 · 16:16 NASDAQ",
"text": "KURA's tracked loss widened 1.08 points to -5.78% as the latest capture slipped 0.53% to $13.04 and moved 0.70% below VWAP. Strong Healthcare-relative performance keeps the treatment-adoption question visible, but fading participation at 0.54 times average volume, a lower-range position and no confirmed structure leave the continuation case unproven.",
"price": 13.04,
"pct": -5.78,
"return_vs_entry_pct": -5.44,
"return_vs_base_pct": -5.44,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": -0.36,
"session_day": 7,
"reference_price": 13.79,
"reference_text": "$13.04 · -5.44% from $13.79 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": false,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "",
"price_as_of": "2026-09-03T19:21:52.173032Z",
"vwap_as_of": null
},
{
"day": 7,
"timestamp": "2026-09-03T14:55:05.360058Z",
"date": "Session 7 · Sep 3, 2026 · 10:55 NASDAQ",
"text": "KURA's tracked loss improved 0.51 points to -4.70% in the latest capture, even as price slipped 0.15% to 13.09 and held 1.08% above VWAP near the middle of the range on only 0.08 times average volume. The insider-and-treatment case has partly repaired in price and long-window Healthcare-relative performance is strong, but participation is fading and no structure is confirmed; continued demand remains unproven.",
"price": 13.09,
"pct": -4.7,
"return_vs_entry_pct": -5.08,
"return_vs_base_pct": -5.08,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": -0.15,
"session_day": 7,
"reference_price": 13.79,
"reference_text": "$13.09 · -5.08% from $13.79 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": false,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "",
"price_as_of": "2026-09-03T14:06:17.841920Z",
"vwap_as_of": null
},
{
"day": 6,
"timestamp": "2026-09-02T22:01:43.753827Z",
"date": "Session 6 · Sep 2, 2026 · 18:01 NASDAQ",
"text": "KURA's tracked loss narrowed 2.09 points to -5.21% after the latest capture rose 1.71% to $13.11. Price is 1.08% above VWAP in the middle of the range on 1.03 times average volume, while participation is fading and no confirmed structure has formed; the insider-and-treatment case has partly repaired in price, but continued demand remains unproven.",
"price": 13.11,
"pct": -5.21,
"return_vs_entry_pct": -4.93,
"return_vs_base_pct": -4.93,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": 1.38,
"session_day": 6,
"reference_price": 13.79,
"reference_text": "$13.11 · -4.93% from $13.79 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": true,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "transcript-entry-2da4829c97ac17506c8ddbe3bd3896c3a814f74f1807b41d8b5e489a6eae3338",
"price_as_of": "2026-09-02T21:18:14Z",
"vwap_as_of": null
},
{
"day": 6,
"timestamp": "2026-09-02T16:09:31.749470Z",
"date": "Session 6 · Sep 2, 2026 · 12:09 NASDAQ",
"text": "KURA tracked loss widened 0.50 points to -7.30% despite a 0.23% rise to 12.92. Price is 1.45% below VWAP near the range floor on 0.22 times average volume, with no confirmed structure; strong Healthcare-relative performance remains supportive, but the insider-and-demand thesis has not repaired in the current tape.",
"price": 12.92,
"pct": -7.3,
"return_vs_entry_pct": -6.31,
"return_vs_base_pct": -6.31,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": 0.22,
"session_day": 6,
"reference_price": 13.79,
"reference_text": "$12.92 · -6.31% from $13.79 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": false,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "",
"price_as_of": "2026-09-02T14:44:54.049824Z",
"vwap_as_of": null
},
{
"day": 5,
"timestamp": "2026-09-01T22:11:52.835171Z",
"date": "Session 5 · Sep 1, 2026 · 18:11 NASDAQ",
"text": "KURA's tracked loss remains -6.80% as the latest capture rose 1.90% to $12.89. Price is 1.26% above VWAP near the top of its range, but participation is 0.82x average and decelerating, RSI is 71.98 and no confirmed structure has formed; supportive Healthcare context helps, yet treatment-adoption follow-through remains unproven.",
"price": 12.89,
"pct": -6.8,
"return_vs_entry_pct": -6.53,
"return_vs_base_pct": -6.53,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": 0.14,
"session_day": 5,
"reference_price": 13.79,
"reference_text": "$12.89 · -6.53% from $13.79 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": false,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "",
"price_as_of": "2026-09-01T21:40:15Z",
"vwap_as_of": null
},
{
"day": 5,
"timestamp": "2026-09-01T21:05:59.051947Z",
"date": "Session 5 · Sep 1, 2026 · 17:05 NASDAQ",
"text": "KURA's tracked loss narrowed 1.96 points to -6.72% as the capture rose 1.74% and held 1.22% above VWAP near the range top. Supportive Healthcare context and bullish EMA alignment help, but RSI 71.9, only 0.46x average volume, decelerating participation, neutral flow and no confirmed structure leave treatment-adoption follow-through unproven.",
"price": 12.87,
"pct": -6.8,
"return_vs_entry_pct": -6.67,
"return_vs_base_pct": -6.67,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": 1.89,
"session_day": 5,
"reference_price": 13.79,
"reference_text": "$12.87 · -6.67% from $13.79 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": false,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "",
"price_as_of": "2026-09-01T19:21:29.772075Z",
"vwap_as_of": null
},
{
"day": 5,
"timestamp": "2026-09-01T16:18:26.867697Z",
"date": "Session 5 · Sep 1, 2026 · 12:18 NASDAQ",
"text": "KURA's tracked loss widened 0.15 points to -8.68% as the current capture eased 0.32%, though price remained 0.56% above VWAP in the upper part of its range. Supportive Healthcare context and healthy EMAs remain, but 0.10x average volume, neutral flow, decelerating participation and no confirmed structure leave treatment-adoption follow-through unproven.",
"price": 12.61,
"pct": -8.68,
"return_vs_entry_pct": -8.56,
"return_vs_base_pct": -8.56,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": -0.29,
"session_day": 5,
"reference_price": 13.79,
"reference_text": "$12.61 · -8.56% from $13.79 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": false,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "",
"price_as_of": "2026-09-01T14:13:30.142689Z",
"vwap_as_of": null
},
{
"day": 4,
"timestamp": "2026-08-31T22:10:08.130356Z",
"date": "Session 4 · Aug 31, 2026 · 18:10 NASDAQ",
"text": "KURA was nearly unchanged at -8.53%, holding 0.17% above VWAP with volume at 1.06x average and a supportive sector backdrop. The stock is still without confirmed structure and the tracked loss remains deep, so treatment-adoption follow-through is not established despite the improved participation.",
"price": 12.65,
"pct": -8.53,
"return_vs_entry_pct": -8.27,
"return_vs_base_pct": -8.27,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": 0.0,
"session_day": 4,
"reference_price": 13.79,
"reference_text": "$12.65 · -8.27% from $13.79 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": false,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "",
"price_as_of": "2026-08-31T21:40:51Z",
"vwap_as_of": null
},
{
"day": 4,
"timestamp": "2026-08-31T20:05:54.687642Z",
"date": "Session 4 · Aug 31, 2026 · 16:05 NASDAQ",
"text": "KURA improved 0.57 points to -8.40%, with price only 0.15% above VWAP around the middle of its range. Healthcare relative strength and a healthy EMA context keep the treatment-demand case alive, but volume is 0.54x average, accumulation is neutral with negative money flow, and no confirmed structure has formed.",
"price": 12.649,
"pct": -8.4,
"return_vs_entry_pct": -8.27,
"return_vs_base_pct": -8.27,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": -0.08,
"session_day": 4,
"reference_price": 13.79,
"reference_text": "$12.65 · -8.27% from $13.79 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": false,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "",
"price_as_of": "2026-08-31T19:21:03.615633Z",
"vwap_as_of": null
},
{
"day": 4,
"timestamp": "2026-08-31T15:00:54.221936Z",
"date": "Session 4 · Aug 31, 2026 · 11:00 NASDAQ",
"text": "KURA stayed at 12.66 while the tracked result slipped to -8.97%; price is only 0.06% above VWAP on 0.15x average volume. The treatment-demand context remains specific, but negative flow and a high-range position keep continuation unproven.",
"price": 12.66,
"pct": -8.97,
"return_vs_entry_pct": -8.19,
"return_vs_base_pct": -8.19,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": 0.0,
"session_day": 4,
"reference_price": 13.79,
"reference_text": "$12.66 · -8.19% from $13.79 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": false,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "",
"price_as_of": "2026-08-31T14:06:24.388513Z",
"vwap_as_of": null
},
{
"day": 3,
"timestamp": "2026-08-29T05:44:23.744442Z",
"date": "Session 3 · Aug 29, 2026 · 01:44 NASDAQ",
"text": "KURA tracked result eased 0.81 points to -8.46% as the current capture fell 3.95% to 12.66 on roughly average volume, with no fresh VWAP reading or confirmed structure. The treatment-demand and insider-purchase signals remain specific context, and the stock still leads Healthcare over 20 sessions at +41.57% versus +4.93%, but negative money flow and a 91.1% position in the 52-week range keep continuation unproven.",
"price": 12.66,
"pct": -8.46,
"return_vs_entry_pct": -8.19,
"return_vs_base_pct": -8.19,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": -1.01,
"session_day": 3,
"reference_price": 13.79,
"reference_text": "$12.66 · -8.19% from $13.79 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": true,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "transcript-entry-04bc6c0226fc08e2267537a394ce7cb8e2c00cd45b6ab7e9403b76cfa36f8ef7",
"price_as_of": "2026-08-29T05:01:43.976820Z",
"vwap_as_of": null
},
{
"day": 3,
"timestamp": "2026-08-28T15:29:01.233907Z",
"date": "Session 3 · Aug 28, 2026 · 11:29 NASDAQ",
"text": "KURA's tracked result worsened 2.95 points to -7.65% as the capture fell 2.88% to 12.80, 1.25% below VWAP on 0.14x average volume. The treatment-adoption and insider-purchase signal remains a specific thesis, but the current loss of structure and fading participation leave follow-through unresolved.",
"price": 12.8,
"pct": -7.65,
"return_vs_entry_pct": -7.18,
"return_vs_base_pct": -7.18,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": -2.76,
"session_day": 3,
"reference_price": 13.79,
"reference_text": "$12.80 · -7.18% from $13.79 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": false,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "",
"price_as_of": "2026-08-28T14:07:04.955352Z",
"vwap_as_of": null
},
{
"day": 2,
"timestamp": "2026-08-27T21:54:05.066659Z",
"date": "Session 2 · Aug 27, 2026 · 17:54 NASDAQ",
"text": "KURA's tracked result worsened 1.08 points to -4.70% even as price rose 0.92% to 13.18, 0.19% above VWAP. The treatment-demand and insider-purchase case retains a narrow price hold, but decelerating flow, neutral accumulation and a 2.02-ATR extension leave follow-through unresolved.",
"price": 13.18,
"pct": -4.7,
"return_vs_entry_pct": -4.42,
"return_vs_base_pct": -4.42,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": -0.87,
"session_day": 2,
"reference_price": 13.79,
"reference_text": "$13.18 · -4.42% from $13.79 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": false,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "",
"price_as_of": "2026-08-27T21:12:55Z",
"vwap_as_of": null
},
{
"day": 2,
"timestamp": "2026-08-27T20:00:57.897256Z",
"date": "Session 2 · Aug 27, 2026 · 16:00 NASDAQ",
"text": "KURA's tracked result improved 1.30 points to -3.62%, and today's capture rose 1.84% to 13.30, 1.33% above VWAP near the top of its range. The treatment-demand and insider-purchase case has a better price test, but neutral flow, 0.83 times average participation and a 2.15 ATR extension leave follow-through unresolved.",
"price": 13.3,
"pct": -3.62,
"return_vs_entry_pct": -3.55,
"return_vs_base_pct": -3.55,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": 1.53,
"session_day": 2,
"reference_price": 13.79,
"reference_text": "$13.30 · -3.55% from $13.79 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": false,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "",
"price_as_of": "2026-08-27T19:33:09.484369Z",
"vwap_as_of": null
},
{
"day": 2,
"timestamp": "2026-08-27T14:51:59.547458Z",
"date": "Session 2 · Aug 27, 2026 · 10:51 NASDAQ",
"text": "KURA's tracked result improved 0.65 points to -4.92%, and today's capture rose 0.23% while holding 0.23% above VWAP at 13.06. The treatment-demand and insider-purchase case remains specific, but neutral flow and no confirmed structure leave follow-through unresolved.",
"price": 13.09,
"pct": -4.92,
"return_vs_entry_pct": -5.08,
"return_vs_base_pct": -5.08,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": 0.21,
"session_day": 2,
"reference_price": 13.79,
"reference_text": "$13.09 · -5.08% from $13.79 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": false,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "",
"price_as_of": "2026-08-27T14:06:46.334429Z",
"vwap_as_of": null
},
{
"day": 1,
"timestamp": "2026-08-26T21:47:55.006642Z",
"date": "Session 1 · Aug 26, 2026 · 17:47 NASDAQ",
"text": "KURA's tracked result fell 0.87 points to -5.57% as the latest capture dropped 3.90% and sat 1.27% below VWAP near the bottom 10% of its range, despite 1.49 times average participation. Decelerating flow and neutral money flow mean the treatment-demand and insider-purchase case still lacks direct follow-through, even with a 41.86-point Healthcare edge.",
"price": 13.06,
"pct": -5.57,
"return_vs_entry_pct": -5.29,
"return_vs_base_pct": -5.29,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": -0.83,
"session_day": 1,
"reference_price": 13.79,
"reference_text": "$13.06 · -5.29% from $13.79 base",
"timing": "",
"market_marker": {
"phase": "post",
"text": "Aftermarket update: $13.19 (+1.00% vs regular close) · Aug 26, 2026 · 17:25 NASDAQ"
},
"extended_hours": {
"phase": "post",
"price": 13.19,
"ext_pct": 1.0,
"as_of": "2026-08-26T21:25:01Z",
"persisted": false
},
"relevant": false,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "",
"price_as_of": "2026-08-26T21:25:01Z",
"vwap_as_of": null
},
{
"day": 1,
"timestamp": "2026-08-26T19:40:00Z",
"date": "Session 1 · Aug 26, 2026 · 15:40 NASDAQ",
"text": "KURA's tracked result fell 1.19 points to -4.70% as the first follow-up capture dropped 3.05% and sat below VWAP in the lower part of its range on 1.04 times average participation with fading flow. The treatment-demand and insider-purchase case remains specific, but healthcare-relative strength cannot replace the absent direct follow-through from the initial thesis.",
"price": 13.175,
"pct": -4.7,
"return_vs_entry_pct": -4.46,
"return_vs_base_pct": -4.46,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": -0.47,
"session_day": 1,
"reference_price": 13.79,
"reference_text": "$13.18 · -4.46% from $13.79 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": false,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "",
"price_as_of": "2026-08-26T19:21:32.845331Z",
"vwap_as_of": null
},
{
"day": 1,
"timestamp": "2026-08-26T14:40:52.704122Z",
"date": "Session 1 · Aug 26, 2026 · 10:40 NASDAQ",
"text": "KURA's tracked result fell 1.77 points to -3.51% as the first follow-up capture dropped 2.58% below VWAP on 0.27 times average volume. The treatment-demand and insider-purchase case remains specific, with Healthcare-relative performance 43.15 points ahead, but RSI at 81.43, a 2.30-ATR extension and fading flow leave the initial thesis without direct follow-through.",
"price": 13.24,
"pct": -3.51,
"return_vs_entry_pct": -3.99,
"return_vs_base_pct": -3.99,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": -2.54,
"session_day": 1,
"reference_price": 13.79,
"reference_text": "$13.24 · -3.99% from $13.79 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": true,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "transcript-entry-3fd7d23ffefe58534fb59f855725d879fc84dfcf04c48e111b29b786f7d8d9e9",
"price_as_of": "2026-08-26T14:08:15.387867Z",
"vwap_as_of": null
},
{
"day": 0,
"timestamp": "2026-08-25T21:57:02.522139Z",
"date": "Session 0 · Aug 25, 2026 · 17:57 NASDAQ",
"text": "KURA rose 9.60% in the current capture and sits 0.52% above VWAP on 3.02 times average volume, with strong Healthcare-relative performance. The treatment-demand and insider-purchase signals give the move a specific thesis, but RSI at 86.40, a 3.04-ATR extension and decelerating flow near the high leave direct follow-through unproven.",
"price": 13.59,
"pct": -1.74,
"return_vs_entry_pct": -1.45,
"return_vs_base_pct": -1.45,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": -0.87,
"session_day": 0,
"reference_price": 13.79,
"reference_text": "$13.59 · -1.45% from $13.79 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": false,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "",
"price_as_of": "2026-08-25T21:25:59Z",
"vwap_as_of": null
},
{
"day": 0,
"timestamp": "2026-08-25T19:59:51.167561Z",
"date": "Session 0 · Aug 25, 2026 · 15:59 NASDAQ",
"text": "KURA gained 10.56% in the current capture and sits 1.78% above the session average on 2.29 times average volume, with strong Healthcare-relative performance. The treatment-demand and insider-purchase signals give the move a specific thesis, but flow is decelerating, RSI is 86.67 and the move is 3.16 ATR extended near its high; direct follow-through remains unproven.",
"price": 13.71,
"pct": -1.41,
"return_vs_entry_pct": -0.58,
"return_vs_base_pct": -0.58,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": -0.58,
"session_day": 0,
"reference_price": 13.79,
"reference_text": "$13.71 · -0.58% from $13.79 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": false,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "",
"price_as_of": "2026-08-25T19:21:23.301842Z",
"vwap_as_of": null
}
],
"observed_outcomes": [
{
"label": "+1 sessions",
"status": "complete",
"return": -5.57,
"reference_text": "-5.57% from $13.79 base",
"price": 13.06,
"updated": "Aug 26, 2026 · 17:06 NASDAQ",
"mfe": -1.23,
"mae": -6.11
},
{
"label": "+5 sessions",
"status": "complete",
"return": -6.8,
"reference_text": "-6.80% from $13.79 base",
"price": 12.89,
"updated": "Sep 1, 2026 · 17:06 NASDAQ",
"mfe": -1.23,
"mae": -10.11
},
{
"label": "+10 sessions",
"status": "complete",
"return": -12.58,
"reference_text": "-12.58% from $13.79 base",
"price": 12.09,
"updated": "Sep 9, 2026 · 17:05 NASDAQ",
"mfe": -1.23,
"mae": -13.3
},
{
"label": "+15 sessions",
"status": "complete",
"return": -19.02,
"reference_text": "-19.02% from $13.79 base",
"price": 11.2,
"updated": "Sep 16, 2026 · 17:05 NASDAQ",
"mfe": -1.23,
"mae": -20.28
}
],
"candidate_comparison_history": [
{
"day": 0,
"timestamp": "2026-08-25T19:59:51.167561Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-08-25T19:59:51.167561Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "KURA",
"role": "selected",
"price": 13.71,
"base_price": 13.79,
"return_since_base_pct": -0.5801,
"session_return_pct": 10.56,
"change_since_prior_pct": 0.1461,
"volume_ratio": 2.29,
"rsi": 86.67,
"vwap": 13.47,
"vwap_distance_pct": 1.7817,
"position_52w_pct": 98.6,
"extended_hours_pct": null,
"as_of": "2026-08-25T19:21:23.301842Z",
"source": "yfinance_quote",
"name": "Kura Oncology, Inc.",
"episode_id": "n0:KURA:2026-08-25",
"ema_trend": "11.97 > 11.15 > 10.58",
"vwap_state": "above",
"price_as_of": "2026-08-25T19:21:23.301842Z",
"vwap_as_of": null
},
{
"symbol": "CRML",
"role": "alternative",
"price": 7.8416,
"base_price": 7.865,
"return_since_base_pct": -0.2975,
"session_return_pct": 17.5563,
"change_since_prior_pct": -0.3647,
"volume_ratio": null,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T19:50:14Z",
"source": "yfinance_quote",
"name": "Critical Metals Corp.",
"episode_id": "n0:CRML:2026-08-25",
"price_as_of": "2026-08-25T19:50:14Z",
"vwap_as_of": null
},
{
"symbol": "LEU",
"role": "alternative",
"price": 192.8,
"base_price": 184.29,
"return_since_base_pct": 4.6177,
"session_return_pct": 8.8405,
"change_since_prior_pct": 1.5753,
"volume_ratio": null,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T19:50:17Z",
"source": "yfinance_quote",
"name": "Centrus Energy Corp.",
"episode_id": "narrative:LEU:d551ea7899e32218",
"price_as_of": "2026-08-25T19:50:17Z",
"vwap_as_of": null
},
{
"symbol": "GENB",
"role": "alternative",
"price": 19.75,
"base_price": 20.96,
"return_since_base_pct": -5.7729,
"session_return_pct": 11.456,
"change_since_prior_pct": 0.2538,
"volume_ratio": null,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T19:50:07Z",
"source": "yfinance_quote",
"name": "Generate Biomedicines, Inc.",
"episode_id": "n0:GENB:2026-08-25",
"price_as_of": "2026-08-25T19:50:07Z",
"vwap_as_of": null
},
{
"symbol": "MRK",
"role": "alternative",
"price": 156.46,
"base_price": 154.5,
"return_since_base_pct": 1.2686,
"session_return_pct": 3.8497,
"change_since_prior_pct": 0.2981,
"volume_ratio": null,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T19:50:27Z",
"source": "yfinance_quote",
"name": "Merck & Co., Inc.",
"episode_id": "narrative:MRK:5a78131dec6b3a0e",
"price_as_of": "2026-08-25T19:50:27Z",
"vwap_as_of": null
}
],
"benchmarks": [],
"coverage": {
"candidate_rows": 5,
"candidate_prices": 5,
"candidate_technical": 1,
"benchmark_rows": 0
}
}
},
{
"day": 0,
"timestamp": "2026-08-25T21:57:02.522139Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-08-25T21:57:02.522139Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "KURA",
"role": "selected",
"price": 13.73,
"base_price": 13.79,
"return_since_base_pct": -0.4351,
"session_return_pct": 9.6,
"change_since_prior_pct": 0.1459,
"volume_ratio": 3.02,
"rsi": 86.4,
"vwap": 13.48,
"vwap_distance_pct": 1.8546,
"position_52w_pct": 97.8,
"extended_hours_pct": 1.01,
"as_of": "2026-08-25T21:25:59Z",
"source": "sealed_extended_quote",
"name": "Kura Oncology, Inc.",
"episode_id": "n0:KURA:2026-08-25",
"ema_trend": "11.94 > 11.13 > 10.57",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:58.818200Z",
"facts": [
"KURA gained 11.21%, with a 1.42x volume ratio, an 85.7 volume percentile and +10.76% relative strength versus QQQ.",
"The sealed catalyst package includes a reported $1.24 million CEO stock purchase, 57% KOMZIFTI revenue growth and 35% growth in new patient starts.",
"The captured intraday view showed KURA above VWAP and up, with an intraday range position of 0.998."
],
"benchmark_excess_pct": {
"sp500": 9.2809,
"nasdaq100": 8.959,
"russell2000": 9.8601
},
"price_as_of": "2026-08-25T21:25:59Z",
"vwap_as_of": null
},
{
"symbol": "CRML",
"role": "alternative",
"price": 8.4469,
"base_price": 7.955,
"return_since_base_pct": 6.1835,
"session_return_pct": 4.2827,
"change_since_prior_pct": 7.7191,
"volume_ratio": 1.64,
"rsi": 61.49,
"vwap": 7.6,
"vwap_distance_pct": 11.1434,
"position_52w_pct": 24.71,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:20:04Z",
"source": "yfinance_quote",
"name": "Critical Metals Corp.",
"episode_id": "n0:CRML:2026-08-25",
"ema_trend": "6.8 > 6.75 > 7.63",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:50.354399Z",
"facts": [
"CRML gained 19.27% with +18.82% relative strength versus QQQ and a 1.64x volume ratio.",
"The rare-earth and European lithium merger narrative had no company announcement in the secondary news packet.",
"Short interest was 29.37% and the move was 1.98 ATR above the EMA reference."
],
"benchmark_excess_pct": {
"sp500": 3.9636,
"nasdaq100": 3.6417,
"russell2000": 4.5428
},
"price_as_of": "2026-08-25T21:20:04Z",
"vwap_as_of": null
},
{
"symbol": "LEU",
"role": "alternative",
"price": 193.0,
"base_price": 184.29,
"return_since_base_pct": 4.7262,
"session_return_pct": -0.2017,
"change_since_prior_pct": 0.1037,
"volume_ratio": null,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:17:47Z",
"source": "yfinance_quote",
"name": "Centrus Energy Corp.",
"episode_id": "narrative:LEU:d551ea7899e32218",
"facts": [
"LEU was above VWAP and up, with a 0.963 intraday range position and a +5.44% relative-strength reading versus QQQ.",
"The sealed catalyst package connected X-Energy, Ohio and federal attention to domestic fuel and energy-security activity.",
"Volume ratio was only 0.29x, while the quoted options spread was 11.36%."
],
"benchmark_excess_pct": {
"sp500": -0.5208,
"nasdaq100": -0.8427,
"russell2000": 0.0584
},
"price_as_of": "2026-08-25T21:17:47Z",
"vwap_as_of": null
},
{
"symbol": "GENB",
"role": "alternative",
"price": 20.11,
"base_price": 20.869,
"return_since_base_pct": -3.637,
"session_return_pct": -1.3248,
"change_since_prior_pct": 1.8228,
"volume_ratio": 3.06,
"rsi": 80.02,
"vwap": 20.73,
"vwap_distance_pct": -2.9908,
"position_52w_pct": 91.84,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:12:46Z",
"source": "yfinance_quote",
"name": "Generate Biomedicines, Inc.",
"episode_id": "n0:GENB:2026-08-25",
"ema_trend": "17.05 > 15.86 > 15.0",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:23.027806Z",
"facts": [
"GENB gained 17.77% with a 3.06x volume ratio and +17.32% relative strength versus QQQ.",
"The sealed options snapshot was unavailable.",
"The catalyst was not a direct issuer-specific event in the corrected evidence."
],
"benchmark_excess_pct": {
"sp500": -1.6439,
"nasdaq100": -1.9658,
"russell2000": -1.0647
},
"price_as_of": "2026-08-25T21:12:46Z",
"vwap_as_of": null
},
{
"symbol": "MRK",
"role": "alternative",
"price": 156.38,
"base_price": 154.5,
"return_since_base_pct": 1.2168,
"session_return_pct": -0.0447,
"change_since_prior_pct": -0.0511,
"volume_ratio": null,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:20:21Z",
"source": "yfinance_quote",
"name": "Merck & Co., Inc.",
"episode_id": "narrative:MRK:5a78131dec6b3a0e",
"facts": [
"MRK gained 2.80%, traded above VWAP and up, and showed a 0.938 intraday range position.",
"The sealed catalyst related to a Moderna cancer-vaccine and melanoma partnership.",
"RSI was 83.74, the move was 3.53 ATR above the EMA reference, and volume ratio was 0.48x."
],
"benchmark_excess_pct": {
"sp500": -0.3638,
"nasdaq100": -0.6857,
"russell2000": 0.2154
},
"price_as_of": "2026-08-25T21:20:21Z",
"vwap_as_of": null
}
],
"benchmarks": [
{
"id": "sp500",
"symbol": "^GSPC",
"label": "S&P 500",
"role": "benchmark",
"price": 7677.28,
"base_price": 7652.86,
"return_since_base_pct": 0.3191,
"session_return_pct": 0.3191,
"as_of": "2026-08-25T21:57:02.194815Z",
"source": "yfinance.ticker_info",
"base_definition": "previous regular close"
},
{
"id": "nasdaq100",
"symbol": "^NDX",
"label": "Nasdaq 100",
"role": "benchmark",
"price": 29209.229,
"base_price": 29023.182,
"return_since_base_pct": 0.641,
"session_return_pct": 0.641,
"as_of": "2026-08-25T21:57:02.194815Z",
"source": "yfinance.ticker_info",
"base_definition": "previous regular close"
},
{
"id": "russell2000",
"symbol": "^RUT",
"label": "Russell 2000",
"role": "benchmark",
"price": 3010.0217,
"base_price": 3017.87,
"return_since_base_pct": -0.2601,
"session_return_pct": -0.2601,
"as_of": "2026-08-25T21:57:02.194815Z",
"source": "yfinance.ticker_info",
"base_definition": "previous regular close"
}
],
"coverage": {
"candidate_rows": 5,
"candidate_prices": 5,
"candidate_technical": 3,
"benchmark_rows": 3
}
}
},
{
"day": 1,
"timestamp": "2026-08-26T14:40:52.704122Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-08-26T14:40:52.704122Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "KURA",
"role": "selected",
"price": 13.24,
"base_price": 13.79,
"return_since_base_pct": -3.9884,
"session_return_pct": -2.58,
"change_since_prior_pct": -3.5688,
"volume_ratio": 0.27,
"rsi": 81.43,
"vwap": 13.29,
"vwap_distance_pct": -0.3762,
"position_52w_pct": 95.3,
"extended_hours_pct": null,
"as_of": "2026-08-26T14:08:15.387867Z",
"source": "yfinance_quote",
"name": "Kura Oncology, Inc.",
"episode_id": "n0:KURA:2026-08-25",
"ema_trend": "12.2 > 11.33 > 10.68",
"vwap_state": "below",
"selection_as_of": "2026-08-25T15:15:58.818200Z",
"facts": [
"KURA gained 11.21%, with a 1.42x volume ratio, an 85.7 volume percentile and +10.76% relative strength versus QQQ.",
"The sealed catalyst package includes a reported $1.24 million CEO stock purchase, 57% KOMZIFTI revenue growth and 35% growth in new patient starts.",
"The captured intraday view showed KURA above VWAP and up, with an intraday range position of 0.998."
],
"price_as_of": "2026-08-26T14:08:15.387867Z",
"vwap_as_of": null
},
{
"symbol": "CRML",
"role": "alternative",
"price": 8.4469,
"base_price": 7.955,
"return_since_base_pct": 6.1835,
"session_return_pct": 4.2827,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.64,
"rsi": 61.49,
"vwap": 7.6,
"vwap_distance_pct": 11.1434,
"position_52w_pct": 24.71,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:20:04Z",
"source": "yfinance_quote",
"name": "Critical Metals Corp.",
"episode_id": "n0:CRML:2026-08-25",
"ema_trend": "6.8 > 6.75 > 7.63",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:50.354399Z",
"facts": [
"CRML gained 19.27% with +18.82% relative strength versus QQQ and a 1.64x volume ratio.",
"The rare-earth and European lithium merger narrative had no company announcement in the secondary news packet.",
"Short interest was 29.37% and the move was 1.98 ATR above the EMA reference."
],
"price_as_of": "2026-08-25T21:20:04Z",
"vwap_as_of": null
},
{
"symbol": "LEU",
"role": "alternative",
"price": 193.0,
"base_price": 184.29,
"return_since_base_pct": 4.7262,
"session_return_pct": -0.2017,
"change_since_prior_pct": 0.0,
"volume_ratio": null,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:17:47Z",
"source": "yfinance_quote",
"name": "Centrus Energy Corp.",
"episode_id": "narrative:LEU:d551ea7899e32218",
"facts": [
"LEU was above VWAP and up, with a 0.963 intraday range position and a +5.44% relative-strength reading versus QQQ.",
"The sealed catalyst package connected X-Energy, Ohio and federal attention to domestic fuel and energy-security activity.",
"Volume ratio was only 0.29x, while the quoted options spread was 11.36%."
],
"price_as_of": "2026-08-25T21:17:47Z",
"vwap_as_of": null
},
{
"symbol": "GENB",
"role": "alternative",
"price": 20.11,
"base_price": 20.869,
"return_since_base_pct": -3.637,
"session_return_pct": -1.3248,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.06,
"rsi": 80.02,
"vwap": 20.73,
"vwap_distance_pct": -2.9908,
"position_52w_pct": 91.84,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:12:46Z",
"source": "yfinance_quote",
"name": "Generate Biomedicines, Inc.",
"episode_id": "n0:GENB:2026-08-25",
"ema_trend": "17.05 > 15.86 > 15.0",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:23.027806Z",
"facts": [
"GENB gained 17.77% with a 3.06x volume ratio and +17.32% relative strength versus QQQ.",
"The sealed options snapshot was unavailable.",
"The catalyst was not a direct issuer-specific event in the corrected evidence."
],
"price_as_of": "2026-08-25T21:12:46Z",
"vwap_as_of": null
},
{
"symbol": "MRK",
"role": "alternative",
"price": 156.38,
"base_price": 154.5,
"return_since_base_pct": 1.2168,
"session_return_pct": -0.0447,
"change_since_prior_pct": 0.0,
"volume_ratio": null,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:20:21Z",
"source": "yfinance_quote",
"name": "Merck & Co., Inc.",
"episode_id": "narrative:MRK:5a78131dec6b3a0e",
"facts": [
"MRK gained 2.80%, traded above VWAP and up, and showed a 0.938 intraday range position.",
"The sealed catalyst related to a Moderna cancer-vaccine and melanoma partnership.",
"RSI was 83.74, the move was 3.53 ATR above the EMA reference, and volume ratio was 0.48x."
],
"price_as_of": "2026-08-25T21:20:21Z",
"vwap_as_of": null
}
],
"benchmarks": [],
"coverage": {
"candidate_rows": 5,
"candidate_prices": 5,
"candidate_technical": 3,
"benchmark_rows": 0
}
}
},
{
"day": 1,
"timestamp": "2026-08-26T19:40:00Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-08-26T19:40:00Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "KURA",
"role": "selected",
"price": 13.175,
"base_price": 13.79,
"return_since_base_pct": -4.4598,
"session_return_pct": -3.05,
"change_since_prior_pct": -0.4909,
"volume_ratio": 0.99,
"rsi": 80.6,
"vwap": 13.24,
"vwap_distance_pct": -0.4909,
"position_52w_pct": 94.8,
"extended_hours_pct": null,
"as_of": "2026-08-26T19:21:32.845331Z",
"source": "yfinance_quote",
"name": "Kura Oncology, Inc.",
"episode_id": "n0:KURA:2026-08-25",
"ema_trend": "12.19 > 11.32 > 10.68",
"vwap_state": "below",
"selection_as_of": "2026-08-25T15:15:58.818200Z",
"facts": [
"KURA gained 11.21%, with a 1.42x volume ratio, an 85.7 volume percentile and +10.76% relative strength versus QQQ.",
"The sealed catalyst package includes a reported $1.24 million CEO stock purchase, 57% KOMZIFTI revenue growth and 35% growth in new patient starts.",
"The captured intraday view showed KURA above VWAP and up, with an intraday range position of 0.998."
],
"price_as_of": "2026-08-26T19:21:32.845331Z",
"vwap_as_of": null
},
{
"symbol": "CRML",
"role": "alternative",
"price": 8.4469,
"base_price": 7.955,
"return_since_base_pct": 6.1835,
"session_return_pct": 4.2827,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.64,
"rsi": 61.49,
"vwap": 7.6,
"vwap_distance_pct": 11.1434,
"position_52w_pct": 24.71,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:20:04Z",
"source": "yfinance_quote",
"name": "Critical Metals Corp.",
"episode_id": "n0:CRML:2026-08-25",
"ema_trend": "6.8 > 6.75 > 7.63",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:50.354399Z",
"facts": [
"CRML gained 19.27% with +18.82% relative strength versus QQQ and a 1.64x volume ratio.",
"The rare-earth and European lithium merger narrative had no company announcement in the secondary news packet.",
"Short interest was 29.37% and the move was 1.98 ATR above the EMA reference."
],
"price_as_of": "2026-08-25T21:20:04Z",
"vwap_as_of": null
},
{
"symbol": "LEU",
"role": "alternative",
"price": 193.0,
"base_price": 184.29,
"return_since_base_pct": 4.7262,
"session_return_pct": -0.2017,
"change_since_prior_pct": 0.0,
"volume_ratio": null,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:17:47Z",
"source": "yfinance_quote",
"name": "Centrus Energy Corp.",
"episode_id": "narrative:LEU:d551ea7899e32218",
"facts": [
"LEU was above VWAP and up, with a 0.963 intraday range position and a +5.44% relative-strength reading versus QQQ.",
"The sealed catalyst package connected X-Energy, Ohio and federal attention to domestic fuel and energy-security activity.",
"Volume ratio was only 0.29x, while the quoted options spread was 11.36%."
],
"price_as_of": "2026-08-25T21:17:47Z",
"vwap_as_of": null
},
{
"symbol": "GENB",
"role": "alternative",
"price": 20.11,
"base_price": 20.869,
"return_since_base_pct": -3.637,
"session_return_pct": -1.3248,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.06,
"rsi": 80.02,
"vwap": 20.73,
"vwap_distance_pct": -2.9908,
"position_52w_pct": 91.84,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:12:46Z",
"source": "yfinance_quote",
"name": "Generate Biomedicines, Inc.",
"episode_id": "n0:GENB:2026-08-25",
"ema_trend": "17.05 > 15.86 > 15.0",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:23.027806Z",
"facts": [
"GENB gained 17.77% with a 3.06x volume ratio and +17.32% relative strength versus QQQ.",
"The sealed options snapshot was unavailable.",
"The catalyst was not a direct issuer-specific event in the corrected evidence."
],
"price_as_of": "2026-08-25T21:12:46Z",
"vwap_as_of": null
},
{
"symbol": "MRK",
"role": "alternative",
"price": 156.38,
"base_price": 154.5,
"return_since_base_pct": 1.2168,
"session_return_pct": -0.0447,
"change_since_prior_pct": 0.0,
"volume_ratio": null,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:20:21Z",
"source": "yfinance_quote",
"name": "Merck & Co., Inc.",
"episode_id": "narrative:MRK:5a78131dec6b3a0e",
"facts": [
"MRK gained 2.80%, traded above VWAP and up, and showed a 0.938 intraday range position.",
"The sealed catalyst related to a Moderna cancer-vaccine and melanoma partnership.",
"RSI was 83.74, the move was 3.53 ATR above the EMA reference, and volume ratio was 0.48x."
],
"price_as_of": "2026-08-25T21:20:21Z",
"vwap_as_of": null
}
],
"benchmarks": [],
"coverage": {
"candidate_rows": 5,
"candidate_prices": 5,
"candidate_technical": 3,
"benchmark_rows": 0
}
}
},
{
"day": 1,
"timestamp": "2026-08-26T21:47:55.006642Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-08-26T21:47:55.006642Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "KURA",
"role": "selected",
"price": 13.19,
"base_price": 13.79,
"return_since_base_pct": -4.351,
"session_return_pct": -3.9,
"change_since_prior_pct": 0.1139,
"volume_ratio": 1.49,
"rsi": 79.17,
"vwap": 13.22,
"vwap_distance_pct": -0.2269,
"position_52w_pct": 94.0,
"extended_hours_pct": 1.0,
"as_of": "2026-08-26T21:25:01Z",
"source": "sealed_extended_quote",
"name": "Kura Oncology, Inc.",
"episode_id": "n0:KURA:2026-08-25",
"ema_trend": "12.17 > 11.31 > 10.67",
"vwap_state": "below",
"selection_as_of": "2026-08-25T15:15:58.818200Z",
"facts": [
"KURA gained 11.21%, with a 1.42x volume ratio, an 85.7 volume percentile and +10.76% relative strength versus QQQ.",
"The sealed catalyst package includes a reported $1.24 million CEO stock purchase, 57% KOMZIFTI revenue growth and 35% growth in new patient starts.",
"The captured intraday view showed KURA above VWAP and up, with an intraday range position of 0.998."
],
"price_as_of": "2026-08-26T21:25:01Z",
"vwap_as_of": null
},
{
"symbol": "CRML",
"role": "alternative",
"price": 8.4469,
"base_price": 7.955,
"return_since_base_pct": 6.1835,
"session_return_pct": 4.2827,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.64,
"rsi": 61.49,
"vwap": 7.6,
"vwap_distance_pct": 11.1434,
"position_52w_pct": 24.71,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:20:04Z",
"source": "yfinance_quote",
"name": "Critical Metals Corp.",
"episode_id": "n0:CRML:2026-08-25",
"ema_trend": "6.8 > 6.75 > 7.63",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:50.354399Z",
"facts": [
"CRML gained 19.27% with +18.82% relative strength versus QQQ and a 1.64x volume ratio.",
"The rare-earth and European lithium merger narrative had no company announcement in the secondary news packet.",
"Short interest was 29.37% and the move was 1.98 ATR above the EMA reference."
],
"price_as_of": "2026-08-25T21:20:04Z",
"vwap_as_of": null
},
{
"symbol": "LEU",
"role": "alternative",
"price": 193.0,
"base_price": 184.29,
"return_since_base_pct": 4.7262,
"session_return_pct": -0.2017,
"change_since_prior_pct": 0.0,
"volume_ratio": null,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:17:47Z",
"source": "yfinance_quote",
"name": "Centrus Energy Corp.",
"episode_id": "narrative:LEU:d551ea7899e32218",
"facts": [
"LEU was above VWAP and up, with a 0.963 intraday range position and a +5.44% relative-strength reading versus QQQ.",
"The sealed catalyst package connected X-Energy, Ohio and federal attention to domestic fuel and energy-security activity.",
"Volume ratio was only 0.29x, while the quoted options spread was 11.36%."
],
"price_as_of": "2026-08-25T21:17:47Z",
"vwap_as_of": null
},
{
"symbol": "GENB",
"role": "alternative",
"price": 20.11,
"base_price": 20.869,
"return_since_base_pct": -3.637,
"session_return_pct": -1.3248,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.06,
"rsi": 80.02,
"vwap": 20.73,
"vwap_distance_pct": -2.9908,
"position_52w_pct": 91.84,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:12:46Z",
"source": "yfinance_quote",
"name": "Generate Biomedicines, Inc.",
"episode_id": "n0:GENB:2026-08-25",
"ema_trend": "17.05 > 15.86 > 15.0",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:23.027806Z",
"facts": [
"GENB gained 17.77% with a 3.06x volume ratio and +17.32% relative strength versus QQQ.",
"The sealed options snapshot was unavailable.",
"The catalyst was not a direct issuer-specific event in the corrected evidence."
],
"price_as_of": "2026-08-25T21:12:46Z",
"vwap_as_of": null
},
{
"symbol": "MRK",
"role": "alternative",
"price": 156.38,
"base_price": 154.5,
"return_since_base_pct": 1.2168,
"session_return_pct": -0.0447,
"change_since_prior_pct": 0.0,
"volume_ratio": null,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:20:21Z",
"source": "yfinance_quote",
"name": "Merck & Co., Inc.",
"episode_id": "narrative:MRK:5a78131dec6b3a0e",
"facts": [
"MRK gained 2.80%, traded above VWAP and up, and showed a 0.938 intraday range position.",
"The sealed catalyst related to a Moderna cancer-vaccine and melanoma partnership.",
"RSI was 83.74, the move was 3.53 ATR above the EMA reference, and volume ratio was 0.48x."
],
"price_as_of": "2026-08-25T21:20:21Z",
"vwap_as_of": null
}
],
"benchmarks": [],
"coverage": {
"candidate_rows": 5,
"candidate_prices": 5,
"candidate_technical": 3,
"benchmark_rows": 0
}
}
},
{
"day": 2,
"timestamp": "2026-08-27T14:51:59.547458Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-08-27T14:51:59.547458Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "KURA",
"role": "selected",
"price": 13.09,
"base_price": 13.79,
"return_since_base_pct": -5.0761,
"session_return_pct": 0.23,
"change_since_prior_pct": -0.7582,
"volume_ratio": 0.14,
"rsi": 78.3,
"vwap": 13.06,
"vwap_distance_pct": 0.2297,
"position_52w_pct": 94.2,
"extended_hours_pct": null,
"as_of": "2026-08-27T14:06:46.334429Z",
"source": "yfinance_quote",
"name": "Kura Oncology, Inc.",
"episode_id": "n0:KURA:2026-08-25",
"ema_trend": "12.35 > 11.47 > 10.77",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:58.818200Z",
"facts": [
"KURA gained 11.21%, with a 1.42x volume ratio, an 85.7 volume percentile and +10.76% relative strength versus QQQ.",
"The sealed catalyst package includes a reported $1.24 million CEO stock purchase, 57% KOMZIFTI revenue growth and 35% growth in new patient starts.",
"The captured intraday view showed KURA above VWAP and up, with an intraday range position of 0.998."
],
"price_as_of": "2026-08-27T14:06:46.334429Z",
"vwap_as_of": null
},
{
"symbol": "CRML",
"role": "alternative",
"price": 8.4469,
"base_price": 7.955,
"return_since_base_pct": 6.1835,
"session_return_pct": 4.2827,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.64,
"rsi": 61.49,
"vwap": 7.6,
"vwap_distance_pct": 11.1434,
"position_52w_pct": 24.71,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:20:04Z",
"source": "yfinance_quote",
"name": "Critical Metals Corp.",
"episode_id": "n0:CRML:2026-08-25",
"ema_trend": "6.8 > 6.75 > 7.63",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:50.354399Z",
"facts": [
"CRML gained 19.27% with +18.82% relative strength versus QQQ and a 1.64x volume ratio.",
"The rare-earth and European lithium merger narrative had no company announcement in the secondary news packet.",
"Short interest was 29.37% and the move was 1.98 ATR above the EMA reference."
],
"price_as_of": "2026-08-25T21:20:04Z",
"vwap_as_of": null
},
{
"symbol": "LEU",
"role": "alternative",
"price": 193.0,
"base_price": 184.29,
"return_since_base_pct": 4.7262,
"session_return_pct": -0.2017,
"change_since_prior_pct": 0.0,
"volume_ratio": null,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:17:47Z",
"source": "yfinance_quote",
"name": "Centrus Energy Corp.",
"episode_id": "narrative:LEU:d551ea7899e32218",
"facts": [
"LEU was above VWAP and up, with a 0.963 intraday range position and a +5.44% relative-strength reading versus QQQ.",
"The sealed catalyst package connected X-Energy, Ohio and federal attention to domestic fuel and energy-security activity.",
"Volume ratio was only 0.29x, while the quoted options spread was 11.36%."
],
"price_as_of": "2026-08-25T21:17:47Z",
"vwap_as_of": null
},
{
"symbol": "GENB",
"role": "alternative",
"price": 20.11,
"base_price": 20.869,
"return_since_base_pct": -3.637,
"session_return_pct": -1.3248,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.06,
"rsi": 80.02,
"vwap": 20.73,
"vwap_distance_pct": -2.9908,
"position_52w_pct": 91.84,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:12:46Z",
"source": "yfinance_quote",
"name": "Generate Biomedicines, Inc.",
"episode_id": "n0:GENB:2026-08-25",
"ema_trend": "17.05 > 15.86 > 15.0",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:23.027806Z",
"facts": [
"GENB gained 17.77% with a 3.06x volume ratio and +17.32% relative strength versus QQQ.",
"The sealed options snapshot was unavailable.",
"The catalyst was not a direct issuer-specific event in the corrected evidence."
],
"price_as_of": "2026-08-25T21:12:46Z",
"vwap_as_of": null
},
{
"symbol": "MRK",
"role": "alternative",
"price": 156.38,
"base_price": 154.5,
"return_since_base_pct": 1.2168,
"session_return_pct": -0.0447,
"change_since_prior_pct": 0.0,
"volume_ratio": null,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:20:21Z",
"source": "yfinance_quote",
"name": "Merck & Co., Inc.",
"episode_id": "narrative:MRK:5a78131dec6b3a0e",
"facts": [
"MRK gained 2.80%, traded above VWAP and up, and showed a 0.938 intraday range position.",
"The sealed catalyst related to a Moderna cancer-vaccine and melanoma partnership.",
"RSI was 83.74, the move was 3.53 ATR above the EMA reference, and volume ratio was 0.48x."
],
"price_as_of": "2026-08-25T21:20:21Z",
"vwap_as_of": null
}
],
"benchmarks": [],
"coverage": {
"candidate_rows": 5,
"candidate_prices": 5,
"candidate_technical": 3,
"benchmark_rows": 0
}
}
},
{
"day": 2,
"timestamp": "2026-08-27T20:00:57.897256Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-08-27T20:00:57.897256Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "KURA",
"role": "selected",
"price": 13.3,
"base_price": 13.79,
"return_since_base_pct": -3.5533,
"session_return_pct": 1.84,
"change_since_prior_pct": 1.6043,
"volume_ratio": 0.83,
"rsi": 79.0,
"vwap": 13.13,
"vwap_distance_pct": 1.2947,
"position_52w_pct": 95.7,
"extended_hours_pct": null,
"as_of": "2026-08-27T19:33:09.484369Z",
"source": "yfinance_quote",
"name": "Kura Oncology, Inc.",
"episode_id": "n0:KURA:2026-08-25",
"ema_trend": "12.39 > 11.49 > 10.77",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:58.818200Z",
"facts": [
"KURA gained 11.21%, with a 1.42x volume ratio, an 85.7 volume percentile and +10.76% relative strength versus QQQ.",
"The sealed catalyst package includes a reported $1.24 million CEO stock purchase, 57% KOMZIFTI revenue growth and 35% growth in new patient starts.",
"The captured intraday view showed KURA above VWAP and up, with an intraday range position of 0.998."
],
"benchmark_excess_pct": {
"sp500": 1.1224,
"nasdaq100": 0.413,
"russell2000": 1.4597
},
"price_as_of": "2026-08-27T19:33:09.484369Z",
"vwap_as_of": null
},
{
"symbol": "CRML",
"role": "alternative",
"price": 8.4469,
"base_price": 7.955,
"return_since_base_pct": 6.1835,
"session_return_pct": 4.2827,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.64,
"rsi": 61.49,
"vwap": 7.6,
"vwap_distance_pct": 11.1434,
"position_52w_pct": 24.71,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:20:04Z",
"source": "yfinance_quote",
"name": "Critical Metals Corp.",
"episode_id": "n0:CRML:2026-08-25",
"ema_trend": "6.8 > 6.75 > 7.63",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:50.354399Z",
"facts": [
"CRML gained 19.27% with +18.82% relative strength versus QQQ and a 1.64x volume ratio.",
"The rare-earth and European lithium merger narrative had no company announcement in the secondary news packet.",
"Short interest was 29.37% and the move was 1.98 ATR above the EMA reference."
],
"benchmark_excess_pct": {
"sp500": 3.5651,
"nasdaq100": 2.8557,
"russell2000": 3.9024
},
"price_as_of": "2026-08-25T21:20:04Z",
"vwap_as_of": null
},
{
"symbol": "LEU",
"role": "alternative",
"price": 193.0,
"base_price": 184.29,
"return_since_base_pct": 4.7262,
"session_return_pct": -0.2017,
"change_since_prior_pct": 0.0,
"volume_ratio": null,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:17:47Z",
"source": "yfinance_quote",
"name": "Centrus Energy Corp.",
"episode_id": "narrative:LEU:d551ea7899e32218",
"facts": [
"LEU was above VWAP and up, with a 0.963 intraday range position and a +5.44% relative-strength reading versus QQQ.",
"The sealed catalyst package connected X-Energy, Ohio and federal attention to domestic fuel and energy-security activity.",
"Volume ratio was only 0.29x, while the quoted options spread was 11.36%."
],
"benchmark_excess_pct": {
"sp500": -0.9193,
"nasdaq100": -1.6287,
"russell2000": -0.582
},
"price_as_of": "2026-08-25T21:17:47Z",
"vwap_as_of": null
},
{
"symbol": "GENB",
"role": "alternative",
"price": 20.11,
"base_price": 20.869,
"return_since_base_pct": -3.637,
"session_return_pct": -1.3248,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.06,
"rsi": 80.02,
"vwap": 20.73,
"vwap_distance_pct": -2.9908,
"position_52w_pct": 91.84,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:12:46Z",
"source": "yfinance_quote",
"name": "Generate Biomedicines, Inc.",
"episode_id": "n0:GENB:2026-08-25",
"ema_trend": "17.05 > 15.86 > 15.0",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:23.027806Z",
"facts": [
"GENB gained 17.77% with a 3.06x volume ratio and +17.32% relative strength versus QQQ.",
"The sealed options snapshot was unavailable.",
"The catalyst was not a direct issuer-specific event in the corrected evidence."
],
"benchmark_excess_pct": {
"sp500": -2.0424,
"nasdaq100": -2.7518,
"russell2000": -1.7051
},
"price_as_of": "2026-08-25T21:12:46Z",
"vwap_as_of": null
},
{
"symbol": "MRK",
"role": "alternative",
"price": 156.38,
"base_price": 154.5,
"return_since_base_pct": 1.2168,
"session_return_pct": -0.0447,
"change_since_prior_pct": 0.0,
"volume_ratio": null,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:20:21Z",
"source": "yfinance_quote",
"name": "Merck & Co., Inc.",
"episode_id": "narrative:MRK:5a78131dec6b3a0e",
"facts": [
"MRK gained 2.80%, traded above VWAP and up, and showed a 0.938 intraday range position.",
"The sealed catalyst related to a Moderna cancer-vaccine and melanoma partnership.",
"RSI was 83.74, the move was 3.53 ATR above the EMA reference, and volume ratio was 0.48x."
],
"benchmark_excess_pct": {
"sp500": -0.7623,
"nasdaq100": -1.4717,
"russell2000": -0.425
},
"price_as_of": "2026-08-25T21:20:21Z",
"vwap_as_of": null
}
],
"benchmarks": [
{
"id": "sp500",
"symbol": "^GSPC",
"label": "S&P 500",
"role": "benchmark",
"price": 7730.78,
"base_price": 7675.7,
"return_since_base_pct": 0.7176,
"session_return_pct": 0.7176,
"as_of": "2026-08-27T20:00:23.396555Z",
"source": "yfinance.ticker_info",
"base_definition": "previous regular close"
},
{
"id": "nasdaq100",
"symbol": "^NDX",
"label": "Nasdaq 100",
"role": "benchmark",
"price": 29641.56,
"base_price": 29224.521,
"return_since_base_pct": 1.427,
"session_return_pct": 1.427,
"as_of": "2026-08-27T20:00:23.396555Z",
"source": "yfinance.ticker_info",
"base_definition": "previous regular close"
},
{
"id": "russell2000",
"symbol": "^RUT",
"label": "Russell 2000",
"role": "benchmark",
"price": 3017.3308,
"base_price": 3005.9001,
"return_since_base_pct": 0.3803,
"session_return_pct": 0.3803,
"as_of": "2026-08-27T20:00:23.396555Z",
"source": "yfinance.ticker_info",
"base_definition": "previous regular close"
}
],
"coverage": {
"candidate_rows": 5,
"candidate_prices": 5,
"candidate_technical": 3,
"benchmark_rows": 3
}
}
},
{
"day": 2,
"timestamp": "2026-08-27T21:54:05.066659Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-08-27T21:54:05.066659Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "KURA",
"role": "selected",
"price": 13.35,
"base_price": 13.79,
"return_since_base_pct": -3.1907,
"session_return_pct": 0.92,
"change_since_prior_pct": 0.3759,
"volume_ratio": 1.29,
"rsi": 78.61,
"vwap": 13.14,
"vwap_distance_pct": 1.5982,
"position_52w_pct": 94.8,
"extended_hours_pct": 1.29,
"as_of": "2026-08-27T21:12:55Z",
"source": "sealed_extended_quote",
"name": "Kura Oncology, Inc.",
"episode_id": "n0:KURA:2026-08-25",
"ema_trend": "12.37 > 11.48 > 10.77",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:58.818200Z",
"facts": [
"KURA gained 11.21%, with a 1.42x volume ratio, an 85.7 volume percentile and +10.76% relative strength versus QQQ.",
"The sealed catalyst package includes a reported $1.24 million CEO stock purchase, 57% KOMZIFTI revenue growth and 35% growth in new patient starts.",
"The captured intraday view showed KURA above VWAP and up, with an intraday range position of 0.998."
],
"price_as_of": "2026-08-27T21:12:55Z",
"vwap_as_of": null
},
{
"symbol": "CRML",
"role": "alternative",
"price": 8.4469,
"base_price": 7.955,
"return_since_base_pct": 6.1835,
"session_return_pct": 4.2827,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.64,
"rsi": 61.49,
"vwap": 7.6,
"vwap_distance_pct": 11.1434,
"position_52w_pct": 24.71,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:20:04Z",
"source": "yfinance_quote",
"name": "Critical Metals Corp.",
"episode_id": "n0:CRML:2026-08-25",
"ema_trend": "6.8 > 6.75 > 7.63",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:50.354399Z",
"facts": [
"CRML gained 19.27% with +18.82% relative strength versus QQQ and a 1.64x volume ratio.",
"The rare-earth and European lithium merger narrative had no company announcement in the secondary news packet.",
"Short interest was 29.37% and the move was 1.98 ATR above the EMA reference."
],
"price_as_of": "2026-08-25T21:20:04Z",
"vwap_as_of": null
},
{
"symbol": "LEU",
"role": "alternative",
"price": 193.0,
"base_price": 184.29,
"return_since_base_pct": 4.7262,
"session_return_pct": -0.2017,
"change_since_prior_pct": 0.0,
"volume_ratio": null,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:17:47Z",
"source": "yfinance_quote",
"name": "Centrus Energy Corp.",
"episode_id": "narrative:LEU:d551ea7899e32218",
"facts": [
"LEU was above VWAP and up, with a 0.963 intraday range position and a +5.44% relative-strength reading versus QQQ.",
"The sealed catalyst package connected X-Energy, Ohio and federal attention to domestic fuel and energy-security activity.",
"Volume ratio was only 0.29x, while the quoted options spread was 11.36%."
],
"price_as_of": "2026-08-25T21:17:47Z",
"vwap_as_of": null
},
{
"symbol": "GENB",
"role": "alternative",
"price": 20.11,
"base_price": 20.869,
"return_since_base_pct": -3.637,
"session_return_pct": -1.3248,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.06,
"rsi": 80.02,
"vwap": 20.73,
"vwap_distance_pct": -2.9908,
"position_52w_pct": 91.84,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:12:46Z",
"source": "yfinance_quote",
"name": "Generate Biomedicines, Inc.",
"episode_id": "n0:GENB:2026-08-25",
"ema_trend": "17.05 > 15.86 > 15.0",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:23.027806Z",
"facts": [
"GENB gained 17.77% with a 3.06x volume ratio and +17.32% relative strength versus QQQ.",
"The sealed options snapshot was unavailable.",
"The catalyst was not a direct issuer-specific event in the corrected evidence."
],
"price_as_of": "2026-08-25T21:12:46Z",
"vwap_as_of": null
},
{
"symbol": "MRK",
"role": "alternative",
"price": 156.38,
"base_price": 154.5,
"return_since_base_pct": 1.2168,
"session_return_pct": -0.0447,
"change_since_prior_pct": 0.0,
"volume_ratio": null,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:20:21Z",
"source": "yfinance_quote",
"name": "Merck & Co., Inc.",
"episode_id": "narrative:MRK:5a78131dec6b3a0e",
"facts": [
"MRK gained 2.80%, traded above VWAP and up, and showed a 0.938 intraday range position.",
"The sealed catalyst related to a Moderna cancer-vaccine and melanoma partnership.",
"RSI was 83.74, the move was 3.53 ATR above the EMA reference, and volume ratio was 0.48x."
],
"price_as_of": "2026-08-25T21:20:21Z",
"vwap_as_of": null
}
],
"benchmarks": [],
"coverage": {
"candidate_rows": 5,
"candidate_prices": 5,
"candidate_technical": 3,
"benchmark_rows": 0
}
}
},
{
"day": 3,
"timestamp": "2026-08-28T15:29:01.233907Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-08-28T15:29:01.233907Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "KURA",
"role": "selected",
"price": 12.8,
"base_price": 13.79,
"return_since_base_pct": -7.1791,
"session_return_pct": -2.88,
"change_since_prior_pct": -4.1199,
"volume_ratio": 0.14,
"rsi": 73.01,
"vwap": 12.96,
"vwap_distance_pct": -1.2346,
"position_52w_pct": 92.1,
"extended_hours_pct": null,
"as_of": "2026-08-28T14:07:04.955352Z",
"source": "yfinance_quote",
"name": "Kura Oncology, Inc.",
"episode_id": "n0:KURA:2026-08-25",
"ema_trend": "12.46 > 11.6 > 10.85",
"vwap_state": "below",
"selection_as_of": "2026-08-25T15:15:58.818200Z",
"facts": [
"KURA gained 11.21%, with a 1.42x volume ratio, an 85.7 volume percentile and +10.76% relative strength versus QQQ.",
"The sealed catalyst package includes a reported $1.24 million CEO stock purchase, 57% KOMZIFTI revenue growth and 35% growth in new patient starts.",
"The captured intraday view showed KURA above VWAP and up, with an intraday range position of 0.998."
],
"price_as_of": "2026-08-28T14:07:04.955352Z",
"vwap_as_of": null
},
{
"symbol": "CRML",
"role": "alternative",
"price": 8.4469,
"base_price": 7.955,
"return_since_base_pct": 6.1835,
"session_return_pct": 4.2827,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.64,
"rsi": 61.49,
"vwap": 7.6,
"vwap_distance_pct": 11.1434,
"position_52w_pct": 24.71,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:20:04Z",
"source": "yfinance_quote",
"name": "Critical Metals Corp.",
"episode_id": "n0:CRML:2026-08-25",
"ema_trend": "6.8 > 6.75 > 7.63",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:50.354399Z",
"facts": [
"CRML gained 19.27% with +18.82% relative strength versus QQQ and a 1.64x volume ratio.",
"The rare-earth and European lithium merger narrative had no company announcement in the secondary news packet.",
"Short interest was 29.37% and the move was 1.98 ATR above the EMA reference."
],
"price_as_of": "2026-08-25T21:20:04Z",
"vwap_as_of": null
},
{
"symbol": "LEU",
"role": "alternative",
"price": 193.0,
"base_price": 184.29,
"return_since_base_pct": 4.7262,
"session_return_pct": -0.2017,
"change_since_prior_pct": 0.0,
"volume_ratio": null,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:17:47Z",
"source": "yfinance_quote",
"name": "Centrus Energy Corp.",
"episode_id": "narrative:LEU:d551ea7899e32218",
"facts": [
"LEU was above VWAP and up, with a 0.963 intraday range position and a +5.44% relative-strength reading versus QQQ.",
"The sealed catalyst package connected X-Energy, Ohio and federal attention to domestic fuel and energy-security activity.",
"Volume ratio was only 0.29x, while the quoted options spread was 11.36%."
],
"price_as_of": "2026-08-25T21:17:47Z",
"vwap_as_of": null
},
{
"symbol": "GENB",
"role": "alternative",
"price": 20.11,
"base_price": 20.869,
"return_since_base_pct": -3.637,
"session_return_pct": -1.3248,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.06,
"rsi": 80.02,
"vwap": 20.73,
"vwap_distance_pct": -2.9908,
"position_52w_pct": 91.84,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:12:46Z",
"source": "yfinance_quote",
"name": "Generate Biomedicines, Inc.",
"episode_id": "n0:GENB:2026-08-25",
"ema_trend": "17.05 > 15.86 > 15.0",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:23.027806Z",
"facts": [
"GENB gained 17.77% with a 3.06x volume ratio and +17.32% relative strength versus QQQ.",
"The sealed options snapshot was unavailable.",
"The catalyst was not a direct issuer-specific event in the corrected evidence."
],
"price_as_of": "2026-08-25T21:12:46Z",
"vwap_as_of": null
},
{
"symbol": "MRK",
"role": "alternative",
"price": 156.38,
"base_price": 154.5,
"return_since_base_pct": 1.2168,
"session_return_pct": -0.0447,
"change_since_prior_pct": 0.0,
"volume_ratio": null,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:20:21Z",
"source": "yfinance_quote",
"name": "Merck & Co., Inc.",
"episode_id": "narrative:MRK:5a78131dec6b3a0e",
"facts": [
"MRK gained 2.80%, traded above VWAP and up, and showed a 0.938 intraday range position.",
"The sealed catalyst related to a Moderna cancer-vaccine and melanoma partnership.",
"RSI was 83.74, the move was 3.53 ATR above the EMA reference, and volume ratio was 0.48x."
],
"price_as_of": "2026-08-25T21:20:21Z",
"vwap_as_of": null
}
],
"benchmarks": [],
"coverage": {
"candidate_rows": 5,
"candidate_prices": 5,
"candidate_technical": 3,
"benchmark_rows": 0
}
}
},
{
"day": 3,
"timestamp": "2026-08-29T05:44:23.744442Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-08-29T05:44:23.744442Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "KURA",
"role": "selected",
"price": 12.66,
"base_price": 13.79,
"return_since_base_pct": -8.1943,
"session_return_pct": -3.95,
"change_since_prior_pct": -1.0938,
"volume_ratio": 0.98,
"rsi": 86.86,
"vwap": 13.37,
"vwap_distance_pct": -5.3104,
"position_52w_pct": 91.1,
"extended_hours_pct": null,
"as_of": "2026-08-29T05:01:43.976820Z",
"source": "yfinance_quote",
"name": "Kura Oncology, Inc.",
"episode_id": "n0:KURA:2026-08-25",
"ema_trend": "12.37 > 11.48 > 10.77",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:58.818200Z",
"facts": [
"KURA gained 11.21%, with a 1.42x volume ratio, an 85.7 volume percentile and +10.76% relative strength versus QQQ.",
"The sealed catalyst package includes a reported $1.24 million CEO stock purchase, 57% KOMZIFTI revenue growth and 35% growth in new patient starts.",
"The captured intraday view showed KURA above VWAP and up, with an intraday range position of 0.998."
],
"price_as_of": "2026-08-29T05:01:43.976820Z",
"vwap_as_of": null
},
{
"symbol": "CRML",
"role": "alternative",
"price": 8.4469,
"base_price": 7.955,
"return_since_base_pct": 6.1835,
"session_return_pct": 4.2827,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.64,
"rsi": 61.49,
"vwap": 7.6,
"vwap_distance_pct": 11.1434,
"position_52w_pct": 24.71,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:20:04Z",
"source": "yfinance_quote",
"name": "Critical Metals Corp.",
"episode_id": "n0:CRML:2026-08-25",
"ema_trend": "6.8 > 6.75 > 7.63",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:50.354399Z",
"facts": [
"CRML gained 19.27% with +18.82% relative strength versus QQQ and a 1.64x volume ratio.",
"The rare-earth and European lithium merger narrative had no company announcement in the secondary news packet.",
"Short interest was 29.37% and the move was 1.98 ATR above the EMA reference."
],
"price_as_of": "2026-08-25T21:20:04Z",
"vwap_as_of": null
},
{
"symbol": "LEU",
"role": "alternative",
"price": 193.0,
"base_price": 184.29,
"return_since_base_pct": 4.7262,
"session_return_pct": -0.2017,
"change_since_prior_pct": 0.0,
"volume_ratio": null,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:17:47Z",
"source": "yfinance_quote",
"name": "Centrus Energy Corp.",
"episode_id": "narrative:LEU:d551ea7899e32218",
"facts": [
"LEU was above VWAP and up, with a 0.963 intraday range position and a +5.44% relative-strength reading versus QQQ.",
"The sealed catalyst package connected X-Energy, Ohio and federal attention to domestic fuel and energy-security activity.",
"Volume ratio was only 0.29x, while the quoted options spread was 11.36%."
],
"price_as_of": "2026-08-25T21:17:47Z",
"vwap_as_of": null
},
{
"symbol": "GENB",
"role": "alternative",
"price": 20.11,
"base_price": 20.869,
"return_since_base_pct": -3.637,
"session_return_pct": -1.3248,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.06,
"rsi": 80.02,
"vwap": 20.73,
"vwap_distance_pct": -2.9908,
"position_52w_pct": 91.84,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:12:46Z",
"source": "yfinance_quote",
"name": "Generate Biomedicines, Inc.",
"episode_id": "n0:GENB:2026-08-25",
"ema_trend": "17.05 > 15.86 > 15.0",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:23.027806Z",
"facts": [
"GENB gained 17.77% with a 3.06x volume ratio and +17.32% relative strength versus QQQ.",
"The sealed options snapshot was unavailable.",
"The catalyst was not a direct issuer-specific event in the corrected evidence."
],
"price_as_of": "2026-08-25T21:12:46Z",
"vwap_as_of": null
},
{
"symbol": "MRK",
"role": "alternative",
"price": 156.38,
"base_price": 154.5,
"return_since_base_pct": 1.2168,
"session_return_pct": -0.0447,
"change_since_prior_pct": 0.0,
"volume_ratio": null,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:20:21Z",
"source": "yfinance_quote",
"name": "Merck & Co., Inc.",
"episode_id": "narrative:MRK:5a78131dec6b3a0e",
"facts": [
"MRK gained 2.80%, traded above VWAP and up, and showed a 0.938 intraday range position.",
"The sealed catalyst related to a Moderna cancer-vaccine and melanoma partnership.",
"RSI was 83.74, the move was 3.53 ATR above the EMA reference, and volume ratio was 0.48x."
],
"price_as_of": "2026-08-25T21:20:21Z",
"vwap_as_of": null
}
],
"benchmarks": [],
"coverage": {
"candidate_rows": 5,
"candidate_prices": 5,
"candidate_technical": 3,
"benchmark_rows": 0
}
}
},
{
"day": 4,
"timestamp": "2026-08-31T15:00:54.221936Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-08-31T15:00:54.221936Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "KURA",
"role": "selected",
"price": 12.66,
"base_price": 13.79,
"return_since_base_pct": -8.1943,
"session_return_pct": 1.0581,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.15,
"rsi": 71.1,
"vwap": 12.65,
"vwap_distance_pct": 0.0791,
"position_52w_pct": 91.1,
"extended_hours_pct": null,
"as_of": "2026-08-31T14:06:24.388513Z",
"source": "yfinance_quote",
"name": "Kura Oncology, Inc.",
"episode_id": "n0:KURA:2026-08-25",
"ema_trend": "12.47 > 11.68 > 10.92",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:58.818200Z",
"facts": [
"KURA gained 11.21%, with a 1.42x volume ratio, an 85.7 volume percentile and +10.76% relative strength versus QQQ.",
"The sealed catalyst package includes a reported $1.24 million CEO stock purchase, 57% KOMZIFTI revenue growth and 35% growth in new patient starts.",
"The captured intraday view showed KURA above VWAP and up, with an intraday range position of 0.998."
],
"price_as_of": "2026-08-31T14:06:24.388513Z",
"vwap_as_of": null
},
{
"symbol": "CRML",
"role": "alternative",
"price": 8.4469,
"base_price": 7.955,
"return_since_base_pct": 6.1835,
"session_return_pct": 4.2827,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.64,
"rsi": 61.49,
"vwap": 7.6,
"vwap_distance_pct": 11.1434,
"position_52w_pct": 24.71,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:20:04Z",
"source": "yfinance_quote",
"name": "Critical Metals Corp.",
"episode_id": "n0:CRML:2026-08-25",
"ema_trend": "6.8 > 6.75 > 7.63",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:50.354399Z",
"facts": [
"CRML gained 19.27% with +18.82% relative strength versus QQQ and a 1.64x volume ratio.",
"The rare-earth and European lithium merger narrative had no company announcement in the secondary news packet.",
"Short interest was 29.37% and the move was 1.98 ATR above the EMA reference."
],
"price_as_of": "2026-08-25T21:20:04Z",
"vwap_as_of": null
},
{
"symbol": "LEU",
"role": "alternative",
"price": 193.0,
"base_price": 184.29,
"return_since_base_pct": 4.7262,
"session_return_pct": -0.2017,
"change_since_prior_pct": 0.0,
"volume_ratio": null,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:17:47Z",
"source": "yfinance_quote",
"name": "Centrus Energy Corp.",
"episode_id": "narrative:LEU:d551ea7899e32218",
"facts": [
"LEU was above VWAP and up, with a 0.963 intraday range position and a +5.44% relative-strength reading versus QQQ.",
"The sealed catalyst package connected X-Energy, Ohio and federal attention to domestic fuel and energy-security activity.",
"Volume ratio was only 0.29x, while the quoted options spread was 11.36%."
],
"price_as_of": "2026-08-25T21:17:47Z",
"vwap_as_of": null
},
{
"symbol": "GENB",
"role": "alternative",
"price": 20.11,
"base_price": 20.869,
"return_since_base_pct": -3.637,
"session_return_pct": -1.3248,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.06,
"rsi": 80.02,
"vwap": 20.73,
"vwap_distance_pct": -2.9908,
"position_52w_pct": 91.84,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:12:46Z",
"source": "yfinance_quote",
"name": "Generate Biomedicines, Inc.",
"episode_id": "n0:GENB:2026-08-25",
"ema_trend": "17.05 > 15.86 > 15.0",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:23.027806Z",
"facts": [
"GENB gained 17.77% with a 3.06x volume ratio and +17.32% relative strength versus QQQ.",
"The sealed options snapshot was unavailable.",
"The catalyst was not a direct issuer-specific event in the corrected evidence."
],
"price_as_of": "2026-08-25T21:12:46Z",
"vwap_as_of": null
},
{
"symbol": "MRK",
"role": "alternative",
"price": 156.38,
"base_price": 154.5,
"return_since_base_pct": 1.2168,
"session_return_pct": -0.0447,
"change_since_prior_pct": 0.0,
"volume_ratio": null,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:20:21Z",
"source": "yfinance_quote",
"name": "Merck & Co., Inc.",
"episode_id": "narrative:MRK:5a78131dec6b3a0e",
"facts": [
"MRK gained 2.80%, traded above VWAP and up, and showed a 0.938 intraday range position.",
"The sealed catalyst related to a Moderna cancer-vaccine and melanoma partnership.",
"RSI was 83.74, the move was 3.53 ATR above the EMA reference, and volume ratio was 0.48x."
],
"price_as_of": "2026-08-25T21:20:21Z",
"vwap_as_of": null
}
],
"benchmarks": [],
"coverage": {
"candidate_rows": 5,
"candidate_prices": 5,
"candidate_technical": 3,
"benchmark_rows": 0
}
}
},
{
"day": 4,
"timestamp": "2026-08-31T20:05:54.687642Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-08-31T20:05:54.687642Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "KURA",
"role": "selected",
"price": 12.649,
"base_price": 13.79,
"return_since_base_pct": -8.2741,
"session_return_pct": -0.09,
"change_since_prior_pct": -0.0869,
"volume_ratio": 0.54,
"rsi": 70.98,
"vwap": 12.63,
"vwap_distance_pct": 0.1504,
"position_52w_pct": 91.0,
"extended_hours_pct": null,
"as_of": "2026-08-31T19:21:03.615633Z",
"source": "yfinance_quote",
"name": "Kura Oncology, Inc.",
"episode_id": "n0:KURA:2026-08-25",
"ema_trend": "12.47 > 11.68 > 10.91",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:58.818200Z",
"facts": [
"KURA gained 11.21%, with a 1.42x volume ratio, an 85.7 volume percentile and +10.76% relative strength versus QQQ.",
"The sealed catalyst package includes a reported $1.24 million CEO stock purchase, 57% KOMZIFTI revenue growth and 35% growth in new patient starts.",
"The captured intraday view showed KURA above VWAP and up, with an intraday range position of 0.998."
],
"price_as_of": "2026-08-31T19:21:03.615633Z",
"vwap_as_of": null
},
{
"symbol": "CRML",
"role": "alternative",
"price": 8.4469,
"base_price": 7.955,
"return_since_base_pct": 6.1835,
"session_return_pct": 4.2827,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.64,
"rsi": 61.49,
"vwap": 7.6,
"vwap_distance_pct": 11.1434,
"position_52w_pct": 24.71,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:20:04Z",
"source": "yfinance_quote",
"name": "Critical Metals Corp.",
"episode_id": "n0:CRML:2026-08-25",
"ema_trend": "6.8 > 6.75 > 7.63",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:50.354399Z",
"facts": [
"CRML gained 19.27% with +18.82% relative strength versus QQQ and a 1.64x volume ratio.",
"The rare-earth and European lithium merger narrative had no company announcement in the secondary news packet.",
"Short interest was 29.37% and the move was 1.98 ATR above the EMA reference."
],
"price_as_of": "2026-08-25T21:20:04Z",
"vwap_as_of": null
},
{
"symbol": "LEU",
"role": "alternative",
"price": 193.0,
"base_price": 184.29,
"return_since_base_pct": 4.7262,
"session_return_pct": -0.2017,
"change_since_prior_pct": 0.0,
"volume_ratio": null,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:17:47Z",
"source": "yfinance_quote",
"name": "Centrus Energy Corp.",
"episode_id": "narrative:LEU:d551ea7899e32218",
"facts": [
"LEU was above VWAP and up, with a 0.963 intraday range position and a +5.44% relative-strength reading versus QQQ.",
"The sealed catalyst package connected X-Energy, Ohio and federal attention to domestic fuel and energy-security activity.",
"Volume ratio was only 0.29x, while the quoted options spread was 11.36%."
],
"price_as_of": "2026-08-25T21:17:47Z",
"vwap_as_of": null
},
{
"symbol": "GENB",
"role": "alternative",
"price": 20.11,
"base_price": 20.869,
"return_since_base_pct": -3.637,
"session_return_pct": -1.3248,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.06,
"rsi": 80.02,
"vwap": 20.73,
"vwap_distance_pct": -2.9908,
"position_52w_pct": 91.84,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:12:46Z",
"source": "yfinance_quote",
"name": "Generate Biomedicines, Inc.",
"episode_id": "n0:GENB:2026-08-25",
"ema_trend": "17.05 > 15.86 > 15.0",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:23.027806Z",
"facts": [
"GENB gained 17.77% with a 3.06x volume ratio and +17.32% relative strength versus QQQ.",
"The sealed options snapshot was unavailable.",
"The catalyst was not a direct issuer-specific event in the corrected evidence."
],
"price_as_of": "2026-08-25T21:12:46Z",
"vwap_as_of": null
},
{
"symbol": "MRK",
"role": "alternative",
"price": 156.38,
"base_price": 154.5,
"return_since_base_pct": 1.2168,
"session_return_pct": -0.0447,
"change_since_prior_pct": 0.0,
"volume_ratio": null,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:20:21Z",
"source": "yfinance_quote",
"name": "Merck & Co., Inc.",
"episode_id": "narrative:MRK:5a78131dec6b3a0e",
"facts": [
"MRK gained 2.80%, traded above VWAP and up, and showed a 0.938 intraday range position.",
"The sealed catalyst related to a Moderna cancer-vaccine and melanoma partnership.",
"RSI was 83.74, the move was 3.53 ATR above the EMA reference, and volume ratio was 0.48x."
],
"price_as_of": "2026-08-25T21:20:21Z",
"vwap_as_of": null
}
],
"benchmarks": [],
"coverage": {
"candidate_rows": 5,
"candidate_prices": 5,
"candidate_technical": 3,
"benchmark_rows": 0
}
}
},
{
"day": 4,
"timestamp": "2026-08-31T22:10:08.130356Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-08-31T22:10:08.130356Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "KURA",
"role": "selected",
"price": 12.75,
"base_price": 13.79,
"return_since_base_pct": -7.5417,
"session_return_pct": -0.08,
"change_since_prior_pct": 0.7985,
"volume_ratio": 1.06,
"rsi": 70.99,
"vwap": 12.64,
"vwap_distance_pct": 0.8703,
"position_52w_pct": 91.0,
"extended_hours_pct": 0.76,
"as_of": "2026-08-31T21:40:51Z",
"source": "sealed_extended_quote",
"name": "Kura Oncology, Inc.",
"episode_id": "n0:KURA:2026-08-25",
"ema_trend": "12.47 > 11.68 > 10.91",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:58.818200Z",
"facts": [
"KURA gained 11.21%, with a 1.42x volume ratio, an 85.7 volume percentile and +10.76% relative strength versus QQQ.",
"The sealed catalyst package includes a reported $1.24 million CEO stock purchase, 57% KOMZIFTI revenue growth and 35% growth in new patient starts.",
"The captured intraday view showed KURA above VWAP and up, with an intraday range position of 0.998."
],
"price_as_of": "2026-08-31T21:40:51Z",
"vwap_as_of": null
},
{
"symbol": "CRML",
"role": "alternative",
"price": 8.4469,
"base_price": 7.955,
"return_since_base_pct": 6.1835,
"session_return_pct": 4.2827,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.64,
"rsi": 61.49,
"vwap": 7.6,
"vwap_distance_pct": 11.1434,
"position_52w_pct": 24.71,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:20:04Z",
"source": "yfinance_quote",
"name": "Critical Metals Corp.",
"episode_id": "n0:CRML:2026-08-25",
"ema_trend": "6.8 > 6.75 > 7.63",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:50.354399Z",
"facts": [
"CRML gained 19.27% with +18.82% relative strength versus QQQ and a 1.64x volume ratio.",
"The rare-earth and European lithium merger narrative had no company announcement in the secondary news packet.",
"Short interest was 29.37% and the move was 1.98 ATR above the EMA reference."
],
"price_as_of": "2026-08-25T21:20:04Z",
"vwap_as_of": null
},
{
"symbol": "LEU",
"role": "alternative",
"price": 193.0,
"base_price": 185.37,
"return_since_base_pct": 4.1161,
"session_return_pct": -0.2017,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.29,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:17:47Z",
"source": "yfinance_quote",
"name": "Centrus Energy Corp.",
"episode_id": "narrative:LEU:d551ea7899e32218",
"selection_as_of": "2026-08-25T17:00:00Z",
"facts": [
"LEU was above VWAP and up, with a 0.963 intraday range position and a +5.44% relative-strength reading versus QQQ.",
"The sealed catalyst package connected X-Energy, Ohio and federal attention to domestic fuel and energy-security activity.",
"Volume ratio was only 0.29x, while the quoted options spread was 11.36%."
],
"price_as_of": "2026-08-25T21:17:47Z",
"vwap_as_of": null
},
{
"symbol": "GENB",
"role": "alternative",
"price": 20.11,
"base_price": 20.869,
"return_since_base_pct": -3.637,
"session_return_pct": -1.3248,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.06,
"rsi": 80.02,
"vwap": 20.73,
"vwap_distance_pct": -2.9908,
"position_52w_pct": 91.84,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:12:46Z",
"source": "yfinance_quote",
"name": "Generate Biomedicines, Inc.",
"episode_id": "n0:GENB:2026-08-25",
"ema_trend": "17.05 > 15.86 > 15.0",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:23.027806Z",
"facts": [
"GENB gained 17.77% with a 3.06x volume ratio and +17.32% relative strength versus QQQ.",
"The sealed options snapshot was unavailable.",
"The catalyst was not a direct issuer-specific event in the corrected evidence."
],
"price_as_of": "2026-08-25T21:12:46Z",
"vwap_as_of": null
},
{
"symbol": "MRK",
"role": "alternative",
"price": 156.38,
"base_price": 154.8999,
"return_since_base_pct": 0.9555,
"session_return_pct": -0.0447,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.48,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:20:21Z",
"source": "yfinance_quote",
"name": "Merck & Co., Inc.",
"episode_id": "narrative:MRK:5a78131dec6b3a0e",
"selection_as_of": "2026-08-25T17:00:19Z",
"facts": [
"MRK gained 2.80%, traded above VWAP and up, and showed a 0.938 intraday range position.",
"The sealed catalyst related to a Moderna cancer-vaccine and melanoma partnership.",
"RSI was 83.74, the move was 3.53 ATR above the EMA reference, and volume ratio was 0.48x."
],
"price_as_of": "2026-08-25T21:20:21Z",
"vwap_as_of": null
}
],
"benchmarks": [],
"coverage": {
"candidate_rows": 5,
"candidate_prices": 5,
"candidate_technical": 3,
"benchmark_rows": 0
}
}
},
{
"day": 5,
"timestamp": "2026-09-01T16:18:26.867697Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-09-01T16:18:26.867697Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "KURA",
"role": "selected",
"price": 12.61,
"base_price": 13.79,
"return_since_base_pct": -8.5569,
"session_return_pct": -0.32,
"change_since_prior_pct": -1.098,
"volume_ratio": 0.1,
"rsi": 70.51,
"vwap": 12.54,
"vwap_distance_pct": 0.5582,
"position_52w_pct": 90.7,
"extended_hours_pct": null,
"as_of": "2026-09-01T14:13:30.142689Z",
"source": "yfinance_quote",
"name": "Kura Oncology, Inc.",
"episode_id": "n0:KURA:2026-08-25",
"ema_trend": "12.5 > 11.77 > 10.98",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:58.818200Z",
"facts": [
"KURA gained 11.21%, with a 1.42x volume ratio, an 85.7 volume percentile and +10.76% relative strength versus QQQ.",
"The sealed catalyst package includes a reported $1.24 million CEO stock purchase, 57% KOMZIFTI revenue growth and 35% growth in new patient starts.",
"The captured intraday view showed KURA above VWAP and up, with an intraday range position of 0.998."
],
"price_as_of": "2026-09-01T14:13:30.142689Z",
"vwap_as_of": null
},
{
"symbol": "CRML",
"role": "alternative",
"price": 8.4469,
"base_price": 7.955,
"return_since_base_pct": 6.1835,
"session_return_pct": 4.2827,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.64,
"rsi": 61.49,
"vwap": 7.6,
"vwap_distance_pct": 11.1434,
"position_52w_pct": 24.71,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:20:04Z",
"source": "yfinance_quote",
"name": "Critical Metals Corp.",
"episode_id": "n0:CRML:2026-08-25",
"ema_trend": "6.8 > 6.75 > 7.63",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:50.354399Z",
"facts": [
"CRML gained 19.27% with +18.82% relative strength versus QQQ and a 1.64x volume ratio.",
"The rare-earth and European lithium merger narrative had no company announcement in the secondary news packet.",
"Short interest was 29.37% and the move was 1.98 ATR above the EMA reference."
],
"price_as_of": "2026-08-25T21:20:04Z",
"vwap_as_of": null
},
{
"symbol": "LEU",
"role": "alternative",
"price": 193.0,
"base_price": 185.37,
"return_since_base_pct": 4.1161,
"session_return_pct": -0.2017,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.29,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:17:47Z",
"source": "yfinance_quote",
"name": "Centrus Energy Corp.",
"episode_id": "narrative:LEU:d551ea7899e32218",
"selection_as_of": "2026-08-25T17:00:00Z",
"facts": [
"LEU was above VWAP and up, with a 0.963 intraday range position and a +5.44% relative-strength reading versus QQQ.",
"The sealed catalyst package connected X-Energy, Ohio and federal attention to domestic fuel and energy-security activity.",
"Volume ratio was only 0.29x, while the quoted options spread was 11.36%."
],
"price_as_of": "2026-08-25T21:17:47Z",
"vwap_as_of": null
},
{
"symbol": "GENB",
"role": "alternative",
"price": 20.11,
"base_price": 20.869,
"return_since_base_pct": -3.637,
"session_return_pct": -1.3248,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.06,
"rsi": 80.02,
"vwap": 20.73,
"vwap_distance_pct": -2.9908,
"position_52w_pct": 91.84,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:12:46Z",
"source": "yfinance_quote",
"name": "Generate Biomedicines, Inc.",
"episode_id": "n0:GENB:2026-08-25",
"ema_trend": "17.05 > 15.86 > 15.0",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:23.027806Z",
"facts": [
"GENB gained 17.77% with a 3.06x volume ratio and +17.32% relative strength versus QQQ.",
"The sealed options snapshot was unavailable.",
"The catalyst was not a direct issuer-specific event in the corrected evidence."
],
"price_as_of": "2026-08-25T21:12:46Z",
"vwap_as_of": null
},
{
"symbol": "MRK",
"role": "alternative",
"price": 156.38,
"base_price": 154.8999,
"return_since_base_pct": 0.9555,
"session_return_pct": -0.0447,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.48,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:20:21Z",
"source": "yfinance_quote",
"name": "Merck & Co., Inc.",
"episode_id": "narrative:MRK:5a78131dec6b3a0e",
"selection_as_of": "2026-08-25T17:00:19Z",
"facts": [
"MRK gained 2.80%, traded above VWAP and up, and showed a 0.938 intraday range position.",
"The sealed catalyst related to a Moderna cancer-vaccine and melanoma partnership.",
"RSI was 83.74, the move was 3.53 ATR above the EMA reference, and volume ratio was 0.48x."
],
"price_as_of": "2026-08-25T21:20:21Z",
"vwap_as_of": null
}
],
"benchmarks": [],
"coverage": {
"candidate_rows": 5,
"candidate_prices": 5,
"candidate_technical": 3,
"benchmark_rows": 0
}
}
},
{
"day": 5,
"timestamp": "2026-09-01T21:05:59.051947Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-09-01T21:05:59.051947Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "KURA",
"role": "selected",
"price": 12.87,
"base_price": 13.79,
"return_since_base_pct": -6.6715,
"session_return_pct": 1.74,
"change_since_prior_pct": 2.0619,
"volume_ratio": 0.46,
"rsi": 71.9,
"vwap": 12.71,
"vwap_distance_pct": 1.2589,
"position_52w_pct": 92.6,
"extended_hours_pct": null,
"as_of": "2026-09-01T19:21:29.772075Z",
"source": "yfinance_quote",
"name": "Kura Oncology, Inc.",
"episode_id": "n0:KURA:2026-08-25",
"ema_trend": "12.55 > 11.79 > 10.99",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:58.818200Z",
"facts": [
"KURA gained 11.21%, with a 1.42x volume ratio, an 85.7 volume percentile and +10.76% relative strength versus QQQ.",
"The sealed catalyst package includes a reported $1.24 million CEO stock purchase, 57% KOMZIFTI revenue growth and 35% growth in new patient starts.",
"The captured intraday view showed KURA above VWAP and up, with an intraday range position of 0.998."
],
"price_as_of": "2026-09-01T19:21:29.772075Z",
"vwap_as_of": null
},
{
"symbol": "CRML",
"role": "alternative",
"price": 8.4469,
"base_price": 7.955,
"return_since_base_pct": 6.1835,
"session_return_pct": 4.2827,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.64,
"rsi": 61.49,
"vwap": 7.6,
"vwap_distance_pct": 11.1434,
"position_52w_pct": 24.71,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:20:04Z",
"source": "yfinance_quote",
"name": "Critical Metals Corp.",
"episode_id": "n0:CRML:2026-08-25",
"ema_trend": "6.8 > 6.75 > 7.63",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:50.354399Z",
"facts": [
"CRML gained 19.27% with +18.82% relative strength versus QQQ and a 1.64x volume ratio.",
"The rare-earth and European lithium merger narrative had no company announcement in the secondary news packet.",
"Short interest was 29.37% and the move was 1.98 ATR above the EMA reference."
],
"price_as_of": "2026-08-25T21:20:04Z",
"vwap_as_of": null
},
{
"symbol": "LEU",
"role": "alternative",
"price": 193.0,
"base_price": 185.37,
"return_since_base_pct": 4.1161,
"session_return_pct": -0.2017,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.29,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:17:47Z",
"source": "yfinance_quote",
"name": "Centrus Energy Corp.",
"episode_id": "narrative:LEU:d551ea7899e32218",
"selection_as_of": "2026-08-25T17:00:00Z",
"facts": [
"LEU was above VWAP and up, with a 0.963 intraday range position and a +5.44% relative-strength reading versus QQQ.",
"The sealed catalyst package connected X-Energy, Ohio and federal attention to domestic fuel and energy-security activity.",
"Volume ratio was only 0.29x, while the quoted options spread was 11.36%."
],
"price_as_of": "2026-08-25T21:17:47Z",
"vwap_as_of": null
},
{
"symbol": "GENB",
"role": "alternative",
"price": 20.11,
"base_price": 20.869,
"return_since_base_pct": -3.637,
"session_return_pct": -1.3248,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.06,
"rsi": 80.02,
"vwap": 20.73,
"vwap_distance_pct": -2.9908,
"position_52w_pct": 91.84,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:12:46Z",
"source": "yfinance_quote",
"name": "Generate Biomedicines, Inc.",
"episode_id": "n0:GENB:2026-08-25",
"ema_trend": "17.05 > 15.86 > 15.0",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:23.027806Z",
"facts": [
"GENB gained 17.77% with a 3.06x volume ratio and +17.32% relative strength versus QQQ.",
"The sealed options snapshot was unavailable.",
"The catalyst was not a direct issuer-specific event in the corrected evidence."
],
"price_as_of": "2026-08-25T21:12:46Z",
"vwap_as_of": null
},
{
"symbol": "MRK",
"role": "alternative",
"price": 156.38,
"base_price": 154.8999,
"return_since_base_pct": 0.9555,
"session_return_pct": -0.0447,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.48,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:20:21Z",
"source": "yfinance_quote",
"name": "Merck & Co., Inc.",
"episode_id": "narrative:MRK:5a78131dec6b3a0e",
"selection_as_of": "2026-08-25T17:00:19Z",
"facts": [
"MRK gained 2.80%, traded above VWAP and up, and showed a 0.938 intraday range position.",
"The sealed catalyst related to a Moderna cancer-vaccine and melanoma partnership.",
"RSI was 83.74, the move was 3.53 ATR above the EMA reference, and volume ratio was 0.48x."
],
"price_as_of": "2026-08-25T21:20:21Z",
"vwap_as_of": null
}
],
"benchmarks": [],
"coverage": {
"candidate_rows": 5,
"candidate_prices": 5,
"candidate_technical": 3,
"benchmark_rows": 0
}
}
},
{
"day": 5,
"timestamp": "2026-09-01T22:11:52.835171Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-09-01T22:11:52.835171Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "KURA",
"role": "selected",
"price": 12.8,
"base_price": 13.79,
"return_since_base_pct": -7.1791,
"session_return_pct": 1.9,
"change_since_prior_pct": -0.5439,
"volume_ratio": 0.82,
"rsi": 71.98,
"vwap": 12.73,
"vwap_distance_pct": 0.5499,
"position_52w_pct": 92.7,
"extended_hours_pct": -0.7,
"as_of": "2026-09-01T21:40:15Z",
"source": "sealed_extended_quote",
"name": "Kura Oncology, Inc.",
"episode_id": "n0:KURA:2026-08-25",
"ema_trend": "12.56 > 11.79 > 10.99",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:58.818200Z",
"facts": [
"KURA gained 11.21%, with a 1.42x volume ratio, an 85.7 volume percentile and +10.76% relative strength versus QQQ.",
"The sealed catalyst package includes a reported $1.24 million CEO stock purchase, 57% KOMZIFTI revenue growth and 35% growth in new patient starts.",
"The captured intraday view showed KURA above VWAP and up, with an intraday range position of 0.998."
],
"benchmark_excess_pct": {
"sp500": 2.6113,
"nasdaq100": 3.1892,
"russell2000": 3.1285
},
"price_as_of": "2026-09-01T21:40:15Z",
"vwap_as_of": null
},
{
"symbol": "CRML",
"role": "alternative",
"price": 8.4469,
"base_price": 7.955,
"return_since_base_pct": 6.1835,
"session_return_pct": 4.2827,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.64,
"rsi": 61.49,
"vwap": 7.6,
"vwap_distance_pct": 11.1434,
"position_52w_pct": 24.71,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:20:04Z",
"source": "yfinance_quote",
"name": "Critical Metals Corp.",
"episode_id": "n0:CRML:2026-08-25",
"ema_trend": "6.8 > 6.75 > 7.63",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:50.354399Z",
"facts": [
"CRML gained 19.27% with +18.82% relative strength versus QQQ and a 1.64x volume ratio.",
"The rare-earth and European lithium merger narrative had no company announcement in the secondary news packet.",
"Short interest was 29.37% and the move was 1.98 ATR above the EMA reference."
],
"benchmark_excess_pct": {
"sp500": 4.994,
"nasdaq100": 5.5719,
"russell2000": 5.5112
},
"price_as_of": "2026-08-25T21:20:04Z",
"vwap_as_of": null
},
{
"symbol": "LEU",
"role": "alternative",
"price": 193.0,
"base_price": 185.37,
"return_since_base_pct": 4.1161,
"session_return_pct": -0.2017,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.29,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:17:47Z",
"source": "yfinance_quote",
"name": "Centrus Energy Corp.",
"episode_id": "narrative:LEU:d551ea7899e32218",
"selection_as_of": "2026-08-25T17:00:00Z",
"facts": [
"LEU was above VWAP and up, with a 0.963 intraday range position and a +5.44% relative-strength reading versus QQQ.",
"The sealed catalyst package connected X-Energy, Ohio and federal attention to domestic fuel and energy-security activity.",
"Volume ratio was only 0.29x, while the quoted options spread was 11.36%."
],
"benchmark_excess_pct": {
"sp500": 0.5096,
"nasdaq100": 1.0875,
"russell2000": 1.0268
},
"price_as_of": "2026-08-25T21:17:47Z",
"vwap_as_of": null
},
{
"symbol": "GENB",
"role": "alternative",
"price": 20.11,
"base_price": 20.869,
"return_since_base_pct": -3.637,
"session_return_pct": -1.3248,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.06,
"rsi": 80.02,
"vwap": 20.73,
"vwap_distance_pct": -2.9908,
"position_52w_pct": 91.84,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:12:46Z",
"source": "yfinance_quote",
"name": "Generate Biomedicines, Inc.",
"episode_id": "n0:GENB:2026-08-25",
"ema_trend": "17.05 > 15.86 > 15.0",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:23.027806Z",
"facts": [
"GENB gained 17.77% with a 3.06x volume ratio and +17.32% relative strength versus QQQ.",
"The sealed options snapshot was unavailable.",
"The catalyst was not a direct issuer-specific event in the corrected evidence."
],
"benchmark_excess_pct": {
"sp500": -0.6135,
"nasdaq100": -0.0356,
"russell2000": -0.0963
},
"price_as_of": "2026-08-25T21:12:46Z",
"vwap_as_of": null
},
{
"symbol": "MRK",
"role": "alternative",
"price": 156.38,
"base_price": 154.8999,
"return_since_base_pct": 0.9555,
"session_return_pct": -0.0447,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.48,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:20:21Z",
"source": "yfinance_quote",
"name": "Merck & Co., Inc.",
"episode_id": "narrative:MRK:5a78131dec6b3a0e",
"selection_as_of": "2026-08-25T17:00:19Z",
"facts": [
"MRK gained 2.80%, traded above VWAP and up, and showed a 0.938 intraday range position.",
"The sealed catalyst related to a Moderna cancer-vaccine and melanoma partnership.",
"RSI was 83.74, the move was 3.53 ATR above the EMA reference, and volume ratio was 0.48x."
],
"benchmark_excess_pct": {
"sp500": 0.6666,
"nasdaq100": 1.2445,
"russell2000": 1.1838
},
"price_as_of": "2026-08-25T21:20:21Z",
"vwap_as_of": null
}
],
"benchmarks": [
{
"id": "sp500",
"symbol": "^GSPC",
"label": "S&P 500",
"role": "benchmark",
"price": 7631.47,
"base_price": 7686.14,
"return_since_base_pct": -0.7113,
"session_return_pct": -0.7113,
"as_of": "2026-09-01T22:07:32.433629Z",
"source": "yfinance.ticker_info",
"base_definition": "previous regular close"
},
{
"id": "nasdaq100",
"symbol": "^NDX",
"label": "Nasdaq 100",
"role": "benchmark",
"price": 29077.22,
"base_price": 29456.973,
"return_since_base_pct": -1.2892,
"session_return_pct": -1.2892,
"as_of": "2026-09-01T22:07:32.433629Z",
"source": "yfinance.ticker_info",
"base_definition": "previous regular close"
},
{
"id": "russell2000",
"symbol": "^RUT",
"label": "Russell 2000",
"role": "benchmark",
"price": 2920.1323,
"base_price": 2956.452,
"return_since_base_pct": -1.2285,
"session_return_pct": -1.2285,
"as_of": "2026-09-01T22:07:32.433629Z",
"source": "yfinance.ticker_info",
"base_definition": "previous regular close"
}
],
"coverage": {
"candidate_rows": 5,
"candidate_prices": 5,
"candidate_technical": 3,
"benchmark_rows": 3
}
}
},
{
"day": 6,
"timestamp": "2026-09-02T16:09:31.749470Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-09-02T16:09:31.749470Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "KURA",
"role": "selected",
"price": 12.92,
"base_price": 13.79,
"return_since_base_pct": -6.3089,
"session_return_pct": 0.23,
"change_since_prior_pct": 0.9375,
"volume_ratio": 0.22,
"rsi": 71.47,
"vwap": 13.11,
"vwap_distance_pct": -1.4493,
"position_52w_pct": 92.9,
"extended_hours_pct": null,
"as_of": "2026-09-02T14:44:54.049824Z",
"source": "yfinance_quote",
"name": "Kura Oncology, Inc.",
"episode_id": "n0:KURA:2026-08-25",
"ema_trend": "12.63 > 11.9 > 11.07",
"vwap_state": "below",
"selection_as_of": "2026-08-25T15:15:58.818200Z",
"facts": [
"KURA gained 11.21%, with a 1.42x volume ratio, an 85.7 volume percentile and +10.76% relative strength versus QQQ.",
"The sealed catalyst package includes a reported $1.24 million CEO stock purchase, 57% KOMZIFTI revenue growth and 35% growth in new patient starts.",
"The captured intraday view showed KURA above VWAP and up, with an intraday range position of 0.998."
],
"price_as_of": "2026-09-02T14:44:54.049824Z",
"vwap_as_of": null
},
{
"symbol": "CRML",
"role": "alternative",
"price": 8.4469,
"base_price": 7.955,
"return_since_base_pct": 6.1835,
"session_return_pct": 4.2827,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.64,
"rsi": 61.49,
"vwap": 7.6,
"vwap_distance_pct": 11.1434,
"position_52w_pct": 24.71,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:20:04Z",
"source": "yfinance_quote",
"name": "Critical Metals Corp.",
"episode_id": "n0:CRML:2026-08-25",
"ema_trend": "6.8 > 6.75 > 7.63",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:50.354399Z",
"facts": [
"CRML gained 19.27% with +18.82% relative strength versus QQQ and a 1.64x volume ratio.",
"The rare-earth and European lithium merger narrative had no company announcement in the secondary news packet.",
"Short interest was 29.37% and the move was 1.98 ATR above the EMA reference."
],
"price_as_of": "2026-08-25T21:20:04Z",
"vwap_as_of": null
},
{
"symbol": "LEU",
"role": "alternative",
"price": 193.0,
"base_price": 185.37,
"return_since_base_pct": 4.1161,
"session_return_pct": -0.2017,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.29,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:17:47Z",
"source": "yfinance_quote",
"name": "Centrus Energy Corp.",
"episode_id": "narrative:LEU:d551ea7899e32218",
"selection_as_of": "2026-08-25T17:00:00Z",
"facts": [
"LEU was above VWAP and up, with a 0.963 intraday range position and a +5.44% relative-strength reading versus QQQ.",
"The sealed catalyst package connected X-Energy, Ohio and federal attention to domestic fuel and energy-security activity.",
"Volume ratio was only 0.29x, while the quoted options spread was 11.36%."
],
"price_as_of": "2026-08-25T21:17:47Z",
"vwap_as_of": null
},
{
"symbol": "GENB",
"role": "alternative",
"price": 20.11,
"base_price": 20.869,
"return_since_base_pct": -3.637,
"session_return_pct": -1.3248,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.06,
"rsi": 80.02,
"vwap": 20.73,
"vwap_distance_pct": -2.9908,
"position_52w_pct": 91.84,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:12:46Z",
"source": "yfinance_quote",
"name": "Generate Biomedicines, Inc.",
"episode_id": "n0:GENB:2026-08-25",
"ema_trend": "17.05 > 15.86 > 15.0",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:23.027806Z",
"facts": [
"GENB gained 17.77% with a 3.06x volume ratio and +17.32% relative strength versus QQQ.",
"The sealed options snapshot was unavailable.",
"The catalyst was not a direct issuer-specific event in the corrected evidence."
],
"price_as_of": "2026-08-25T21:12:46Z",
"vwap_as_of": null
},
{
"symbol": "MRK",
"role": "alternative",
"price": 156.38,
"base_price": 154.8999,
"return_since_base_pct": 0.9555,
"session_return_pct": -0.0447,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.48,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:20:21Z",
"source": "yfinance_quote",
"name": "Merck & Co., Inc.",
"episode_id": "narrative:MRK:5a78131dec6b3a0e",
"selection_as_of": "2026-08-25T17:00:19Z",
"facts": [
"MRK gained 2.80%, traded above VWAP and up, and showed a 0.938 intraday range position.",
"The sealed catalyst related to a Moderna cancer-vaccine and melanoma partnership.",
"RSI was 83.74, the move was 3.53 ATR above the EMA reference, and volume ratio was 0.48x."
],
"price_as_of": "2026-08-25T21:20:21Z",
"vwap_as_of": null
}
],
"benchmarks": [],
"coverage": {
"candidate_rows": 5,
"candidate_prices": 5,
"candidate_technical": 3,
"benchmark_rows": 0
}
}
},
{
"day": 6,
"timestamp": "2026-09-02T22:01:43.753827Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-09-02T22:01:43.753827Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "KURA",
"role": "selected",
"price": 13.4,
"base_price": 13.79,
"return_since_base_pct": -2.8281,
"session_return_pct": 1.71,
"change_since_prior_pct": 3.7152,
"volume_ratio": 1.03,
"rsi": 72.27,
"vwap": 12.97,
"vwap_distance_pct": 3.3153,
"position_52w_pct": 94.3,
"extended_hours_pct": 2.21,
"as_of": "2026-09-02T21:18:14Z",
"source": "sealed_extended_quote",
"name": "Kura Oncology, Inc.",
"episode_id": "n0:KURA:2026-08-25",
"ema_trend": "12.67 > 11.91 > 11.08",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:58.818200Z",
"facts": [
"KURA gained 11.21%, with a 1.42x volume ratio, an 85.7 volume percentile and +10.76% relative strength versus QQQ.",
"The sealed catalyst package includes a reported $1.24 million CEO stock purchase, 57% KOMZIFTI revenue growth and 35% growth in new patient starts.",
"The captured intraday view showed KURA above VWAP and up, with an intraday range position of 0.998."
],
"benchmark_excess_pct": {
"sp500": 1.2497,
"nasdaq100": 1.4826,
"russell2000": 0.5787
},
"price_as_of": "2026-09-02T21:18:14Z",
"vwap_as_of": null
},
{
"symbol": "CRML",
"role": "alternative",
"price": 8.4469,
"base_price": 7.955,
"return_since_base_pct": 6.1835,
"session_return_pct": 4.2827,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.64,
"rsi": 61.49,
"vwap": 7.6,
"vwap_distance_pct": 11.1434,
"position_52w_pct": 24.71,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:20:04Z",
"source": "yfinance_quote",
"name": "Critical Metals Corp.",
"episode_id": "n0:CRML:2026-08-25",
"ema_trend": "6.8 > 6.75 > 7.63",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:50.354399Z",
"facts": [
"CRML gained 19.27% with +18.82% relative strength versus QQQ and a 1.64x volume ratio.",
"The rare-earth and European lithium merger narrative had no company announcement in the secondary news packet.",
"Short interest was 29.37% and the move was 1.98 ATR above the EMA reference."
],
"benchmark_excess_pct": {
"sp500": 3.8224,
"nasdaq100": 4.0553,
"russell2000": 3.1514
},
"price_as_of": "2026-08-25T21:20:04Z",
"vwap_as_of": null
},
{
"symbol": "LEU",
"role": "alternative",
"price": 193.0,
"base_price": 185.37,
"return_since_base_pct": 4.1161,
"session_return_pct": -0.2017,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.29,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:17:47Z",
"source": "yfinance_quote",
"name": "Centrus Energy Corp.",
"episode_id": "narrative:LEU:d551ea7899e32218",
"selection_as_of": "2026-08-25T17:00:00Z",
"facts": [
"LEU was above VWAP and up, with a 0.963 intraday range position and a +5.44% relative-strength reading versus QQQ.",
"The sealed catalyst package connected X-Energy, Ohio and federal attention to domestic fuel and energy-security activity.",
"Volume ratio was only 0.29x, while the quoted options spread was 11.36%."
],
"benchmark_excess_pct": {
"sp500": -0.662,
"nasdaq100": -0.4291,
"russell2000": -1.333
},
"price_as_of": "2026-08-25T21:17:47Z",
"vwap_as_of": null
},
{
"symbol": "GENB",
"role": "alternative",
"price": 20.11,
"base_price": 20.869,
"return_since_base_pct": -3.637,
"session_return_pct": -1.3248,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.06,
"rsi": 80.02,
"vwap": 20.73,
"vwap_distance_pct": -2.9908,
"position_52w_pct": 91.84,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:12:46Z",
"source": "yfinance_quote",
"name": "Generate Biomedicines, Inc.",
"episode_id": "n0:GENB:2026-08-25",
"ema_trend": "17.05 > 15.86 > 15.0",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:23.027806Z",
"facts": [
"GENB gained 17.77% with a 3.06x volume ratio and +17.32% relative strength versus QQQ.",
"The sealed options snapshot was unavailable.",
"The catalyst was not a direct issuer-specific event in the corrected evidence."
],
"benchmark_excess_pct": {
"sp500": -1.7851,
"nasdaq100": -1.5522,
"russell2000": -2.4561
},
"price_as_of": "2026-08-25T21:12:46Z",
"vwap_as_of": null
},
{
"symbol": "MRK",
"role": "alternative",
"price": 156.38,
"base_price": 154.8999,
"return_since_base_pct": 0.9555,
"session_return_pct": -0.0447,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.48,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:20:21Z",
"source": "yfinance_quote",
"name": "Merck & Co., Inc.",
"episode_id": "narrative:MRK:5a78131dec6b3a0e",
"selection_as_of": "2026-08-25T17:00:19Z",
"facts": [
"MRK gained 2.80%, traded above VWAP and up, and showed a 0.938 intraday range position.",
"The sealed catalyst related to a Moderna cancer-vaccine and melanoma partnership.",
"RSI was 83.74, the move was 3.53 ATR above the EMA reference, and volume ratio was 0.48x."
],
"benchmark_excess_pct": {
"sp500": -0.505,
"nasdaq100": -0.2721,
"russell2000": -1.176
},
"price_as_of": "2026-08-25T21:20:21Z",
"vwap_as_of": null
}
],
"benchmarks": [
{
"id": "sp500",
"symbol": "^GSPC",
"label": "S&P 500",
"role": "benchmark",
"price": 7666.6,
"base_price": 7631.47,
"return_since_base_pct": 0.4603,
"session_return_pct": 0.4603,
"as_of": "2026-09-02T21:58:20.334306Z",
"source": "yfinance.ticker_info",
"base_definition": "previous regular close"
},
{
"id": "nasdaq100",
"symbol": "^NDX",
"label": "Nasdaq 100",
"role": "benchmark",
"price": 29143.33,
"base_price": 29077.22,
"return_since_base_pct": 0.2274,
"session_return_pct": 0.2274,
"as_of": "2026-09-02T21:58:20.334306Z",
"source": "yfinance.ticker_info",
"base_definition": "previous regular close"
},
{
"id": "russell2000",
"symbol": "^RUT",
"label": "Russell 2000",
"role": "benchmark",
"price": 2953.1663,
"base_price": 2920.1323,
"return_since_base_pct": 1.1313,
"session_return_pct": 1.1313,
"as_of": "2026-09-02T21:58:20.334306Z",
"source": "yfinance.ticker_info",
"base_definition": "previous regular close"
}
],
"coverage": {
"candidate_rows": 5,
"candidate_prices": 5,
"candidate_technical": 3,
"benchmark_rows": 3
}
}
},
{
"day": 7,
"timestamp": "2026-09-03T14:55:05.360058Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-09-03T14:55:05.360058Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "KURA",
"role": "selected",
"price": 13.09,
"base_price": 13.79,
"return_since_base_pct": -5.0761,
"session_return_pct": -0.15,
"change_since_prior_pct": -2.3134,
"volume_ratio": 0.08,
"rsi": 68.49,
"vwap": 13.04,
"vwap_distance_pct": 0.3834,
"position_52w_pct": 94.2,
"extended_hours_pct": null,
"as_of": "2026-09-03T14:06:17.841920Z",
"source": "yfinance_quote",
"name": "Kura Oncology, Inc.",
"episode_id": "n0:KURA:2026-08-25",
"ema_trend": "12.75 > 12.02 > 11.15",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:58.818200Z",
"facts": [
"KURA gained 11.21%, with a 1.42x volume ratio, an 85.7 volume percentile and +10.76% relative strength versus QQQ.",
"The sealed catalyst package includes a reported $1.24 million CEO stock purchase, 57% KOMZIFTI revenue growth and 35% growth in new patient starts.",
"The captured intraday view showed KURA above VWAP and up, with an intraday range position of 0.998."
],
"price_as_of": "2026-09-03T14:06:17.841920Z",
"vwap_as_of": null
},
{
"symbol": "CRML",
"role": "alternative",
"price": 8.4469,
"base_price": 7.955,
"return_since_base_pct": 6.1835,
"session_return_pct": 4.2827,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.64,
"rsi": 61.49,
"vwap": 7.6,
"vwap_distance_pct": 11.1434,
"position_52w_pct": 24.71,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:20:04Z",
"source": "yfinance_quote",
"name": "Critical Metals Corp.",
"episode_id": "n0:CRML:2026-08-25",
"ema_trend": "6.8 > 6.75 > 7.63",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:50.354399Z",
"facts": [
"CRML gained 19.27% with +18.82% relative strength versus QQQ and a 1.64x volume ratio.",
"The rare-earth and European lithium merger narrative had no company announcement in the secondary news packet.",
"Short interest was 29.37% and the move was 1.98 ATR above the EMA reference."
],
"price_as_of": "2026-08-25T21:20:04Z",
"vwap_as_of": null
},
{
"symbol": "LEU",
"role": "alternative",
"price": 193.0,
"base_price": 185.37,
"return_since_base_pct": 4.1161,
"session_return_pct": -0.2017,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.29,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:17:47Z",
"source": "yfinance_quote",
"name": "Centrus Energy Corp.",
"episode_id": "narrative:LEU:d551ea7899e32218",
"selection_as_of": "2026-08-25T17:00:00Z",
"facts": [
"LEU was above VWAP and up, with a 0.963 intraday range position and a +5.44% relative-strength reading versus QQQ.",
"The sealed catalyst package connected X-Energy, Ohio and federal attention to domestic fuel and energy-security activity.",
"Volume ratio was only 0.29x, while the quoted options spread was 11.36%."
],
"price_as_of": "2026-08-25T21:17:47Z",
"vwap_as_of": null
},
{
"symbol": "GENB",
"role": "alternative",
"price": 20.11,
"base_price": 20.869,
"return_since_base_pct": -3.637,
"session_return_pct": -1.3248,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.06,
"rsi": 80.02,
"vwap": 20.73,
"vwap_distance_pct": -2.9908,
"position_52w_pct": 91.84,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:12:46Z",
"source": "yfinance_quote",
"name": "Generate Biomedicines, Inc.",
"episode_id": "n0:GENB:2026-08-25",
"ema_trend": "17.05 > 15.86 > 15.0",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:23.027806Z",
"facts": [
"GENB gained 17.77% with a 3.06x volume ratio and +17.32% relative strength versus QQQ.",
"The sealed options snapshot was unavailable.",
"The catalyst was not a direct issuer-specific event in the corrected evidence."
],
"price_as_of": "2026-08-25T21:12:46Z",
"vwap_as_of": null
},
{
"symbol": "MRK",
"role": "alternative",
"price": 156.38,
"base_price": 154.8999,
"return_since_base_pct": 0.9555,
"session_return_pct": -0.0447,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.48,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:20:21Z",
"source": "yfinance_quote",
"name": "Merck & Co., Inc.",
"episode_id": "narrative:MRK:5a78131dec6b3a0e",
"selection_as_of": "2026-08-25T17:00:19Z",
"facts": [
"MRK gained 2.80%, traded above VWAP and up, and showed a 0.938 intraday range position.",
"The sealed catalyst related to a Moderna cancer-vaccine and melanoma partnership.",
"RSI was 83.74, the move was 3.53 ATR above the EMA reference, and volume ratio was 0.48x."
],
"price_as_of": "2026-08-25T21:20:21Z",
"vwap_as_of": null
}
],
"benchmarks": [],
"coverage": {
"candidate_rows": 5,
"candidate_prices": 5,
"candidate_technical": 3,
"benchmark_rows": 0
}
}
},
{
"day": 7,
"timestamp": "2026-09-03T20:16:41.591302Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-09-03T20:16:41.591302Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "KURA",
"role": "selected",
"price": 13.04,
"base_price": 13.79,
"return_since_base_pct": -5.4387,
"session_return_pct": -0.53,
"change_since_prior_pct": -0.382,
"volume_ratio": 0.54,
"rsi": 67.93,
"vwap": 13.13,
"vwap_distance_pct": -0.6855,
"position_52w_pct": 93.8,
"extended_hours_pct": null,
"as_of": "2026-09-03T19:21:52.173032Z",
"source": "yfinance_quote",
"name": "Kura Oncology, Inc.",
"episode_id": "n0:KURA:2026-08-25",
"ema_trend": "12.74 > 12.02 > 11.15",
"vwap_state": "below",
"selection_as_of": "2026-08-25T15:15:58.818200Z",
"facts": [
"KURA gained 11.21%, with a 1.42x volume ratio, an 85.7 volume percentile and +10.76% relative strength versus QQQ.",
"The sealed catalyst package includes a reported $1.24 million CEO stock purchase, 57% KOMZIFTI revenue growth and 35% growth in new patient starts.",
"The captured intraday view showed KURA above VWAP and up, with an intraday range position of 0.998."
],
"price_as_of": "2026-09-03T19:21:52.173032Z",
"vwap_as_of": null
},
{
"symbol": "CRML",
"role": "alternative",
"price": 8.4469,
"base_price": 7.955,
"return_since_base_pct": 6.1835,
"session_return_pct": 4.2827,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.64,
"rsi": 61.49,
"vwap": 7.6,
"vwap_distance_pct": 11.1434,
"position_52w_pct": 24.71,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:20:04Z",
"source": "yfinance_quote",
"name": "Critical Metals Corp.",
"episode_id": "n0:CRML:2026-08-25",
"ema_trend": "6.8 > 6.75 > 7.63",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:50.354399Z",
"facts": [
"CRML gained 19.27% with +18.82% relative strength versus QQQ and a 1.64x volume ratio.",
"The rare-earth and European lithium merger narrative had no company announcement in the secondary news packet.",
"Short interest was 29.37% and the move was 1.98 ATR above the EMA reference."
],
"price_as_of": "2026-08-25T21:20:04Z",
"vwap_as_of": null
},
{
"symbol": "LEU",
"role": "alternative",
"price": 193.0,
"base_price": 185.37,
"return_since_base_pct": 4.1161,
"session_return_pct": -0.2017,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.29,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:17:47Z",
"source": "yfinance_quote",
"name": "Centrus Energy Corp.",
"episode_id": "narrative:LEU:d551ea7899e32218",
"selection_as_of": "2026-08-25T17:00:00Z",
"facts": [
"LEU was above VWAP and up, with a 0.963 intraday range position and a +5.44% relative-strength reading versus QQQ.",
"The sealed catalyst package connected X-Energy, Ohio and federal attention to domestic fuel and energy-security activity.",
"Volume ratio was only 0.29x, while the quoted options spread was 11.36%."
],
"price_as_of": "2026-08-25T21:17:47Z",
"vwap_as_of": null
},
{
"symbol": "GENB",
"role": "alternative",
"price": 20.11,
"base_price": 20.869,
"return_since_base_pct": -3.637,
"session_return_pct": -1.3248,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.06,
"rsi": 80.02,
"vwap": 20.73,
"vwap_distance_pct": -2.9908,
"position_52w_pct": 91.84,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:12:46Z",
"source": "yfinance_quote",
"name": "Generate Biomedicines, Inc.",
"episode_id": "n0:GENB:2026-08-25",
"ema_trend": "17.05 > 15.86 > 15.0",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:23.027806Z",
"facts": [
"GENB gained 17.77% with a 3.06x volume ratio and +17.32% relative strength versus QQQ.",
"The sealed options snapshot was unavailable.",
"The catalyst was not a direct issuer-specific event in the corrected evidence."
],
"price_as_of": "2026-08-25T21:12:46Z",
"vwap_as_of": null
},
{
"symbol": "MRK",
"role": "alternative",
"price": 156.38,
"base_price": 154.8999,
"return_since_base_pct": 0.9555,
"session_return_pct": -0.0447,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.48,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:20:21Z",
"source": "yfinance_quote",
"name": "Merck & Co., Inc.",
"episode_id": "narrative:MRK:5a78131dec6b3a0e",
"selection_as_of": "2026-08-25T17:00:19Z",
"facts": [
"MRK gained 2.80%, traded above VWAP and up, and showed a 0.938 intraday range position.",
"The sealed catalyst related to a Moderna cancer-vaccine and melanoma partnership.",
"RSI was 83.74, the move was 3.53 ATR above the EMA reference, and volume ratio was 0.48x."
],
"price_as_of": "2026-08-25T21:20:21Z",
"vwap_as_of": null
}
],
"benchmarks": [],
"coverage": {
"candidate_rows": 5,
"candidate_prices": 5,
"candidate_technical": 3,
"benchmark_rows": 0
}
}
},
{
"day": 8,
"timestamp": "2026-09-04T14:53:58.205607Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-09-04T14:53:58.205607Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "KURA",
"role": "selected",
"price": 13.055,
"base_price": 13.79,
"return_since_base_pct": -5.3299,
"session_return_pct": -0.72,
"change_since_prior_pct": 0.115,
"volume_ratio": 0.1,
"rsi": 65.5,
"vwap": 12.99,
"vwap_distance_pct": 0.5004,
"position_52w_pct": 93.9,
"extended_hours_pct": null,
"as_of": "2026-09-04T14:06:17.385242Z",
"source": "yfinance_quote",
"name": "Kura Oncology, Inc.",
"episode_id": "n0:KURA:2026-08-25",
"ema_trend": "12.82 > 12.12 > 11.23",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:58.818200Z",
"facts": [
"KURA gained 11.21%, with a 1.42x volume ratio, an 85.7 volume percentile and +10.76% relative strength versus QQQ.",
"The sealed catalyst package includes a reported $1.24 million CEO stock purchase, 57% KOMZIFTI revenue growth and 35% growth in new patient starts.",
"The captured intraday view showed KURA above VWAP and up, with an intraday range position of 0.998."
],
"price_as_of": "2026-09-04T14:06:17.385242Z",
"vwap_as_of": null
},
{
"symbol": "CRML",
"role": "alternative",
"price": 8.4469,
"base_price": 7.955,
"return_since_base_pct": 6.1835,
"session_return_pct": 4.2827,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.64,
"rsi": 61.49,
"vwap": 7.6,
"vwap_distance_pct": 11.1434,
"position_52w_pct": 24.71,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:20:04Z",
"source": "yfinance_quote",
"name": "Critical Metals Corp.",
"episode_id": "n0:CRML:2026-08-25",
"ema_trend": "6.8 > 6.75 > 7.63",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:50.354399Z",
"facts": [
"CRML gained 19.27% with +18.82% relative strength versus QQQ and a 1.64x volume ratio.",
"The rare-earth and European lithium merger narrative had no company announcement in the secondary news packet.",
"Short interest was 29.37% and the move was 1.98 ATR above the EMA reference."
],
"price_as_of": "2026-08-25T21:20:04Z",
"vwap_as_of": null
},
{
"symbol": "LEU",
"role": "alternative",
"price": 193.0,
"base_price": 185.37,
"return_since_base_pct": 4.1161,
"session_return_pct": -0.2017,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.29,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:17:47Z",
"source": "yfinance_quote",
"name": "Centrus Energy Corp.",
"episode_id": "narrative:LEU:d551ea7899e32218",
"selection_as_of": "2026-08-25T17:00:00Z",
"facts": [
"LEU was above VWAP and up, with a 0.963 intraday range position and a +5.44% relative-strength reading versus QQQ.",
"The sealed catalyst package connected X-Energy, Ohio and federal attention to domestic fuel and energy-security activity.",
"Volume ratio was only 0.29x, while the quoted options spread was 11.36%."
],
"price_as_of": "2026-08-25T21:17:47Z",
"vwap_as_of": null
},
{
"symbol": "GENB",
"role": "alternative",
"price": 20.11,
"base_price": 20.869,
"return_since_base_pct": -3.637,
"session_return_pct": -1.3248,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.06,
"rsi": 80.02,
"vwap": 20.73,
"vwap_distance_pct": -2.9908,
"position_52w_pct": 91.84,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:12:46Z",
"source": "yfinance_quote",
"name": "Generate Biomedicines, Inc.",
"episode_id": "n0:GENB:2026-08-25",
"ema_trend": "17.05 > 15.86 > 15.0",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:23.027806Z",
"facts": [
"GENB gained 17.77% with a 3.06x volume ratio and +17.32% relative strength versus QQQ.",
"The sealed options snapshot was unavailable.",
"The catalyst was not a direct issuer-specific event in the corrected evidence."
],
"price_as_of": "2026-08-25T21:12:46Z",
"vwap_as_of": null
},
{
"symbol": "MRK",
"role": "alternative",
"price": 156.38,
"base_price": 154.8999,
"return_since_base_pct": 0.9555,
"session_return_pct": -0.0447,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.48,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:20:21Z",
"source": "yfinance_quote",
"name": "Merck & Co., Inc.",
"episode_id": "narrative:MRK:5a78131dec6b3a0e",
"selection_as_of": "2026-08-25T17:00:19Z",
"facts": [
"MRK gained 2.80%, traded above VWAP and up, and showed a 0.938 intraday range position.",
"The sealed catalyst related to a Moderna cancer-vaccine and melanoma partnership.",
"RSI was 83.74, the move was 3.53 ATR above the EMA reference, and volume ratio was 0.48x."
],
"price_as_of": "2026-08-25T21:20:21Z",
"vwap_as_of": null
}
],
"benchmarks": [],
"coverage": {
"candidate_rows": 5,
"candidate_prices": 5,
"candidate_technical": 3,
"benchmark_rows": 0
}
}
},
{
"day": 8,
"timestamp": "2026-09-04T20:02:39.091485Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-09-04T20:02:39.091485Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "KURA",
"role": "selected",
"price": 13.2185,
"base_price": 13.79,
"return_since_base_pct": -4.1443,
"session_return_pct": 0.52,
"change_since_prior_pct": 1.2524,
"volume_ratio": 0.47,
"rsi": 67.01,
"vwap": 13.09,
"vwap_distance_pct": 0.9817,
"position_52w_pct": 95.1,
"extended_hours_pct": null,
"as_of": "2026-09-04T19:21:46.989147Z",
"source": "yfinance_quote",
"name": "Kura Oncology, Inc.",
"episode_id": "n0:KURA:2026-08-25",
"ema_trend": "12.85 > 12.13 > 11.24",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:58.818200Z",
"facts": [
"KURA gained 11.21%, with a 1.42x volume ratio, an 85.7 volume percentile and +10.76% relative strength versus QQQ.",
"The sealed catalyst package includes a reported $1.24 million CEO stock purchase, 57% KOMZIFTI revenue growth and 35% growth in new patient starts.",
"The captured intraday view showed KURA above VWAP and up, with an intraday range position of 0.998."
],
"price_as_of": "2026-09-04T19:21:46.989147Z",
"vwap_as_of": null
},
{
"symbol": "CRML",
"role": "alternative",
"price": 8.4469,
"base_price": 7.955,
"return_since_base_pct": 6.1835,
"session_return_pct": 4.2827,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.64,
"rsi": 61.49,
"vwap": 7.6,
"vwap_distance_pct": 11.1434,
"position_52w_pct": 24.71,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:20:04Z",
"source": "yfinance_quote",
"name": "Critical Metals Corp.",
"episode_id": "n0:CRML:2026-08-25",
"ema_trend": "6.8 > 6.75 > 7.63",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:50.354399Z",
"facts": [
"CRML gained 19.27% with +18.82% relative strength versus QQQ and a 1.64x volume ratio.",
"The rare-earth and European lithium merger narrative had no company announcement in the secondary news packet.",
"Short interest was 29.37% and the move was 1.98 ATR above the EMA reference."
],
"price_as_of": "2026-08-25T21:20:04Z",
"vwap_as_of": null
},
{
"symbol": "LEU",
"role": "alternative",
"price": 193.0,
"base_price": 185.37,
"return_since_base_pct": 4.1161,
"session_return_pct": -0.2017,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.29,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:17:47Z",
"source": "yfinance_quote",
"name": "Centrus Energy Corp.",
"episode_id": "narrative:LEU:d551ea7899e32218",
"selection_as_of": "2026-08-25T17:00:00Z",
"facts": [
"LEU was above VWAP and up, with a 0.963 intraday range position and a +5.44% relative-strength reading versus QQQ.",
"The sealed catalyst package connected X-Energy, Ohio and federal attention to domestic fuel and energy-security activity.",
"Volume ratio was only 0.29x, while the quoted options spread was 11.36%."
],
"price_as_of": "2026-08-25T21:17:47Z",
"vwap_as_of": null
},
{
"symbol": "GENB",
"role": "alternative",
"price": 20.11,
"base_price": 20.869,
"return_since_base_pct": -3.637,
"session_return_pct": -1.3248,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.06,
"rsi": 80.02,
"vwap": 20.73,
"vwap_distance_pct": -2.9908,
"position_52w_pct": 91.84,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:12:46Z",
"source": "yfinance_quote",
"name": "Generate Biomedicines, Inc.",
"episode_id": "n0:GENB:2026-08-25",
"ema_trend": "17.05 > 15.86 > 15.0",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:23.027806Z",
"facts": [
"GENB gained 17.77% with a 3.06x volume ratio and +17.32% relative strength versus QQQ.",
"The sealed options snapshot was unavailable.",
"The catalyst was not a direct issuer-specific event in the corrected evidence."
],
"price_as_of": "2026-08-25T21:12:46Z",
"vwap_as_of": null
},
{
"symbol": "MRK",
"role": "alternative",
"price": 156.38,
"base_price": 154.8999,
"return_since_base_pct": 0.9555,
"session_return_pct": -0.0447,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.48,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:20:21Z",
"source": "yfinance_quote",
"name": "Merck & Co., Inc.",
"episode_id": "narrative:MRK:5a78131dec6b3a0e",
"selection_as_of": "2026-08-25T17:00:19Z",
"facts": [
"MRK gained 2.80%, traded above VWAP and up, and showed a 0.938 intraday range position.",
"The sealed catalyst related to a Moderna cancer-vaccine and melanoma partnership.",
"RSI was 83.74, the move was 3.53 ATR above the EMA reference, and volume ratio was 0.48x."
],
"price_as_of": "2026-08-25T21:20:21Z",
"vwap_as_of": null
}
],
"benchmarks": [],
"coverage": {
"candidate_rows": 5,
"candidate_prices": 5,
"candidate_technical": 3,
"benchmark_rows": 0
}
}
},
{
"day": 8,
"timestamp": "2026-09-04T22:02:21.741193Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-09-04T22:02:21.741193Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "KURA",
"role": "selected",
"price": 13.01,
"base_price": 13.79,
"return_since_base_pct": -5.6563,
"session_return_pct": 0.76,
"change_since_prior_pct": -1.5773,
"volume_ratio": 0.72,
"rsi": 67.19,
"vwap": 13.09,
"vwap_distance_pct": -0.6112,
"position_52w_pct": 95.3,
"extended_hours_pct": -1.81,
"as_of": "2026-09-04T21:27:38Z",
"source": "sealed_extended_quote",
"name": "Kura Oncology, Inc.",
"episode_id": "n0:KURA:2026-08-25",
"ema_trend": "12.86 > 12.14 > 11.24",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:58.818200Z",
"facts": [
"KURA gained 11.21%, with a 1.42x volume ratio, an 85.7 volume percentile and +10.76% relative strength versus QQQ.",
"The sealed catalyst package includes a reported $1.24 million CEO stock purchase, 57% KOMZIFTI revenue growth and 35% growth in new patient starts.",
"The captured intraday view showed KURA above VWAP and up, with an intraday range position of 0.998."
],
"price_as_of": "2026-09-04T21:27:38Z",
"vwap_as_of": null
},
{
"symbol": "CRML",
"role": "alternative",
"price": 8.4469,
"base_price": 7.955,
"return_since_base_pct": 6.1835,
"session_return_pct": 4.2827,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.64,
"rsi": 61.49,
"vwap": 7.6,
"vwap_distance_pct": 11.1434,
"position_52w_pct": 24.71,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:20:04Z",
"source": "yfinance_quote",
"name": "Critical Metals Corp.",
"episode_id": "n0:CRML:2026-08-25",
"ema_trend": "6.8 > 6.75 > 7.63",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:50.354399Z",
"facts": [
"CRML gained 19.27% with +18.82% relative strength versus QQQ and a 1.64x volume ratio.",
"The rare-earth and European lithium merger narrative had no company announcement in the secondary news packet.",
"Short interest was 29.37% and the move was 1.98 ATR above the EMA reference."
],
"price_as_of": "2026-08-25T21:20:04Z",
"vwap_as_of": null
},
{
"symbol": "LEU",
"role": "alternative",
"price": 193.0,
"base_price": 185.37,
"return_since_base_pct": 4.1161,
"session_return_pct": -0.2017,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.29,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:17:47Z",
"source": "yfinance_quote",
"name": "Centrus Energy Corp.",
"episode_id": "narrative:LEU:d551ea7899e32218",
"selection_as_of": "2026-08-25T17:00:00Z",
"facts": [
"LEU was above VWAP and up, with a 0.963 intraday range position and a +5.44% relative-strength reading versus QQQ.",
"The sealed catalyst package connected X-Energy, Ohio and federal attention to domestic fuel and energy-security activity.",
"Volume ratio was only 0.29x, while the quoted options spread was 11.36%."
],
"price_as_of": "2026-08-25T21:17:47Z",
"vwap_as_of": null
},
{
"symbol": "GENB",
"role": "alternative",
"price": 20.11,
"base_price": 20.869,
"return_since_base_pct": -3.637,
"session_return_pct": -1.3248,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.06,
"rsi": 80.02,
"vwap": 20.73,
"vwap_distance_pct": -2.9908,
"position_52w_pct": 91.84,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:12:46Z",
"source": "yfinance_quote",
"name": "Generate Biomedicines, Inc.",
"episode_id": "n0:GENB:2026-08-25",
"ema_trend": "17.05 > 15.86 > 15.0",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:23.027806Z",
"facts": [
"GENB gained 17.77% with a 3.06x volume ratio and +17.32% relative strength versus QQQ.",
"The sealed options snapshot was unavailable.",
"The catalyst was not a direct issuer-specific event in the corrected evidence."
],
"price_as_of": "2026-08-25T21:12:46Z",
"vwap_as_of": null
},
{
"symbol": "MRK",
"role": "alternative",
"price": 156.38,
"base_price": 154.8999,
"return_since_base_pct": 0.9555,
"session_return_pct": -0.0447,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.48,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:20:21Z",
"source": "yfinance_quote",
"name": "Merck & Co., Inc.",
"episode_id": "narrative:MRK:5a78131dec6b3a0e",
"selection_as_of": "2026-08-25T17:00:19Z",
"facts": [
"MRK gained 2.80%, traded above VWAP and up, and showed a 0.938 intraday range position.",
"The sealed catalyst related to a Moderna cancer-vaccine and melanoma partnership.",
"RSI was 83.74, the move was 3.53 ATR above the EMA reference, and volume ratio was 0.48x."
],
"price_as_of": "2026-08-25T21:20:21Z",
"vwap_as_of": null
}
],
"benchmarks": [],
"coverage": {
"candidate_rows": 5,
"candidate_prices": 5,
"candidate_technical": 3,
"benchmark_rows": 0
}
}
},
{
"day": 9,
"timestamp": "2026-09-08T14:32:56.297090Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-09-08T14:32:56.297090Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "KURA",
"role": "selected",
"price": 12.76,
"base_price": 13.79,
"return_since_base_pct": -7.4692,
"session_return_pct": -3.7,
"change_since_prior_pct": -1.9216,
"volume_ratio": 0.14,
"rsi": 54.16,
"vwap": 12.75,
"vwap_distance_pct": 0.0784,
"position_52w_pct": 91.8,
"extended_hours_pct": null,
"as_of": "2026-09-08T14:06:19.550837Z",
"source": "yfinance_quote",
"name": "Kura Oncology, Inc.",
"episode_id": "n0:KURA:2026-08-25",
"ema_trend": "12.84 > 12.19 > 11.3",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:58.818200Z",
"facts": [
"KURA gained 11.21%, with a 1.42x volume ratio, an 85.7 volume percentile and +10.76% relative strength versus QQQ.",
"The sealed catalyst package includes a reported $1.24 million CEO stock purchase, 57% KOMZIFTI revenue growth and 35% growth in new patient starts.",
"The captured intraday view showed KURA above VWAP and up, with an intraday range position of 0.998."
],
"price_as_of": "2026-09-08T14:06:19.550837Z",
"vwap_as_of": null
},
{
"symbol": "CRML",
"role": "alternative",
"price": 8.4469,
"base_price": 7.955,
"return_since_base_pct": 6.1835,
"session_return_pct": 4.2827,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.64,
"rsi": 61.49,
"vwap": 7.6,
"vwap_distance_pct": 11.1434,
"position_52w_pct": 24.71,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:20:04Z",
"source": "yfinance_quote",
"name": "Critical Metals Corp.",
"episode_id": "n0:CRML:2026-08-25",
"ema_trend": "6.8 > 6.75 > 7.63",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:50.354399Z",
"facts": [
"CRML gained 19.27% with +18.82% relative strength versus QQQ and a 1.64x volume ratio.",
"The rare-earth and European lithium merger narrative had no company announcement in the secondary news packet.",
"Short interest was 29.37% and the move was 1.98 ATR above the EMA reference."
],
"price_as_of": "2026-08-25T21:20:04Z",
"vwap_as_of": null
},
{
"symbol": "LEU",
"role": "alternative",
"price": 193.0,
"base_price": 185.37,
"return_since_base_pct": 4.1161,
"session_return_pct": -0.2017,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.29,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:17:47Z",
"source": "yfinance_quote",
"name": "Centrus Energy Corp.",
"episode_id": "narrative:LEU:d551ea7899e32218",
"selection_as_of": "2026-08-25T17:00:00Z",
"facts": [
"LEU was above VWAP and up, with a 0.963 intraday range position and a +5.44% relative-strength reading versus QQQ.",
"The sealed catalyst package connected X-Energy, Ohio and federal attention to domestic fuel and energy-security activity.",
"Volume ratio was only 0.29x, while the quoted options spread was 11.36%."
],
"price_as_of": "2026-08-25T21:17:47Z",
"vwap_as_of": null
},
{
"symbol": "GENB",
"role": "alternative",
"price": 20.11,
"base_price": 20.869,
"return_since_base_pct": -3.637,
"session_return_pct": -1.3248,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.06,
"rsi": 80.02,
"vwap": 20.73,
"vwap_distance_pct": -2.9908,
"position_52w_pct": 91.84,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:12:46Z",
"source": "yfinance_quote",
"name": "Generate Biomedicines, Inc.",
"episode_id": "n0:GENB:2026-08-25",
"ema_trend": "17.05 > 15.86 > 15.0",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:23.027806Z",
"facts": [
"GENB gained 17.77% with a 3.06x volume ratio and +17.32% relative strength versus QQQ.",
"The sealed options snapshot was unavailable.",
"The catalyst was not a direct issuer-specific event in the corrected evidence."
],
"price_as_of": "2026-08-25T21:12:46Z",
"vwap_as_of": null
},
{
"symbol": "MRK",
"role": "alternative",
"price": 156.38,
"base_price": 154.8999,
"return_since_base_pct": 0.9555,
"session_return_pct": -0.0447,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.48,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:20:21Z",
"source": "yfinance_quote",
"name": "Merck & Co., Inc.",
"episode_id": "narrative:MRK:5a78131dec6b3a0e",
"selection_as_of": "2026-08-25T17:00:19Z",
"facts": [
"MRK gained 2.80%, traded above VWAP and up, and showed a 0.938 intraday range position.",
"The sealed catalyst related to a Moderna cancer-vaccine and melanoma partnership.",
"RSI was 83.74, the move was 3.53 ATR above the EMA reference, and volume ratio was 0.48x."
],
"price_as_of": "2026-08-25T21:20:21Z",
"vwap_as_of": null
}
],
"benchmarks": [],
"coverage": {
"candidate_rows": 5,
"candidate_prices": 5,
"candidate_technical": 3,
"benchmark_rows": 0
}
}
},
{
"day": 9,
"timestamp": "2026-09-08T19:47:47.440697Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-09-08T19:47:47.440697Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "KURA",
"role": "selected",
"price": 12.625,
"base_price": 13.79,
"return_since_base_pct": -8.4482,
"session_return_pct": -4.72,
"change_since_prior_pct": -1.058,
"volume_ratio": 0.61,
"rsi": 52.78,
"vwap": 12.76,
"vwap_distance_pct": -1.058,
"position_52w_pct": 90.8,
"extended_hours_pct": null,
"as_of": "2026-09-08T19:22:03.550453Z",
"source": "yfinance_quote",
"name": "Kura Oncology, Inc.",
"episode_id": "n0:KURA:2026-08-25",
"ema_trend": "12.81 > 12.18 > 11.29",
"vwap_state": "below",
"selection_as_of": "2026-08-25T15:15:58.818200Z",
"facts": [
"KURA gained 11.21%, with a 1.42x volume ratio, an 85.7 volume percentile and +10.76% relative strength versus QQQ.",
"The sealed catalyst package includes a reported $1.24 million CEO stock purchase, 57% KOMZIFTI revenue growth and 35% growth in new patient starts.",
"The captured intraday view showed KURA above VWAP and up, with an intraday range position of 0.998."
],
"price_as_of": "2026-09-08T19:22:03.550453Z",
"vwap_as_of": null
},
{
"symbol": "CRML",
"role": "alternative",
"price": 8.4469,
"base_price": 7.955,
"return_since_base_pct": 6.1835,
"session_return_pct": 4.2827,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.64,
"rsi": 61.49,
"vwap": 7.6,
"vwap_distance_pct": 11.1434,
"position_52w_pct": 24.71,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:20:04Z",
"source": "yfinance_quote",
"name": "Critical Metals Corp.",
"episode_id": "n0:CRML:2026-08-25",
"ema_trend": "6.8 > 6.75 > 7.63",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:50.354399Z",
"facts": [
"CRML gained 19.27% with +18.82% relative strength versus QQQ and a 1.64x volume ratio.",
"The rare-earth and European lithium merger narrative had no company announcement in the secondary news packet.",
"Short interest was 29.37% and the move was 1.98 ATR above the EMA reference."
],
"price_as_of": "2026-08-25T21:20:04Z",
"vwap_as_of": null
},
{
"symbol": "LEU",
"role": "alternative",
"price": 193.0,
"base_price": 185.37,
"return_since_base_pct": 4.1161,
"session_return_pct": -0.2017,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.29,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:17:47Z",
"source": "yfinance_quote",
"name": "Centrus Energy Corp.",
"episode_id": "narrative:LEU:d551ea7899e32218",
"selection_as_of": "2026-08-25T17:00:00Z",
"facts": [
"LEU was above VWAP and up, with a 0.963 intraday range position and a +5.44% relative-strength reading versus QQQ.",
"The sealed catalyst package connected X-Energy, Ohio and federal attention to domestic fuel and energy-security activity.",
"Volume ratio was only 0.29x, while the quoted options spread was 11.36%."
],
"price_as_of": "2026-08-25T21:17:47Z",
"vwap_as_of": null
},
{
"symbol": "GENB",
"role": "alternative",
"price": 20.11,
"base_price": 20.869,
"return_since_base_pct": -3.637,
"session_return_pct": -1.3248,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.06,
"rsi": 80.02,
"vwap": 20.73,
"vwap_distance_pct": -2.9908,
"position_52w_pct": 91.84,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:12:46Z",
"source": "yfinance_quote",
"name": "Generate Biomedicines, Inc.",
"episode_id": "n0:GENB:2026-08-25",
"ema_trend": "17.05 > 15.86 > 15.0",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:23.027806Z",
"facts": [
"GENB gained 17.77% with a 3.06x volume ratio and +17.32% relative strength versus QQQ.",
"The sealed options snapshot was unavailable.",
"The catalyst was not a direct issuer-specific event in the corrected evidence."
],
"price_as_of": "2026-08-25T21:12:46Z",
"vwap_as_of": null
},
{
"symbol": "MRK",
"role": "alternative",
"price": 156.38,
"base_price": 154.8999,
"return_since_base_pct": 0.9555,
"session_return_pct": -0.0447,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.48,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:20:21Z",
"source": "yfinance_quote",
"name": "Merck & Co., Inc.",
"episode_id": "narrative:MRK:5a78131dec6b3a0e",
"selection_as_of": "2026-08-25T17:00:19Z",
"facts": [
"MRK gained 2.80%, traded above VWAP and up, and showed a 0.938 intraday range position.",
"The sealed catalyst related to a Moderna cancer-vaccine and melanoma partnership.",
"RSI was 83.74, the move was 3.53 ATR above the EMA reference, and volume ratio was 0.48x."
],
"price_as_of": "2026-08-25T21:20:21Z",
"vwap_as_of": null
}
],
"benchmarks": [],
"coverage": {
"candidate_rows": 5,
"candidate_prices": 5,
"candidate_technical": 3,
"benchmark_rows": 0
}
}
},
{
"day": 9,
"timestamp": "2026-09-08T22:00:29.448100Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-09-08T22:00:29.448100Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "KURA",
"role": "selected",
"price": 12.57,
"base_price": 13.79,
"return_since_base_pct": -8.847,
"session_return_pct": -5.51,
"change_since_prior_pct": -0.4356,
"volume_ratio": 0.84,
"rsi": 51.76,
"vwap": 12.76,
"vwap_distance_pct": -1.489,
"position_52w_pct": 90.1,
"extended_hours_pct": 0.4,
"as_of": "2026-09-08T21:13:23Z",
"source": "sealed_extended_quote",
"name": "Kura Oncology, Inc.",
"episode_id": "n0:KURA:2026-08-25",
"ema_trend": "12.79 > 12.17 > 11.29",
"vwap_state": "below",
"selection_as_of": "2026-08-25T15:15:58.818200Z",
"facts": [
"KURA gained 11.21%, with a 1.42x volume ratio, an 85.7 volume percentile and +10.76% relative strength versus QQQ.",
"The sealed catalyst package includes a reported $1.24 million CEO stock purchase, 57% KOMZIFTI revenue growth and 35% growth in new patient starts.",
"The captured intraday view showed KURA above VWAP and up, with an intraday range position of 0.998."
],
"benchmark_excess_pct": {
"sp500": -4.926,
"nasdaq100": -5.3866,
"russell2000": -4.991
},
"price_as_of": "2026-09-08T21:13:23Z",
"vwap_as_of": null
},
{
"symbol": "CRML",
"role": "alternative",
"price": 8.4469,
"base_price": 7.955,
"return_since_base_pct": 6.1835,
"session_return_pct": 4.2827,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.64,
"rsi": 61.49,
"vwap": 7.6,
"vwap_distance_pct": 11.1434,
"position_52w_pct": 24.71,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:20:04Z",
"source": "yfinance_quote",
"name": "Critical Metals Corp.",
"episode_id": "n0:CRML:2026-08-25",
"ema_trend": "6.8 > 6.75 > 7.63",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:50.354399Z",
"facts": [
"CRML gained 19.27% with +18.82% relative strength versus QQQ and a 1.64x volume ratio.",
"The rare-earth and European lithium merger narrative had no company announcement in the secondary news packet.",
"Short interest was 29.37% and the move was 1.98 ATR above the EMA reference."
],
"benchmark_excess_pct": {
"sp500": 4.8667,
"nasdaq100": 4.4061,
"russell2000": 4.8017
},
"price_as_of": "2026-08-25T21:20:04Z",
"vwap_as_of": null
},
{
"symbol": "LEU",
"role": "alternative",
"price": 193.0,
"base_price": 185.37,
"return_since_base_pct": 4.1161,
"session_return_pct": -0.2017,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.29,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:17:47Z",
"source": "yfinance_quote",
"name": "Centrus Energy Corp.",
"episode_id": "narrative:LEU:d551ea7899e32218",
"selection_as_of": "2026-08-25T17:00:00Z",
"facts": [
"LEU was above VWAP and up, with a 0.963 intraday range position and a +5.44% relative-strength reading versus QQQ.",
"The sealed catalyst package connected X-Energy, Ohio and federal attention to domestic fuel and energy-security activity.",
"Volume ratio was only 0.29x, while the quoted options spread was 11.36%."
],
"benchmark_excess_pct": {
"sp500": 0.3823,
"nasdaq100": -0.0783,
"russell2000": 0.3173
},
"price_as_of": "2026-08-25T21:17:47Z",
"vwap_as_of": null
},
{
"symbol": "GENB",
"role": "alternative",
"price": 20.11,
"base_price": 20.869,
"return_since_base_pct": -3.637,
"session_return_pct": -1.3248,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.06,
"rsi": 80.02,
"vwap": 20.73,
"vwap_distance_pct": -2.9908,
"position_52w_pct": 91.84,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:12:46Z",
"source": "yfinance_quote",
"name": "Generate Biomedicines, Inc.",
"episode_id": "n0:GENB:2026-08-25",
"ema_trend": "17.05 > 15.86 > 15.0",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:23.027806Z",
"facts": [
"GENB gained 17.77% with a 3.06x volume ratio and +17.32% relative strength versus QQQ.",
"The sealed options snapshot was unavailable.",
"The catalyst was not a direct issuer-specific event in the corrected evidence."
],
"benchmark_excess_pct": {
"sp500": -0.7408,
"nasdaq100": -1.2014,
"russell2000": -0.8058
},
"price_as_of": "2026-08-25T21:12:46Z",
"vwap_as_of": null
},
{
"symbol": "MRK",
"role": "alternative",
"price": 156.38,
"base_price": 154.8999,
"return_since_base_pct": 0.9555,
"session_return_pct": -0.0447,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.48,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:20:21Z",
"source": "yfinance_quote",
"name": "Merck & Co., Inc.",
"episode_id": "narrative:MRK:5a78131dec6b3a0e",
"selection_as_of": "2026-08-25T17:00:19Z",
"facts": [
"MRK gained 2.80%, traded above VWAP and up, and showed a 0.938 intraday range position.",
"The sealed catalyst related to a Moderna cancer-vaccine and melanoma partnership.",
"RSI was 83.74, the move was 3.53 ATR above the EMA reference, and volume ratio was 0.48x."
],
"benchmark_excess_pct": {
"sp500": 0.5393,
"nasdaq100": 0.0787,
"russell2000": 0.4743
},
"price_as_of": "2026-08-25T21:20:21Z",
"vwap_as_of": null
}
],
"benchmarks": [
{
"id": "sp500",
"symbol": "^GSPC",
"label": "S&P 500",
"role": "benchmark",
"price": 7673.52,
"base_price": 7718.6,
"return_since_base_pct": -0.584,
"session_return_pct": -0.584,
"as_of": "2026-09-08T22:00:24.149802Z",
"source": "yfinance.ticker_info",
"base_definition": "previous regular close"
},
{
"id": "nasdaq100",
"symbol": "^NDX",
"label": "Nasdaq 100",
"role": "benchmark",
"price": 29507.701,
"base_price": 29544.154,
"return_since_base_pct": -0.1234,
"session_return_pct": -0.1234,
"as_of": "2026-09-08T22:00:24.149802Z",
"source": "yfinance.ticker_info",
"base_definition": "previous regular close"
},
{
"id": "russell2000",
"symbol": "^RUT",
"label": "Russell 2000",
"role": "benchmark",
"price": 2960.2036,
"base_price": 2975.648,
"return_since_base_pct": -0.519,
"session_return_pct": -0.519,
"as_of": "2026-09-08T22:00:24.149802Z",
"source": "yfinance.ticker_info",
"base_definition": "previous regular close"
}
],
"coverage": {
"candidate_rows": 5,
"candidate_prices": 5,
"candidate_technical": 3,
"benchmark_rows": 3
}
}
},
{
"day": 10,
"timestamp": "2026-09-09T14:34:38.262426Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-09-09T14:34:38.262426Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "KURA",
"role": "selected",
"price": 12.46,
"base_price": 13.79,
"return_since_base_pct": -9.6447,
"session_return_pct": -0.48,
"change_since_prior_pct": -0.8751,
"volume_ratio": 0.14,
"rsi": 49.34,
"vwap": 12.48,
"vwap_distance_pct": -0.1603,
"position_52w_pct": 89.6,
"extended_hours_pct": null,
"as_of": "2026-09-09T14:06:47.281893Z",
"source": "yfinance_quote",
"name": "Kura Oncology, Inc.",
"episode_id": "n0:KURA:2026-08-25",
"ema_trend": "12.73 > 12.2 > 11.34",
"vwap_state": "below",
"selection_as_of": "2026-08-25T15:15:58.818200Z",
"facts": [
"KURA gained 11.21%, with a 1.42x volume ratio, an 85.7 volume percentile and +10.76% relative strength versus QQQ.",
"The sealed catalyst package includes a reported $1.24 million CEO stock purchase, 57% KOMZIFTI revenue growth and 35% growth in new patient starts.",
"The captured intraday view showed KURA above VWAP and up, with an intraday range position of 0.998."
],
"price_as_of": "2026-09-09T14:06:47.281893Z",
"vwap_as_of": null
},
{
"symbol": "CRML",
"role": "alternative",
"price": 8.4469,
"base_price": 7.955,
"return_since_base_pct": 6.1835,
"session_return_pct": 4.2827,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.64,
"rsi": 61.49,
"vwap": 7.6,
"vwap_distance_pct": 11.1434,
"position_52w_pct": 24.71,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:20:04Z",
"source": "yfinance_quote",
"name": "Critical Metals Corp.",
"episode_id": "n0:CRML:2026-08-25",
"ema_trend": "6.8 > 6.75 > 7.63",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:50.354399Z",
"facts": [
"CRML gained 19.27% with +18.82% relative strength versus QQQ and a 1.64x volume ratio.",
"The rare-earth and European lithium merger narrative had no company announcement in the secondary news packet.",
"Short interest was 29.37% and the move was 1.98 ATR above the EMA reference."
],
"price_as_of": "2026-08-25T21:20:04Z",
"vwap_as_of": null
},
{
"symbol": "LEU",
"role": "alternative",
"price": 193.0,
"base_price": 185.37,
"return_since_base_pct": 4.1161,
"session_return_pct": -0.2017,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.29,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:17:47Z",
"source": "yfinance_quote",
"name": "Centrus Energy Corp.",
"episode_id": "narrative:LEU:d551ea7899e32218",
"selection_as_of": "2026-08-25T17:00:00Z",
"facts": [
"LEU was above VWAP and up, with a 0.963 intraday range position and a +5.44% relative-strength reading versus QQQ.",
"The sealed catalyst package connected X-Energy, Ohio and federal attention to domestic fuel and energy-security activity.",
"Volume ratio was only 0.29x, while the quoted options spread was 11.36%."
],
"price_as_of": "2026-08-25T21:17:47Z",
"vwap_as_of": null
},
{
"symbol": "GENB",
"role": "alternative",
"price": 20.11,
"base_price": 20.869,
"return_since_base_pct": -3.637,
"session_return_pct": -1.3248,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.06,
"rsi": 80.02,
"vwap": 20.73,
"vwap_distance_pct": -2.9908,
"position_52w_pct": 91.84,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:12:46Z",
"source": "yfinance_quote",
"name": "Generate Biomedicines, Inc.",
"episode_id": "n0:GENB:2026-08-25",
"ema_trend": "17.05 > 15.86 > 15.0",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:23.027806Z",
"facts": [
"GENB gained 17.77% with a 3.06x volume ratio and +17.32% relative strength versus QQQ.",
"The sealed options snapshot was unavailable.",
"The catalyst was not a direct issuer-specific event in the corrected evidence."
],
"price_as_of": "2026-08-25T21:12:46Z",
"vwap_as_of": null
},
{
"symbol": "MRK",
"role": "alternative",
"price": 156.38,
"base_price": 154.8999,
"return_since_base_pct": 0.9555,
"session_return_pct": -0.0447,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.48,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:20:21Z",
"source": "yfinance_quote",
"name": "Merck & Co., Inc.",
"episode_id": "narrative:MRK:5a78131dec6b3a0e",
"selection_as_of": "2026-08-25T17:00:19Z",
"facts": [
"MRK gained 2.80%, traded above VWAP and up, and showed a 0.938 intraday range position.",
"The sealed catalyst related to a Moderna cancer-vaccine and melanoma partnership.",
"RSI was 83.74, the move was 3.53 ATR above the EMA reference, and volume ratio was 0.48x."
],
"price_as_of": "2026-08-25T21:20:21Z",
"vwap_as_of": null
}
],
"benchmarks": [],
"coverage": {
"candidate_rows": 5,
"candidate_prices": 5,
"candidate_technical": 3,
"benchmark_rows": 0
}
}
},
{
"day": 10,
"timestamp": "2026-09-09T20:21:12.674492Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-09-09T20:21:12.674492Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "KURA",
"role": "selected",
"price": 12.035,
"base_price": 13.79,
"return_since_base_pct": -12.7266,
"session_return_pct": -3.87,
"change_since_prior_pct": -3.4109,
"volume_ratio": 0.82,
"rsi": 45.65,
"vwap": 12.21,
"vwap_distance_pct": -1.4333,
"position_52w_pct": 86.6,
"extended_hours_pct": null,
"as_of": "2026-09-09T19:21:49.561649Z",
"source": "yfinance_quote",
"name": "Kura Oncology, Inc.",
"episode_id": "n0:KURA:2026-08-25",
"ema_trend": "12.64 > 12.16 > 11.32",
"vwap_state": "below",
"selection_as_of": "2026-08-25T15:15:58.818200Z",
"facts": [
"KURA gained 11.21%, with a 1.42x volume ratio, an 85.7 volume percentile and +10.76% relative strength versus QQQ.",
"The sealed catalyst package includes a reported $1.24 million CEO stock purchase, 57% KOMZIFTI revenue growth and 35% growth in new patient starts.",
"The captured intraday view showed KURA above VWAP and up, with an intraday range position of 0.998."
],
"price_as_of": "2026-09-09T19:21:49.561649Z",
"vwap_as_of": null
},
{
"symbol": "CRML",
"role": "alternative",
"price": 8.4469,
"base_price": 7.955,
"return_since_base_pct": 6.1835,
"session_return_pct": 4.2827,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.64,
"rsi": 61.49,
"vwap": 7.6,
"vwap_distance_pct": 11.1434,
"position_52w_pct": 24.71,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:20:04Z",
"source": "yfinance_quote",
"name": "Critical Metals Corp.",
"episode_id": "n0:CRML:2026-08-25",
"ema_trend": "6.8 > 6.75 > 7.63",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:50.354399Z",
"facts": [
"CRML gained 19.27% with +18.82% relative strength versus QQQ and a 1.64x volume ratio.",
"The rare-earth and European lithium merger narrative had no company announcement in the secondary news packet.",
"Short interest was 29.37% and the move was 1.98 ATR above the EMA reference."
],
"price_as_of": "2026-08-25T21:20:04Z",
"vwap_as_of": null
},
{
"symbol": "LEU",
"role": "alternative",
"price": 193.0,
"base_price": 185.37,
"return_since_base_pct": 4.1161,
"session_return_pct": -0.2017,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.29,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:17:47Z",
"source": "yfinance_quote",
"name": "Centrus Energy Corp.",
"episode_id": "narrative:LEU:d551ea7899e32218",
"selection_as_of": "2026-08-25T17:00:00Z",
"facts": [
"LEU was above VWAP and up, with a 0.963 intraday range position and a +5.44% relative-strength reading versus QQQ.",
"The sealed catalyst package connected X-Energy, Ohio and federal attention to domestic fuel and energy-security activity.",
"Volume ratio was only 0.29x, while the quoted options spread was 11.36%."
],
"price_as_of": "2026-08-25T21:17:47Z",
"vwap_as_of": null
},
{
"symbol": "GENB",
"role": "alternative",
"price": 20.11,
"base_price": 20.869,
"return_since_base_pct": -3.637,
"session_return_pct": -1.3248,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.06,
"rsi": 80.02,
"vwap": 20.73,
"vwap_distance_pct": -2.9908,
"position_52w_pct": 91.84,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:12:46Z",
"source": "yfinance_quote",
"name": "Generate Biomedicines, Inc.",
"episode_id": "n0:GENB:2026-08-25",
"ema_trend": "17.05 > 15.86 > 15.0",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:23.027806Z",
"facts": [
"GENB gained 17.77% with a 3.06x volume ratio and +17.32% relative strength versus QQQ.",
"The sealed options snapshot was unavailable.",
"The catalyst was not a direct issuer-specific event in the corrected evidence."
],
"price_as_of": "2026-08-25T21:12:46Z",
"vwap_as_of": null
},
{
"symbol": "MRK",
"role": "alternative",
"price": 156.38,
"base_price": 154.8999,
"return_since_base_pct": 0.9555,
"session_return_pct": -0.0447,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.48,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:20:21Z",
"source": "yfinance_quote",
"name": "Merck & Co., Inc.",
"episode_id": "narrative:MRK:5a78131dec6b3a0e",
"selection_as_of": "2026-08-25T17:00:19Z",
"facts": [
"MRK gained 2.80%, traded above VWAP and up, and showed a 0.938 intraday range position.",
"The sealed catalyst related to a Moderna cancer-vaccine and melanoma partnership.",
"RSI was 83.74, the move was 3.53 ATR above the EMA reference, and volume ratio was 0.48x."
],
"price_as_of": "2026-08-25T21:20:21Z",
"vwap_as_of": null
}
],
"benchmarks": [],
"coverage": {
"candidate_rows": 5,
"candidate_prices": 5,
"candidate_technical": 3,
"benchmark_rows": 0
}
}
},
{
"day": 10,
"timestamp": "2026-09-09T22:21:24.090061Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-09-09T22:21:24.090061Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "KURA",
"role": "selected",
"price": 12.6,
"base_price": 13.79,
"return_since_base_pct": -8.6294,
"session_return_pct": -3.43,
"change_since_prior_pct": 4.6946,
"volume_ratio": 1.24,
"rsi": 46.1,
"vwap": 12.21,
"vwap_distance_pct": 3.1941,
"position_52w_pct": 87.0,
"extended_hours_pct": 4.21,
"as_of": "2026-09-09T21:28:21Z",
"source": "sealed_extended_quote",
"name": "Kura Oncology, Inc.",
"episode_id": "n0:KURA:2026-08-25",
"ema_trend": "12.65 > 12.16 > 11.32",
"vwap_state": "below",
"selection_as_of": "2026-08-25T15:15:58.818200Z",
"facts": [
"KURA gained 11.21%, with a 1.42x volume ratio, an 85.7 volume percentile and +10.76% relative strength versus QQQ.",
"The sealed catalyst package includes a reported $1.24 million CEO stock purchase, 57% KOMZIFTI revenue growth and 35% growth in new patient starts.",
"The captured intraday view showed KURA above VWAP and up, with an intraday range position of 0.998."
],
"price_as_of": "2026-09-09T21:28:21Z",
"vwap_as_of": null
},
{
"symbol": "CRML",
"role": "alternative",
"price": 8.4469,
"base_price": 7.955,
"return_since_base_pct": 6.1835,
"session_return_pct": 4.2827,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.64,
"rsi": 61.49,
"vwap": 7.6,
"vwap_distance_pct": 11.1434,
"position_52w_pct": 24.71,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:20:04Z",
"source": "yfinance_quote",
"name": "Critical Metals Corp.",
"episode_id": "n0:CRML:2026-08-25",
"ema_trend": "6.8 > 6.75 > 7.63",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:50.354399Z",
"facts": [
"CRML gained 19.27% with +18.82% relative strength versus QQQ and a 1.64x volume ratio.",
"The rare-earth and European lithium merger narrative had no company announcement in the secondary news packet.",
"Short interest was 29.37% and the move was 1.98 ATR above the EMA reference."
],
"price_as_of": "2026-08-25T21:20:04Z",
"vwap_as_of": null
},
{
"symbol": "LEU",
"role": "alternative",
"price": 193.0,
"base_price": 185.37,
"return_since_base_pct": 4.1161,
"session_return_pct": -0.2017,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.29,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:17:47Z",
"source": "yfinance_quote",
"name": "Centrus Energy Corp.",
"episode_id": "narrative:LEU:d551ea7899e32218",
"selection_as_of": "2026-08-25T17:00:00Z",
"facts": [
"LEU was above VWAP and up, with a 0.963 intraday range position and a +5.44% relative-strength reading versus QQQ.",
"The sealed catalyst package connected X-Energy, Ohio and federal attention to domestic fuel and energy-security activity.",
"Volume ratio was only 0.29x, while the quoted options spread was 11.36%."
],
"price_as_of": "2026-08-25T21:17:47Z",
"vwap_as_of": null
},
{
"symbol": "GENB",
"role": "alternative",
"price": 20.11,
"base_price": 20.869,
"return_since_base_pct": -3.637,
"session_return_pct": -1.3248,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.06,
"rsi": 80.02,
"vwap": 20.73,
"vwap_distance_pct": -2.9908,
"position_52w_pct": 91.84,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:12:46Z",
"source": "yfinance_quote",
"name": "Generate Biomedicines, Inc.",
"episode_id": "n0:GENB:2026-08-25",
"ema_trend": "17.05 > 15.86 > 15.0",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:23.027806Z",
"facts": [
"GENB gained 17.77% with a 3.06x volume ratio and +17.32% relative strength versus QQQ.",
"The sealed options snapshot was unavailable.",
"The catalyst was not a direct issuer-specific event in the corrected evidence."
],
"price_as_of": "2026-08-25T21:12:46Z",
"vwap_as_of": null
},
{
"symbol": "MRK",
"role": "alternative",
"price": 156.38,
"base_price": 154.8999,
"return_since_base_pct": 0.9555,
"session_return_pct": -0.0447,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.48,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:20:21Z",
"source": "yfinance_quote",
"name": "Merck & Co., Inc.",
"episode_id": "narrative:MRK:5a78131dec6b3a0e",
"selection_as_of": "2026-08-25T17:00:19Z",
"facts": [
"MRK gained 2.80%, traded above VWAP and up, and showed a 0.938 intraday range position.",
"The sealed catalyst related to a Moderna cancer-vaccine and melanoma partnership.",
"RSI was 83.74, the move was 3.53 ATR above the EMA reference, and volume ratio was 0.48x."
],
"price_as_of": "2026-08-25T21:20:21Z",
"vwap_as_of": null
}
],
"benchmarks": [],
"coverage": {
"candidate_rows": 5,
"candidate_prices": 5,
"candidate_technical": 3,
"benchmark_rows": 0
}
}
},
{
"day": 11,
"timestamp": "2026-09-10T14:36:25.701868Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-09-10T14:36:25.701868Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "KURA",
"role": "selected",
"price": 11.78,
"base_price": 13.79,
"return_since_base_pct": -14.5758,
"session_return_pct": -2.56,
"change_since_prior_pct": -6.5079,
"volume_ratio": 0.12,
"rsi": 50.68,
"vwap": 11.83,
"vwap_distance_pct": -0.4227,
"position_52w_pct": 84.7,
"extended_hours_pct": null,
"as_of": "2026-09-10T14:06:15.609526Z",
"source": "yfinance_quote",
"name": "Kura Oncology, Inc.",
"episode_id": "n0:KURA:2026-08-25",
"ema_trend": "12.48 > 12.13 > 11.34",
"vwap_state": "below",
"selection_as_of": "2026-08-25T15:15:58.818200Z",
"facts": [
"KURA gained 11.21%, with a 1.42x volume ratio, an 85.7 volume percentile and +10.76% relative strength versus QQQ.",
"The sealed catalyst package includes a reported $1.24 million CEO stock purchase, 57% KOMZIFTI revenue growth and 35% growth in new patient starts.",
"The captured intraday view showed KURA above VWAP and up, with an intraday range position of 0.998."
],
"price_as_of": "2026-09-10T14:06:15.609526Z",
"vwap_as_of": null
},
{
"symbol": "CRML",
"role": "alternative",
"price": 8.4469,
"base_price": 7.955,
"return_since_base_pct": 6.1835,
"session_return_pct": 4.2827,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.64,
"rsi": 61.49,
"vwap": 7.6,
"vwap_distance_pct": 11.1434,
"position_52w_pct": 24.71,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:20:04Z",
"source": "yfinance_quote",
"name": "Critical Metals Corp.",
"episode_id": "n0:CRML:2026-08-25",
"ema_trend": "6.8 > 6.75 > 7.63",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:50.354399Z",
"facts": [
"CRML gained 19.27% with +18.82% relative strength versus QQQ and a 1.64x volume ratio.",
"The rare-earth and European lithium merger narrative had no company announcement in the secondary news packet.",
"Short interest was 29.37% and the move was 1.98 ATR above the EMA reference."
],
"price_as_of": "2026-08-25T21:20:04Z",
"vwap_as_of": null
},
{
"symbol": "LEU",
"role": "alternative",
"price": 193.0,
"base_price": 185.37,
"return_since_base_pct": 4.1161,
"session_return_pct": -0.2017,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.29,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:17:47Z",
"source": "yfinance_quote",
"name": "Centrus Energy Corp.",
"episode_id": "narrative:LEU:d551ea7899e32218",
"selection_as_of": "2026-08-25T17:00:00Z",
"facts": [
"LEU was above VWAP and up, with a 0.963 intraday range position and a +5.44% relative-strength reading versus QQQ.",
"The sealed catalyst package connected X-Energy, Ohio and federal attention to domestic fuel and energy-security activity.",
"Volume ratio was only 0.29x, while the quoted options spread was 11.36%."
],
"price_as_of": "2026-08-25T21:17:47Z",
"vwap_as_of": null
},
{
"symbol": "GENB",
"role": "alternative",
"price": 20.11,
"base_price": 20.869,
"return_since_base_pct": -3.637,
"session_return_pct": -1.3248,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.06,
"rsi": 80.02,
"vwap": 20.73,
"vwap_distance_pct": -2.9908,
"position_52w_pct": 91.84,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:12:46Z",
"source": "yfinance_quote",
"name": "Generate Biomedicines, Inc.",
"episode_id": "n0:GENB:2026-08-25",
"ema_trend": "17.05 > 15.86 > 15.0",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:23.027806Z",
"facts": [
"GENB gained 17.77% with a 3.06x volume ratio and +17.32% relative strength versus QQQ.",
"The sealed options snapshot was unavailable.",
"The catalyst was not a direct issuer-specific event in the corrected evidence."
],
"price_as_of": "2026-08-25T21:12:46Z",
"vwap_as_of": null
},
{
"symbol": "MRK",
"role": "alternative",
"price": 156.38,
"base_price": 154.8999,
"return_since_base_pct": 0.9555,
"session_return_pct": -0.0447,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.48,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:20:21Z",
"source": "yfinance_quote",
"name": "Merck & Co., Inc.",
"episode_id": "narrative:MRK:5a78131dec6b3a0e",
"selection_as_of": "2026-08-25T17:00:19Z",
"facts": [
"MRK gained 2.80%, traded above VWAP and up, and showed a 0.938 intraday range position.",
"The sealed catalyst related to a Moderna cancer-vaccine and melanoma partnership.",
"RSI was 83.74, the move was 3.53 ATR above the EMA reference, and volume ratio was 0.48x."
],
"price_as_of": "2026-08-25T21:20:21Z",
"vwap_as_of": null
}
],
"benchmarks": [],
"coverage": {
"candidate_rows": 5,
"candidate_prices": 5,
"candidate_technical": 3,
"benchmark_rows": 0
}
}
},
{
"day": 11,
"timestamp": "2026-09-10T20:00:18.313110Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-09-10T20:00:18.313110Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "KURA",
"role": "selected",
"price": 11.525,
"base_price": 13.79,
"return_since_base_pct": -16.4249,
"session_return_pct": -4.67,
"change_since_prior_pct": -2.1647,
"volume_ratio": 0.62,
"rsi": 48.28,
"vwap": 11.66,
"vwap_distance_pct": -1.1578,
"position_52w_pct": 82.9,
"extended_hours_pct": null,
"as_of": "2026-09-10T19:21:10.275300Z",
"source": "yfinance_quote",
"name": "Kura Oncology, Inc.",
"episode_id": "n0:KURA:2026-08-25",
"ema_trend": "12.43 > 12.11 > 11.33",
"vwap_state": "below",
"selection_as_of": "2026-08-25T15:15:58.818200Z",
"facts": [
"KURA gained 11.21%, with a 1.42x volume ratio, an 85.7 volume percentile and +10.76% relative strength versus QQQ.",
"The sealed catalyst package includes a reported $1.24 million CEO stock purchase, 57% KOMZIFTI revenue growth and 35% growth in new patient starts.",
"The captured intraday view showed KURA above VWAP and up, with an intraday range position of 0.998."
],
"price_as_of": "2026-09-10T19:21:10.275300Z",
"vwap_as_of": null
},
{
"symbol": "CRML",
"role": "alternative",
"price": 8.4469,
"base_price": 7.955,
"return_since_base_pct": 6.1835,
"session_return_pct": 4.2827,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.64,
"rsi": 61.49,
"vwap": 7.6,
"vwap_distance_pct": 11.1434,
"position_52w_pct": 24.71,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:20:04Z",
"source": "yfinance_quote",
"name": "Critical Metals Corp.",
"episode_id": "n0:CRML:2026-08-25",
"ema_trend": "6.8 > 6.75 > 7.63",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:50.354399Z",
"facts": [
"CRML gained 19.27% with +18.82% relative strength versus QQQ and a 1.64x volume ratio.",
"The rare-earth and European lithium merger narrative had no company announcement in the secondary news packet.",
"Short interest was 29.37% and the move was 1.98 ATR above the EMA reference."
],
"price_as_of": "2026-08-25T21:20:04Z",
"vwap_as_of": null
},
{
"symbol": "LEU",
"role": "alternative",
"price": 193.0,
"base_price": 185.37,
"return_since_base_pct": 4.1161,
"session_return_pct": -0.2017,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.29,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:17:47Z",
"source": "yfinance_quote",
"name": "Centrus Energy Corp.",
"episode_id": "narrative:LEU:d551ea7899e32218",
"selection_as_of": "2026-08-25T17:00:00Z",
"facts": [
"LEU was above VWAP and up, with a 0.963 intraday range position and a +5.44% relative-strength reading versus QQQ.",
"The sealed catalyst package connected X-Energy, Ohio and federal attention to domestic fuel and energy-security activity.",
"Volume ratio was only 0.29x, while the quoted options spread was 11.36%."
],
"price_as_of": "2026-08-25T21:17:47Z",
"vwap_as_of": null
},
{
"symbol": "GENB",
"role": "alternative",
"price": 20.11,
"base_price": 20.869,
"return_since_base_pct": -3.637,
"session_return_pct": -1.3248,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.06,
"rsi": 80.02,
"vwap": 20.73,
"vwap_distance_pct": -2.9908,
"position_52w_pct": 91.84,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:12:46Z",
"source": "yfinance_quote",
"name": "Generate Biomedicines, Inc.",
"episode_id": "n0:GENB:2026-08-25",
"ema_trend": "17.05 > 15.86 > 15.0",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:23.027806Z",
"facts": [
"GENB gained 17.77% with a 3.06x volume ratio and +17.32% relative strength versus QQQ.",
"The sealed options snapshot was unavailable.",
"The catalyst was not a direct issuer-specific event in the corrected evidence."
],
"price_as_of": "2026-08-25T21:12:46Z",
"vwap_as_of": null
},
{
"symbol": "MRK",
"role": "alternative",
"price": 156.38,
"base_price": 154.8999,
"return_since_base_pct": 0.9555,
"session_return_pct": -0.0447,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.48,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:20:21Z",
"source": "yfinance_quote",
"name": "Merck & Co., Inc.",
"episode_id": "narrative:MRK:5a78131dec6b3a0e",
"selection_as_of": "2026-08-25T17:00:19Z",
"facts": [
"MRK gained 2.80%, traded above VWAP and up, and showed a 0.938 intraday range position.",
"The sealed catalyst related to a Moderna cancer-vaccine and melanoma partnership.",
"RSI was 83.74, the move was 3.53 ATR above the EMA reference, and volume ratio was 0.48x."
],
"price_as_of": "2026-08-25T21:20:21Z",
"vwap_as_of": null
}
],
"benchmarks": [],
"coverage": {
"candidate_rows": 5,
"candidate_prices": 5,
"candidate_technical": 3,
"benchmark_rows": 0
}
}
},
{
"day": 11,
"timestamp": "2026-09-10T21:44:28.957516Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-09-10T21:44:28.957516Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "KURA",
"role": "selected",
"price": 11.58,
"base_price": 13.79,
"return_since_base_pct": -16.0261,
"session_return_pct": -4.3,
"change_since_prior_pct": 0.4772,
"volume_ratio": 1.01,
"rsi": 48.69,
"vwap": 11.66,
"vwap_distance_pct": -0.6861,
"position_52w_pct": 83.2,
"extended_hours_pct": 0.09,
"as_of": "2026-09-10T21:21:35Z",
"source": "sealed_extended_quote",
"name": "Kura Oncology, Inc.",
"episode_id": "n0:KURA:2026-08-25",
"ema_trend": "12.44 > 12.11 > 11.33",
"vwap_state": "below",
"selection_as_of": "2026-08-25T15:15:58.818200Z",
"facts": [
"KURA gained 11.21%, with a 1.42x volume ratio, an 85.7 volume percentile and +10.76% relative strength versus QQQ.",
"The sealed catalyst package includes a reported $1.24 million CEO stock purchase, 57% KOMZIFTI revenue growth and 35% growth in new patient starts.",
"The captured intraday view showed KURA above VWAP and up, with an intraday range position of 0.998."
],
"price_as_of": "2026-09-10T21:21:35Z",
"vwap_as_of": null
},
{
"symbol": "CRML",
"role": "alternative",
"price": 8.4469,
"base_price": 7.955,
"return_since_base_pct": 6.1835,
"session_return_pct": 4.2827,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.64,
"rsi": 61.49,
"vwap": 7.6,
"vwap_distance_pct": 11.1434,
"position_52w_pct": 24.71,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:20:04Z",
"source": "yfinance_quote",
"name": "Critical Metals Corp.",
"episode_id": "n0:CRML:2026-08-25",
"ema_trend": "6.8 > 6.75 > 7.63",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:50.354399Z",
"facts": [
"CRML gained 19.27% with +18.82% relative strength versus QQQ and a 1.64x volume ratio.",
"The rare-earth and European lithium merger narrative had no company announcement in the secondary news packet.",
"Short interest was 29.37% and the move was 1.98 ATR above the EMA reference."
],
"price_as_of": "2026-08-25T21:20:04Z",
"vwap_as_of": null
},
{
"symbol": "LEU",
"role": "alternative",
"price": 193.0,
"base_price": 185.37,
"return_since_base_pct": 4.1161,
"session_return_pct": -0.2017,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.29,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:17:47Z",
"source": "yfinance_quote",
"name": "Centrus Energy Corp.",
"episode_id": "narrative:LEU:d551ea7899e32218",
"selection_as_of": "2026-08-25T17:00:00Z",
"facts": [
"LEU was above VWAP and up, with a 0.963 intraday range position and a +5.44% relative-strength reading versus QQQ.",
"The sealed catalyst package connected X-Energy, Ohio and federal attention to domestic fuel and energy-security activity.",
"Volume ratio was only 0.29x, while the quoted options spread was 11.36%."
],
"price_as_of": "2026-08-25T21:17:47Z",
"vwap_as_of": null
},
{
"symbol": "GENB",
"role": "alternative",
"price": 20.11,
"base_price": 20.869,
"return_since_base_pct": -3.637,
"session_return_pct": -1.3248,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.06,
"rsi": 80.02,
"vwap": 20.73,
"vwap_distance_pct": -2.9908,
"position_52w_pct": 91.84,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:12:46Z",
"source": "yfinance_quote",
"name": "Generate Biomedicines, Inc.",
"episode_id": "n0:GENB:2026-08-25",
"ema_trend": "17.05 > 15.86 > 15.0",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:23.027806Z",
"facts": [
"GENB gained 17.77% with a 3.06x volume ratio and +17.32% relative strength versus QQQ.",
"The sealed options snapshot was unavailable.",
"The catalyst was not a direct issuer-specific event in the corrected evidence."
],
"price_as_of": "2026-08-25T21:12:46Z",
"vwap_as_of": null
},
{
"symbol": "MRK",
"role": "alternative",
"price": 156.38,
"base_price": 154.8999,
"return_since_base_pct": 0.9555,
"session_return_pct": -0.0447,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.48,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:20:21Z",
"source": "yfinance_quote",
"name": "Merck & Co., Inc.",
"episode_id": "narrative:MRK:5a78131dec6b3a0e",
"selection_as_of": "2026-08-25T17:00:19Z",
"facts": [
"MRK gained 2.80%, traded above VWAP and up, and showed a 0.938 intraday range position.",
"The sealed catalyst related to a Moderna cancer-vaccine and melanoma partnership.",
"RSI was 83.74, the move was 3.53 ATR above the EMA reference, and volume ratio was 0.48x."
],
"price_as_of": "2026-08-25T21:20:21Z",
"vwap_as_of": null
}
],
"benchmarks": [],
"coverage": {
"candidate_rows": 5,
"candidate_prices": 5,
"candidate_technical": 3,
"benchmark_rows": 0
}
}
},
{
"day": 12,
"timestamp": "2026-09-11T14:46:30.825300Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-09-11T14:46:30.825300Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "KURA",
"role": "selected",
"price": 11.54,
"base_price": 13.79,
"return_since_base_pct": -16.3162,
"session_return_pct": -0.26,
"change_since_prior_pct": -0.3454,
"volume_ratio": 0.08,
"rsi": 46.63,
"vwap": 11.64,
"vwap_distance_pct": -0.8591,
"position_52w_pct": 83.0,
"extended_hours_pct": null,
"as_of": "2026-09-11T14:06:25.411176Z",
"source": "yfinance_quote",
"name": "Kura Oncology, Inc.",
"episode_id": "n0:KURA:2026-08-25",
"ema_trend": "12.26 > 12.06 > 11.34",
"vwap_state": "below",
"selection_as_of": "2026-08-25T15:15:58.818200Z",
"facts": [
"KURA gained 11.21%, with a 1.42x volume ratio, an 85.7 volume percentile and +10.76% relative strength versus QQQ.",
"The sealed catalyst package includes a reported $1.24 million CEO stock purchase, 57% KOMZIFTI revenue growth and 35% growth in new patient starts.",
"The captured intraday view showed KURA above VWAP and up, with an intraday range position of 0.998."
],
"benchmark_excess_pct": {
"sp500": -1.0855,
"nasdaq100": -1.1195,
"russell2000": -0.8647
},
"price_as_of": "2026-09-11T14:06:25.411176Z",
"vwap_as_of": null
},
{
"symbol": "CRML",
"role": "alternative",
"price": 8.4469,
"base_price": 7.955,
"return_since_base_pct": 6.1835,
"session_return_pct": 4.2827,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.64,
"rsi": 61.49,
"vwap": 7.6,
"vwap_distance_pct": 11.1434,
"position_52w_pct": 24.71,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:20:04Z",
"source": "yfinance_quote",
"name": "Critical Metals Corp.",
"episode_id": "n0:CRML:2026-08-25",
"ema_trend": "6.8 > 6.75 > 7.63",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:50.354399Z",
"facts": [
"CRML gained 19.27% with +18.82% relative strength versus QQQ and a 1.64x volume ratio.",
"The rare-earth and European lithium merger narrative had no company announcement in the secondary news packet.",
"Short interest was 29.37% and the move was 1.98 ATR above the EMA reference."
],
"benchmark_excess_pct": {
"sp500": 3.4572,
"nasdaq100": 3.4232,
"russell2000": 3.678
},
"price_as_of": "2026-08-25T21:20:04Z",
"vwap_as_of": null
},
{
"symbol": "LEU",
"role": "alternative",
"price": 193.0,
"base_price": 185.37,
"return_since_base_pct": 4.1161,
"session_return_pct": -0.2017,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.29,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:17:47Z",
"source": "yfinance_quote",
"name": "Centrus Energy Corp.",
"episode_id": "narrative:LEU:d551ea7899e32218",
"selection_as_of": "2026-08-25T17:00:00Z",
"facts": [
"LEU was above VWAP and up, with a 0.963 intraday range position and a +5.44% relative-strength reading versus QQQ.",
"The sealed catalyst package connected X-Energy, Ohio and federal attention to domestic fuel and energy-security activity.",
"Volume ratio was only 0.29x, while the quoted options spread was 11.36%."
],
"benchmark_excess_pct": {
"sp500": -1.0272,
"nasdaq100": -1.0612,
"russell2000": -0.8064
},
"price_as_of": "2026-08-25T21:17:47Z",
"vwap_as_of": null
},
{
"symbol": "GENB",
"role": "alternative",
"price": 20.11,
"base_price": 20.869,
"return_since_base_pct": -3.637,
"session_return_pct": -1.3248,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.06,
"rsi": 80.02,
"vwap": 20.73,
"vwap_distance_pct": -2.9908,
"position_52w_pct": 91.84,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:12:46Z",
"source": "yfinance_quote",
"name": "Generate Biomedicines, Inc.",
"episode_id": "n0:GENB:2026-08-25",
"ema_trend": "17.05 > 15.86 > 15.0",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:23.027806Z",
"facts": [
"GENB gained 17.77% with a 3.06x volume ratio and +17.32% relative strength versus QQQ.",
"The sealed options snapshot was unavailable.",
"The catalyst was not a direct issuer-specific event in the corrected evidence."
],
"benchmark_excess_pct": {
"sp500": -2.1503,
"nasdaq100": -2.1843,
"russell2000": -1.9295
},
"price_as_of": "2026-08-25T21:12:46Z",
"vwap_as_of": null
},
{
"symbol": "MRK",
"role": "alternative",
"price": 156.38,
"base_price": 154.8999,
"return_since_base_pct": 0.9555,
"session_return_pct": -0.0447,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.48,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:20:21Z",
"source": "yfinance_quote",
"name": "Merck & Co., Inc.",
"episode_id": "narrative:MRK:5a78131dec6b3a0e",
"selection_as_of": "2026-08-25T17:00:19Z",
"facts": [
"MRK gained 2.80%, traded above VWAP and up, and showed a 0.938 intraday range position.",
"The sealed catalyst related to a Moderna cancer-vaccine and melanoma partnership.",
"RSI was 83.74, the move was 3.53 ATR above the EMA reference, and volume ratio was 0.48x."
],
"benchmark_excess_pct": {
"sp500": -0.8702,
"nasdaq100": -0.9042,
"russell2000": -0.6494
},
"price_as_of": "2026-08-25T21:20:21Z",
"vwap_as_of": null
}
],
"benchmarks": [
{
"id": "sp500",
"symbol": "^GSPC",
"label": "S&P 500",
"role": "benchmark",
"price": 7654.37,
"base_price": 7591.7,
"return_since_base_pct": 0.8255,
"session_return_pct": 0.8255,
"as_of": "2026-09-11T14:46:10.433391Z",
"source": "yfinance.ticker_info",
"base_definition": "previous regular close"
},
{
"id": "nasdaq100",
"symbol": "^NDX",
"label": "Nasdaq 100",
"role": "benchmark",
"price": 29353.668,
"base_price": 29103.514,
"return_since_base_pct": 0.8595,
"session_return_pct": 0.8595,
"as_of": "2026-09-11T14:46:10.433391Z",
"source": "yfinance.ticker_info",
"base_definition": "previous regular close"
},
{
"id": "russell2000",
"symbol": "^RUT",
"label": "Russell 2000",
"role": "benchmark",
"price": 2908.4294,
"base_price": 2890.947,
"return_since_base_pct": 0.6047,
"session_return_pct": 0.6047,
"as_of": "2026-09-11T14:46:10.433391Z",
"source": "yfinance.ticker_info",
"base_definition": "previous regular close"
}
],
"coverage": {
"candidate_rows": 5,
"candidate_prices": 5,
"candidate_technical": 3,
"benchmark_rows": 3
}
}
},
{
"day": 12,
"timestamp": "2026-09-11T19:50:39.116519Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-09-11T19:50:39.116519Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "KURA",
"role": "selected",
"price": 11.515,
"base_price": 13.79,
"return_since_base_pct": -16.4975,
"session_return_pct": -0.48,
"change_since_prior_pct": -0.2166,
"volume_ratio": 0.63,
"rsi": 46.4,
"vwap": 11.49,
"vwap_distance_pct": 0.2176,
"position_52w_pct": 82.8,
"extended_hours_pct": null,
"as_of": "2026-09-11T19:21:33.380908Z",
"source": "yfinance_quote",
"name": "Kura Oncology, Inc.",
"episode_id": "n0:KURA:2026-08-25",
"ema_trend": "12.25 > 12.06 > 11.34",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:58.818200Z",
"facts": [
"KURA gained 11.21%, with a 1.42x volume ratio, an 85.7 volume percentile and +10.76% relative strength versus QQQ.",
"The sealed catalyst package includes a reported $1.24 million CEO stock purchase, 57% KOMZIFTI revenue growth and 35% growth in new patient starts.",
"The captured intraday view showed KURA above VWAP and up, with an intraday range position of 0.998."
],
"price_as_of": "2026-09-11T19:21:33.380908Z",
"vwap_as_of": null
},
{
"symbol": "CRML",
"role": "alternative",
"price": 8.4469,
"base_price": 7.955,
"return_since_base_pct": 6.1835,
"session_return_pct": 4.2827,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.64,
"rsi": 61.49,
"vwap": 7.6,
"vwap_distance_pct": 11.1434,
"position_52w_pct": 24.71,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:20:04Z",
"source": "yfinance_quote",
"name": "Critical Metals Corp.",
"episode_id": "n0:CRML:2026-08-25",
"ema_trend": "6.8 > 6.75 > 7.63",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:50.354399Z",
"facts": [
"CRML gained 19.27% with +18.82% relative strength versus QQQ and a 1.64x volume ratio.",
"The rare-earth and European lithium merger narrative had no company announcement in the secondary news packet.",
"Short interest was 29.37% and the move was 1.98 ATR above the EMA reference."
],
"price_as_of": "2026-08-25T21:20:04Z",
"vwap_as_of": null
},
{
"symbol": "LEU",
"role": "alternative",
"price": 193.0,
"base_price": 185.37,
"return_since_base_pct": 4.1161,
"session_return_pct": -0.2017,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.29,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:17:47Z",
"source": "yfinance_quote",
"name": "Centrus Energy Corp.",
"episode_id": "narrative:LEU:d551ea7899e32218",
"selection_as_of": "2026-08-25T17:00:00Z",
"facts": [
"LEU was above VWAP and up, with a 0.963 intraday range position and a +5.44% relative-strength reading versus QQQ.",
"The sealed catalyst package connected X-Energy, Ohio and federal attention to domestic fuel and energy-security activity.",
"Volume ratio was only 0.29x, while the quoted options spread was 11.36%."
],
"price_as_of": "2026-08-25T21:17:47Z",
"vwap_as_of": null
},
{
"symbol": "GENB",
"role": "alternative",
"price": 20.11,
"base_price": 20.869,
"return_since_base_pct": -3.637,
"session_return_pct": -1.3248,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.06,
"rsi": 80.02,
"vwap": 20.73,
"vwap_distance_pct": -2.9908,
"position_52w_pct": 91.84,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:12:46Z",
"source": "yfinance_quote",
"name": "Generate Biomedicines, Inc.",
"episode_id": "n0:GENB:2026-08-25",
"ema_trend": "17.05 > 15.86 > 15.0",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:23.027806Z",
"facts": [
"GENB gained 17.77% with a 3.06x volume ratio and +17.32% relative strength versus QQQ.",
"The sealed options snapshot was unavailable.",
"The catalyst was not a direct issuer-specific event in the corrected evidence."
],
"price_as_of": "2026-08-25T21:12:46Z",
"vwap_as_of": null
},
{
"symbol": "MRK",
"role": "alternative",
"price": 156.38,
"base_price": 154.8999,
"return_since_base_pct": 0.9555,
"session_return_pct": -0.0447,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.48,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:20:21Z",
"source": "yfinance_quote",
"name": "Merck & Co., Inc.",
"episode_id": "narrative:MRK:5a78131dec6b3a0e",
"selection_as_of": "2026-08-25T17:00:19Z",
"facts": [
"MRK gained 2.80%, traded above VWAP and up, and showed a 0.938 intraday range position.",
"The sealed catalyst related to a Moderna cancer-vaccine and melanoma partnership.",
"RSI was 83.74, the move was 3.53 ATR above the EMA reference, and volume ratio was 0.48x."
],
"price_as_of": "2026-08-25T21:20:21Z",
"vwap_as_of": null
}
],
"benchmarks": [],
"coverage": {
"candidate_rows": 5,
"candidate_prices": 5,
"candidate_technical": 3,
"benchmark_rows": 0
}
}
},
{
"day": 12,
"timestamp": "2026-09-11T21:54:40.336253Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-09-11T21:54:40.336253Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "KURA",
"role": "selected",
"price": 11.31,
"base_price": 13.79,
"return_since_base_pct": -17.984,
"session_return_pct": -1.56,
"change_since_prior_pct": -1.7803,
"volume_ratio": 1.19,
"rsi": 45.32,
"vwap": 11.49,
"vwap_distance_pct": -1.5666,
"position_52w_pct": 81.9,
"extended_hours_pct": -0.7,
"as_of": "2026-09-11T21:21:06Z",
"source": "sealed_extended_quote",
"name": "Kura Oncology, Inc.",
"episode_id": "n0:KURA:2026-08-25",
"ema_trend": "12.23 > 12.04 > 11.33",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:58.818200Z",
"facts": [
"KURA gained 11.21%, with a 1.42x volume ratio, an 85.7 volume percentile and +10.76% relative strength versus QQQ.",
"The sealed catalyst package includes a reported $1.24 million CEO stock purchase, 57% KOMZIFTI revenue growth and 35% growth in new patient starts.",
"The captured intraday view showed KURA above VWAP and up, with an intraday range position of 0.998."
],
"price_as_of": "2026-09-11T21:21:06Z",
"vwap_as_of": null
},
{
"symbol": "CRML",
"role": "alternative",
"price": 8.4469,
"base_price": 7.955,
"return_since_base_pct": 6.1835,
"session_return_pct": 4.2827,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.64,
"rsi": 61.49,
"vwap": 7.6,
"vwap_distance_pct": 11.1434,
"position_52w_pct": 24.71,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:20:04Z",
"source": "yfinance_quote",
"name": "Critical Metals Corp.",
"episode_id": "n0:CRML:2026-08-25",
"ema_trend": "6.8 > 6.75 > 7.63",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:50.354399Z",
"facts": [
"CRML gained 19.27% with +18.82% relative strength versus QQQ and a 1.64x volume ratio.",
"The rare-earth and European lithium merger narrative had no company announcement in the secondary news packet.",
"Short interest was 29.37% and the move was 1.98 ATR above the EMA reference."
],
"price_as_of": "2026-08-25T21:20:04Z",
"vwap_as_of": null
},
{
"symbol": "LEU",
"role": "alternative",
"price": 193.0,
"base_price": 185.37,
"return_since_base_pct": 4.1161,
"session_return_pct": -0.2017,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.29,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:17:47Z",
"source": "yfinance_quote",
"name": "Centrus Energy Corp.",
"episode_id": "narrative:LEU:d551ea7899e32218",
"selection_as_of": "2026-08-25T17:00:00Z",
"facts": [
"LEU was above VWAP and up, with a 0.963 intraday range position and a +5.44% relative-strength reading versus QQQ.",
"The sealed catalyst package connected X-Energy, Ohio and federal attention to domestic fuel and energy-security activity.",
"Volume ratio was only 0.29x, while the quoted options spread was 11.36%."
],
"price_as_of": "2026-08-25T21:17:47Z",
"vwap_as_of": null
},
{
"symbol": "GENB",
"role": "alternative",
"price": 20.11,
"base_price": 20.869,
"return_since_base_pct": -3.637,
"session_return_pct": -1.3248,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.06,
"rsi": 80.02,
"vwap": 20.73,
"vwap_distance_pct": -2.9908,
"position_52w_pct": 91.84,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:12:46Z",
"source": "yfinance_quote",
"name": "Generate Biomedicines, Inc.",
"episode_id": "n0:GENB:2026-08-25",
"ema_trend": "17.05 > 15.86 > 15.0",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:23.027806Z",
"facts": [
"GENB gained 17.77% with a 3.06x volume ratio and +17.32% relative strength versus QQQ.",
"The sealed options snapshot was unavailable.",
"The catalyst was not a direct issuer-specific event in the corrected evidence."
],
"price_as_of": "2026-08-25T21:12:46Z",
"vwap_as_of": null
},
{
"symbol": "MRK",
"role": "alternative",
"price": 156.38,
"base_price": 154.8999,
"return_since_base_pct": 0.9555,
"session_return_pct": -0.0447,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.48,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:20:21Z",
"source": "yfinance_quote",
"name": "Merck & Co., Inc.",
"episode_id": "narrative:MRK:5a78131dec6b3a0e",
"selection_as_of": "2026-08-25T17:00:19Z",
"facts": [
"MRK gained 2.80%, traded above VWAP and up, and showed a 0.938 intraday range position.",
"The sealed catalyst related to a Moderna cancer-vaccine and melanoma partnership.",
"RSI was 83.74, the move was 3.53 ATR above the EMA reference, and volume ratio was 0.48x."
],
"price_as_of": "2026-08-25T21:20:21Z",
"vwap_as_of": null
}
],
"benchmarks": [],
"coverage": {
"candidate_rows": 5,
"candidate_prices": 5,
"candidate_technical": 3,
"benchmark_rows": 0
}
}
},
{
"day": 13,
"timestamp": "2026-09-14T14:56:59.079441Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-09-14T14:56:59.079441Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "KURA",
"role": "selected",
"price": 11.46,
"base_price": 13.79,
"return_since_base_pct": -16.8963,
"session_return_pct": 0.61,
"change_since_prior_pct": 1.3263,
"volume_ratio": 0.09,
"rsi": 40.41,
"vwap": 11.39,
"vwap_distance_pct": 0.6146,
"position_52w_pct": 82.4,
"extended_hours_pct": null,
"as_of": "2026-09-14T14:05:55.081234Z",
"source": "yfinance_quote",
"name": "Kura Oncology, Inc.",
"episode_id": "n0:KURA:2026-08-25",
"ema_trend": "12.07 > 11.99 > 11.34",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:58.818200Z",
"facts": [
"KURA gained 11.21%, with a 1.42x volume ratio, an 85.7 volume percentile and +10.76% relative strength versus QQQ.",
"The sealed catalyst package includes a reported $1.24 million CEO stock purchase, 57% KOMZIFTI revenue growth and 35% growth in new patient starts.",
"The captured intraday view showed KURA above VWAP and up, with an intraday range position of 0.998."
],
"price_as_of": "2026-09-14T14:05:55.081234Z",
"vwap_as_of": null
},
{
"symbol": "CRML",
"role": "alternative",
"price": 8.4469,
"base_price": 7.955,
"return_since_base_pct": 6.1835,
"session_return_pct": 4.2827,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.64,
"rsi": 61.49,
"vwap": 7.6,
"vwap_distance_pct": 11.1434,
"position_52w_pct": 24.71,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:20:04Z",
"source": "yfinance_quote",
"name": "Critical Metals Corp.",
"episode_id": "n0:CRML:2026-08-25",
"ema_trend": "6.8 > 6.75 > 7.63",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:50.354399Z",
"facts": [
"CRML gained 19.27% with +18.82% relative strength versus QQQ and a 1.64x volume ratio.",
"The rare-earth and European lithium merger narrative had no company announcement in the secondary news packet.",
"Short interest was 29.37% and the move was 1.98 ATR above the EMA reference."
],
"price_as_of": "2026-08-25T21:20:04Z",
"vwap_as_of": null
},
{
"symbol": "LEU",
"role": "alternative",
"price": 193.0,
"base_price": 185.37,
"return_since_base_pct": 4.1161,
"session_return_pct": -0.2017,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.29,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:17:47Z",
"source": "yfinance_quote",
"name": "Centrus Energy Corp.",
"episode_id": "narrative:LEU:d551ea7899e32218",
"selection_as_of": "2026-08-25T17:00:00Z",
"facts": [
"LEU was above VWAP and up, with a 0.963 intraday range position and a +5.44% relative-strength reading versus QQQ.",
"The sealed catalyst package connected X-Energy, Ohio and federal attention to domestic fuel and energy-security activity.",
"Volume ratio was only 0.29x, while the quoted options spread was 11.36%."
],
"price_as_of": "2026-08-25T21:17:47Z",
"vwap_as_of": null
},
{
"symbol": "GENB",
"role": "alternative",
"price": 20.11,
"base_price": 20.869,
"return_since_base_pct": -3.637,
"session_return_pct": -1.3248,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.06,
"rsi": 80.02,
"vwap": 20.73,
"vwap_distance_pct": -2.9908,
"position_52w_pct": 91.84,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:12:46Z",
"source": "yfinance_quote",
"name": "Generate Biomedicines, Inc.",
"episode_id": "n0:GENB:2026-08-25",
"ema_trend": "17.05 > 15.86 > 15.0",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:23.027806Z",
"facts": [
"GENB gained 17.77% with a 3.06x volume ratio and +17.32% relative strength versus QQQ.",
"The sealed options snapshot was unavailable.",
"The catalyst was not a direct issuer-specific event in the corrected evidence."
],
"price_as_of": "2026-08-25T21:12:46Z",
"vwap_as_of": null
},
{
"symbol": "MRK",
"role": "alternative",
"price": 156.38,
"base_price": 154.8999,
"return_since_base_pct": 0.9555,
"session_return_pct": -0.0447,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.48,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:20:21Z",
"source": "yfinance_quote",
"name": "Merck & Co., Inc.",
"episode_id": "narrative:MRK:5a78131dec6b3a0e",
"selection_as_of": "2026-08-25T17:00:19Z",
"facts": [
"MRK gained 2.80%, traded above VWAP and up, and showed a 0.938 intraday range position.",
"The sealed catalyst related to a Moderna cancer-vaccine and melanoma partnership.",
"RSI was 83.74, the move was 3.53 ATR above the EMA reference, and volume ratio was 0.48x."
],
"price_as_of": "2026-08-25T21:20:21Z",
"vwap_as_of": null
}
],
"benchmarks": [],
"coverage": {
"candidate_rows": 5,
"candidate_prices": 5,
"candidate_technical": 3,
"benchmark_rows": 0
}
}
},
{
"day": 13,
"timestamp": "2026-09-14T22:40:30.492295Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-09-14T22:40:30.492295Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "KURA",
"role": "selected",
"price": 11.58,
"base_price": 13.79,
"return_since_base_pct": -16.0261,
"session_return_pct": 1.49,
"change_since_prior_pct": 1.0471,
"volume_ratio": 0.79,
"rsi": 41.6,
"vwap": 11.52,
"vwap_distance_pct": 0.5208,
"position_52w_pct": 83.2,
"extended_hours_pct": 0.17,
"as_of": "2026-09-14T20:06:30Z",
"source": "sealed_extended_quote",
"name": "Kura Oncology, Inc.",
"episode_id": "n0:KURA:2026-08-25",
"ema_trend": "12.09 > 12.0 > 11.34",
"vwap_state": "below",
"selection_as_of": "2026-08-25T15:15:58.818200Z",
"facts": [
"KURA gained 11.21%, with a 1.42x volume ratio, an 85.7 volume percentile and +10.76% relative strength versus QQQ.",
"The sealed catalyst package includes a reported $1.24 million CEO stock purchase, 57% KOMZIFTI revenue growth and 35% growth in new patient starts.",
"The captured intraday view showed KURA above VWAP and up, with an intraday range position of 0.998."
],
"price_as_of": "2026-09-14T20:06:30Z",
"vwap_as_of": null
},
{
"symbol": "CRML",
"role": "alternative",
"price": 8.4469,
"base_price": 7.955,
"return_since_base_pct": 6.1835,
"session_return_pct": 4.2827,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.64,
"rsi": 61.49,
"vwap": 7.6,
"vwap_distance_pct": 11.1434,
"position_52w_pct": 24.71,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:20:04Z",
"source": "yfinance_quote",
"name": "Critical Metals Corp.",
"episode_id": "n0:CRML:2026-08-25",
"ema_trend": "6.8 > 6.75 > 7.63",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:50.354399Z",
"facts": [
"CRML gained 19.27% with +18.82% relative strength versus QQQ and a 1.64x volume ratio.",
"The rare-earth and European lithium merger narrative had no company announcement in the secondary news packet.",
"Short interest was 29.37% and the move was 1.98 ATR above the EMA reference."
],
"price_as_of": "2026-08-25T21:20:04Z",
"vwap_as_of": null
},
{
"symbol": "LEU",
"role": "alternative",
"price": 193.0,
"base_price": 185.37,
"return_since_base_pct": 4.1161,
"session_return_pct": -0.2017,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.29,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:17:47Z",
"source": "yfinance_quote",
"name": "Centrus Energy Corp.",
"episode_id": "narrative:LEU:d551ea7899e32218",
"selection_as_of": "2026-08-25T17:00:00Z",
"facts": [
"LEU was above VWAP and up, with a 0.963 intraday range position and a +5.44% relative-strength reading versus QQQ.",
"The sealed catalyst package connected X-Energy, Ohio and federal attention to domestic fuel and energy-security activity.",
"Volume ratio was only 0.29x, while the quoted options spread was 11.36%."
],
"price_as_of": "2026-08-25T21:17:47Z",
"vwap_as_of": null
},
{
"symbol": "GENB",
"role": "alternative",
"price": 20.11,
"base_price": 20.869,
"return_since_base_pct": -3.637,
"session_return_pct": -1.3248,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.06,
"rsi": 80.02,
"vwap": 20.73,
"vwap_distance_pct": -2.9908,
"position_52w_pct": 91.84,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:12:46Z",
"source": "yfinance_quote",
"name": "Generate Biomedicines, Inc.",
"episode_id": "n0:GENB:2026-08-25",
"ema_trend": "17.05 > 15.86 > 15.0",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:23.027806Z",
"facts": [
"GENB gained 17.77% with a 3.06x volume ratio and +17.32% relative strength versus QQQ.",
"The sealed options snapshot was unavailable.",
"The catalyst was not a direct issuer-specific event in the corrected evidence."
],
"price_as_of": "2026-08-25T21:12:46Z",
"vwap_as_of": null
},
{
"symbol": "MRK",
"role": "alternative",
"price": 156.38,
"base_price": 154.8999,
"return_since_base_pct": 0.9555,
"session_return_pct": -0.0447,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.48,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:20:21Z",
"source": "yfinance_quote",
"name": "Merck & Co., Inc.",
"episode_id": "narrative:MRK:5a78131dec6b3a0e",
"selection_as_of": "2026-08-25T17:00:19Z",
"facts": [
"MRK gained 2.80%, traded above VWAP and up, and showed a 0.938 intraday range position.",
"The sealed catalyst related to a Moderna cancer-vaccine and melanoma partnership.",
"RSI was 83.74, the move was 3.53 ATR above the EMA reference, and volume ratio was 0.48x."
],
"price_as_of": "2026-08-25T21:20:21Z",
"vwap_as_of": null
}
],
"benchmarks": [],
"coverage": {
"candidate_rows": 5,
"candidate_prices": 5,
"candidate_technical": 3,
"benchmark_rows": 0
}
}
},
{
"day": 13,
"timestamp": "2026-09-14T23:32:40.210908Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-09-14T23:32:40.210908Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "KURA",
"role": "selected",
"price": 11.7,
"base_price": 13.79,
"return_since_base_pct": -15.1559,
"session_return_pct": 1.49,
"change_since_prior_pct": 1.0363,
"volume_ratio": 0.81,
"rsi": 41.6,
"vwap": 11.52,
"vwap_distance_pct": 1.5625,
"position_52w_pct": 83.2,
"extended_hours_pct": 1.21,
"as_of": "2026-09-14T22:47:52Z",
"source": "sealed_extended_quote",
"name": "Kura Oncology, Inc.",
"episode_id": "n0:KURA:2026-08-25",
"ema_trend": "12.09 > 12.0 > 11.34",
"vwap_state": "below",
"selection_as_of": "2026-08-25T15:15:58.818200Z",
"facts": [
"KURA gained 11.21%, with a 1.42x volume ratio, an 85.7 volume percentile and +10.76% relative strength versus QQQ.",
"The sealed catalyst package includes a reported $1.24 million CEO stock purchase, 57% KOMZIFTI revenue growth and 35% growth in new patient starts.",
"The captured intraday view showed KURA above VWAP and up, with an intraday range position of 0.998."
],
"price_as_of": "2026-09-14T22:47:52Z",
"vwap_as_of": null
},
{
"symbol": "CRML",
"role": "alternative",
"price": 8.4469,
"base_price": 7.955,
"return_since_base_pct": 6.1835,
"session_return_pct": 4.2827,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.64,
"rsi": 61.49,
"vwap": 7.6,
"vwap_distance_pct": 11.1434,
"position_52w_pct": 24.71,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:20:04Z",
"source": "yfinance_quote",
"name": "Critical Metals Corp.",
"episode_id": "n0:CRML:2026-08-25",
"ema_trend": "6.8 > 6.75 > 7.63",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:50.354399Z",
"facts": [
"CRML gained 19.27% with +18.82% relative strength versus QQQ and a 1.64x volume ratio.",
"The rare-earth and European lithium merger narrative had no company announcement in the secondary news packet.",
"Short interest was 29.37% and the move was 1.98 ATR above the EMA reference."
],
"price_as_of": "2026-08-25T21:20:04Z",
"vwap_as_of": null
},
{
"symbol": "LEU",
"role": "alternative",
"price": 193.0,
"base_price": 185.37,
"return_since_base_pct": 4.1161,
"session_return_pct": -0.2017,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.29,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:17:47Z",
"source": "yfinance_quote",
"name": "Centrus Energy Corp.",
"episode_id": "narrative:LEU:d551ea7899e32218",
"selection_as_of": "2026-08-25T17:00:00Z",
"facts": [
"LEU was above VWAP and up, with a 0.963 intraday range position and a +5.44% relative-strength reading versus QQQ.",
"The sealed catalyst package connected X-Energy, Ohio and federal attention to domestic fuel and energy-security activity.",
"Volume ratio was only 0.29x, while the quoted options spread was 11.36%."
],
"price_as_of": "2026-08-25T21:17:47Z",
"vwap_as_of": null
},
{
"symbol": "GENB",
"role": "alternative",
"price": 20.11,
"base_price": 20.869,
"return_since_base_pct": -3.637,
"session_return_pct": -1.3248,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.06,
"rsi": 80.02,
"vwap": 20.73,
"vwap_distance_pct": -2.9908,
"position_52w_pct": 91.84,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:12:46Z",
"source": "yfinance_quote",
"name": "Generate Biomedicines, Inc.",
"episode_id": "n0:GENB:2026-08-25",
"ema_trend": "17.05 > 15.86 > 15.0",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:23.027806Z",
"facts": [
"GENB gained 17.77% with a 3.06x volume ratio and +17.32% relative strength versus QQQ.",
"The sealed options snapshot was unavailable.",
"The catalyst was not a direct issuer-specific event in the corrected evidence."
],
"price_as_of": "2026-08-25T21:12:46Z",
"vwap_as_of": null
},
{
"symbol": "MRK",
"role": "alternative",
"price": 156.38,
"base_price": 154.8999,
"return_since_base_pct": 0.9555,
"session_return_pct": -0.0447,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.48,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:20:21Z",
"source": "yfinance_quote",
"name": "Merck & Co., Inc.",
"episode_id": "narrative:MRK:5a78131dec6b3a0e",
"selection_as_of": "2026-08-25T17:00:19Z",
"facts": [
"MRK gained 2.80%, traded above VWAP and up, and showed a 0.938 intraday range position.",
"The sealed catalyst related to a Moderna cancer-vaccine and melanoma partnership.",
"RSI was 83.74, the move was 3.53 ATR above the EMA reference, and volume ratio was 0.48x."
],
"price_as_of": "2026-08-25T21:20:21Z",
"vwap_as_of": null
}
],
"benchmarks": [],
"coverage": {
"candidate_rows": 5,
"candidate_prices": 5,
"candidate_technical": 3,
"benchmark_rows": 0
}
}
},
{
"day": 14,
"timestamp": "2026-09-15T16:22:18.081027Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-09-15T16:22:18.081027Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "KURA",
"role": "selected",
"price": 11.135,
"base_price": 13.79,
"return_since_base_pct": -19.2531,
"session_return_pct": -3.68,
"change_since_prior_pct": -4.8291,
"volume_ratio": 0.35,
"rsi": 21.02,
"vwap": 11.17,
"vwap_distance_pct": -0.3133,
"position_52w_pct": 80.1,
"extended_hours_pct": null,
"as_of": "2026-09-15T15:52:36.865021Z",
"source": "yfinance_quote",
"name": "Kura Oncology, Inc.",
"episode_id": "n0:KURA:2026-08-25",
"ema_trend": "11.9 > 11.92 > 11.33",
"vwap_state": "below",
"selection_as_of": "2026-08-25T15:15:58.818200Z",
"facts": [
"KURA gained 11.21%, with a 1.42x volume ratio, an 85.7 volume percentile and +10.76% relative strength versus QQQ.",
"The sealed catalyst package includes a reported $1.24 million CEO stock purchase, 57% KOMZIFTI revenue growth and 35% growth in new patient starts.",
"The captured intraday view showed KURA above VWAP and up, with an intraday range position of 0.998."
],
"price_as_of": "2026-09-15T15:52:36.865021Z",
"vwap_as_of": null
},
{
"symbol": "CRML",
"role": "alternative",
"price": 8.4469,
"base_price": 7.955,
"return_since_base_pct": 6.1835,
"session_return_pct": 4.2827,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.64,
"rsi": 61.49,
"vwap": 7.6,
"vwap_distance_pct": 11.1434,
"position_52w_pct": 24.71,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:20:04Z",
"source": "yfinance_quote",
"name": "Critical Metals Corp.",
"episode_id": "n0:CRML:2026-08-25",
"ema_trend": "6.8 > 6.75 > 7.63",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:50.354399Z",
"facts": [
"CRML gained 19.27% with +18.82% relative strength versus QQQ and a 1.64x volume ratio.",
"The rare-earth and European lithium merger narrative had no company announcement in the secondary news packet.",
"Short interest was 29.37% and the move was 1.98 ATR above the EMA reference."
],
"price_as_of": "2026-08-25T21:20:04Z",
"vwap_as_of": null
},
{
"symbol": "LEU",
"role": "alternative",
"price": 193.0,
"base_price": 185.37,
"return_since_base_pct": 4.1161,
"session_return_pct": -0.2017,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.29,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:17:47Z",
"source": "yfinance_quote",
"name": "Centrus Energy Corp.",
"episode_id": "narrative:LEU:d551ea7899e32218",
"selection_as_of": "2026-08-25T17:00:00Z",
"facts": [
"LEU was above VWAP and up, with a 0.963 intraday range position and a +5.44% relative-strength reading versus QQQ.",
"The sealed catalyst package connected X-Energy, Ohio and federal attention to domestic fuel and energy-security activity.",
"Volume ratio was only 0.29x, while the quoted options spread was 11.36%."
],
"price_as_of": "2026-08-25T21:17:47Z",
"vwap_as_of": null
},
{
"symbol": "GENB",
"role": "alternative",
"price": 20.11,
"base_price": 20.869,
"return_since_base_pct": -3.637,
"session_return_pct": -1.3248,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.06,
"rsi": 80.02,
"vwap": 20.73,
"vwap_distance_pct": -2.9908,
"position_52w_pct": 91.84,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:12:46Z",
"source": "yfinance_quote",
"name": "Generate Biomedicines, Inc.",
"episode_id": "n0:GENB:2026-08-25",
"ema_trend": "17.05 > 15.86 > 15.0",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:23.027806Z",
"facts": [
"GENB gained 17.77% with a 3.06x volume ratio and +17.32% relative strength versus QQQ.",
"The sealed options snapshot was unavailable.",
"The catalyst was not a direct issuer-specific event in the corrected evidence."
],
"price_as_of": "2026-08-25T21:12:46Z",
"vwap_as_of": null
},
{
"symbol": "MRK",
"role": "alternative",
"price": 156.38,
"base_price": 154.8999,
"return_since_base_pct": 0.9555,
"session_return_pct": -0.0447,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.48,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:20:21Z",
"source": "yfinance_quote",
"name": "Merck & Co., Inc.",
"episode_id": "narrative:MRK:5a78131dec6b3a0e",
"selection_as_of": "2026-08-25T17:00:19Z",
"facts": [
"MRK gained 2.80%, traded above VWAP and up, and showed a 0.938 intraday range position.",
"The sealed catalyst related to a Moderna cancer-vaccine and melanoma partnership.",
"RSI was 83.74, the move was 3.53 ATR above the EMA reference, and volume ratio was 0.48x."
],
"price_as_of": "2026-08-25T21:20:21Z",
"vwap_as_of": null
}
],
"benchmarks": [],
"coverage": {
"candidate_rows": 5,
"candidate_prices": 5,
"candidate_technical": 3,
"benchmark_rows": 0
}
}
},
{
"day": 14,
"timestamp": "2026-09-15T19:27:19.871047Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-09-15T19:27:19.871047Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "KURA",
"role": "selected",
"price": 11.305,
"base_price": 13.79,
"return_since_base_pct": -18.0203,
"session_return_pct": -2.21,
"change_since_prior_pct": 1.5267,
"volume_ratio": 0.7,
"rsi": 21.89,
"vwap": 11.22,
"vwap_distance_pct": 0.7576,
"position_52w_pct": 81.3,
"extended_hours_pct": null,
"as_of": "2026-09-15T19:21:00.581079Z",
"source": "yfinance_quote",
"name": "Kura Oncology, Inc.",
"episode_id": "n0:KURA:2026-08-25",
"ema_trend": "11.94 > 11.94 > 11.34",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:58.818200Z",
"facts": [
"KURA gained 11.21%, with a 1.42x volume ratio, an 85.7 volume percentile and +10.76% relative strength versus QQQ.",
"The sealed catalyst package includes a reported $1.24 million CEO stock purchase, 57% KOMZIFTI revenue growth and 35% growth in new patient starts.",
"The captured intraday view showed KURA above VWAP and up, with an intraday range position of 0.998."
],
"price_as_of": "2026-09-15T19:21:00.581079Z",
"vwap_as_of": null
},
{
"symbol": "CRML",
"role": "alternative",
"price": 8.4469,
"base_price": 7.955,
"return_since_base_pct": 6.1835,
"session_return_pct": 4.2827,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.64,
"rsi": 61.49,
"vwap": 7.6,
"vwap_distance_pct": 11.1434,
"position_52w_pct": 24.71,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:20:04Z",
"source": "yfinance_quote",
"name": "Critical Metals Corp.",
"episode_id": "n0:CRML:2026-08-25",
"ema_trend": "6.8 > 6.75 > 7.63",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:50.354399Z",
"facts": [
"CRML gained 19.27% with +18.82% relative strength versus QQQ and a 1.64x volume ratio.",
"The rare-earth and European lithium merger narrative had no company announcement in the secondary news packet.",
"Short interest was 29.37% and the move was 1.98 ATR above the EMA reference."
],
"price_as_of": "2026-08-25T21:20:04Z",
"vwap_as_of": null
},
{
"symbol": "LEU",
"role": "alternative",
"price": 193.0,
"base_price": 185.37,
"return_since_base_pct": 4.1161,
"session_return_pct": -0.2017,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.29,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:17:47Z",
"source": "yfinance_quote",
"name": "Centrus Energy Corp.",
"episode_id": "narrative:LEU:d551ea7899e32218",
"selection_as_of": "2026-08-25T17:00:00Z",
"facts": [
"LEU was above VWAP and up, with a 0.963 intraday range position and a +5.44% relative-strength reading versus QQQ.",
"The sealed catalyst package connected X-Energy, Ohio and federal attention to domestic fuel and energy-security activity.",
"Volume ratio was only 0.29x, while the quoted options spread was 11.36%."
],
"price_as_of": "2026-08-25T21:17:47Z",
"vwap_as_of": null
},
{
"symbol": "GENB",
"role": "alternative",
"price": 20.11,
"base_price": 20.869,
"return_since_base_pct": -3.637,
"session_return_pct": -1.3248,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.06,
"rsi": 80.02,
"vwap": 20.73,
"vwap_distance_pct": -2.9908,
"position_52w_pct": 91.84,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:12:46Z",
"source": "yfinance_quote",
"name": "Generate Biomedicines, Inc.",
"episode_id": "n0:GENB:2026-08-25",
"ema_trend": "17.05 > 15.86 > 15.0",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:23.027806Z",
"facts": [
"GENB gained 17.77% with a 3.06x volume ratio and +17.32% relative strength versus QQQ.",
"The sealed options snapshot was unavailable.",
"The catalyst was not a direct issuer-specific event in the corrected evidence."
],
"price_as_of": "2026-08-25T21:12:46Z",
"vwap_as_of": null
},
{
"symbol": "MRK",
"role": "alternative",
"price": 156.38,
"base_price": 154.8999,
"return_since_base_pct": 0.9555,
"session_return_pct": -0.0447,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.48,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:20:21Z",
"source": "yfinance_quote",
"name": "Merck & Co., Inc.",
"episode_id": "narrative:MRK:5a78131dec6b3a0e",
"selection_as_of": "2026-08-25T17:00:19Z",
"facts": [
"MRK gained 2.80%, traded above VWAP and up, and showed a 0.938 intraday range position.",
"The sealed catalyst related to a Moderna cancer-vaccine and melanoma partnership.",
"RSI was 83.74, the move was 3.53 ATR above the EMA reference, and volume ratio was 0.48x."
],
"price_as_of": "2026-08-25T21:20:21Z",
"vwap_as_of": null
}
],
"benchmarks": [],
"coverage": {
"candidate_rows": 5,
"candidate_prices": 5,
"candidate_technical": 3,
"benchmark_rows": 0
}
}
},
{
"day": 14,
"timestamp": "2026-09-15T21:47:08.562235Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-09-15T21:47:08.562235Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "KURA",
"role": "selected",
"price": 11.43,
"base_price": 13.79,
"return_since_base_pct": -17.1139,
"session_return_pct": -2.25,
"change_since_prior_pct": 1.1057,
"volume_ratio": 1.02,
"rsi": 21.87,
"vwap": 11.22,
"vwap_distance_pct": 1.8717,
"position_52w_pct": 81.3,
"extended_hours_pct": 1.19,
"as_of": "2026-09-15T21:34:25Z",
"source": "sealed_extended_quote",
"name": "Kura Oncology, Inc.",
"episode_id": "n0:KURA:2026-08-25",
"ema_trend": "11.93 > 11.94 > 11.34",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:58.818200Z",
"facts": [
"KURA gained 11.21%, with a 1.42x volume ratio, an 85.7 volume percentile and +10.76% relative strength versus QQQ.",
"The sealed catalyst package includes a reported $1.24 million CEO stock purchase, 57% KOMZIFTI revenue growth and 35% growth in new patient starts.",
"The captured intraday view showed KURA above VWAP and up, with an intraday range position of 0.998."
],
"price_as_of": "2026-09-15T21:34:25Z",
"vwap_as_of": null
},
{
"symbol": "CRML",
"role": "alternative",
"price": 8.4469,
"base_price": 7.955,
"return_since_base_pct": 6.1835,
"session_return_pct": 4.2827,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.64,
"rsi": 61.49,
"vwap": 7.6,
"vwap_distance_pct": 11.1434,
"position_52w_pct": 24.71,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:20:04Z",
"source": "yfinance_quote",
"name": "Critical Metals Corp.",
"episode_id": "n0:CRML:2026-08-25",
"ema_trend": "6.8 > 6.75 > 7.63",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:50.354399Z",
"facts": [
"CRML gained 19.27% with +18.82% relative strength versus QQQ and a 1.64x volume ratio.",
"The rare-earth and European lithium merger narrative had no company announcement in the secondary news packet.",
"Short interest was 29.37% and the move was 1.98 ATR above the EMA reference."
],
"price_as_of": "2026-08-25T21:20:04Z",
"vwap_as_of": null
},
{
"symbol": "LEU",
"role": "alternative",
"price": 193.0,
"base_price": 185.37,
"return_since_base_pct": 4.1161,
"session_return_pct": -0.2017,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.29,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:17:47Z",
"source": "yfinance_quote",
"name": "Centrus Energy Corp.",
"episode_id": "narrative:LEU:d551ea7899e32218",
"selection_as_of": "2026-08-25T17:00:00Z",
"facts": [
"LEU was above VWAP and up, with a 0.963 intraday range position and a +5.44% relative-strength reading versus QQQ.",
"The sealed catalyst package connected X-Energy, Ohio and federal attention to domestic fuel and energy-security activity.",
"Volume ratio was only 0.29x, while the quoted options spread was 11.36%."
],
"price_as_of": "2026-08-25T21:17:47Z",
"vwap_as_of": null
},
{
"symbol": "GENB",
"role": "alternative",
"price": 20.11,
"base_price": 20.869,
"return_since_base_pct": -3.637,
"session_return_pct": -1.3248,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.06,
"rsi": 80.02,
"vwap": 20.73,
"vwap_distance_pct": -2.9908,
"position_52w_pct": 91.84,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:12:46Z",
"source": "yfinance_quote",
"name": "Generate Biomedicines, Inc.",
"episode_id": "n0:GENB:2026-08-25",
"ema_trend": "17.05 > 15.86 > 15.0",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:23.027806Z",
"facts": [
"GENB gained 17.77% with a 3.06x volume ratio and +17.32% relative strength versus QQQ.",
"The sealed options snapshot was unavailable.",
"The catalyst was not a direct issuer-specific event in the corrected evidence."
],
"price_as_of": "2026-08-25T21:12:46Z",
"vwap_as_of": null
},
{
"symbol": "MRK",
"role": "alternative",
"price": 156.38,
"base_price": 154.8999,
"return_since_base_pct": 0.9555,
"session_return_pct": -0.0447,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.48,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:20:21Z",
"source": "yfinance_quote",
"name": "Merck & Co., Inc.",
"episode_id": "narrative:MRK:5a78131dec6b3a0e",
"selection_as_of": "2026-08-25T17:00:19Z",
"facts": [
"MRK gained 2.80%, traded above VWAP and up, and showed a 0.938 intraday range position.",
"The sealed catalyst related to a Moderna cancer-vaccine and melanoma partnership.",
"RSI was 83.74, the move was 3.53 ATR above the EMA reference, and volume ratio was 0.48x."
],
"price_as_of": "2026-08-25T21:20:21Z",
"vwap_as_of": null
}
],
"benchmarks": [],
"coverage": {
"candidate_rows": 5,
"candidate_prices": 5,
"candidate_technical": 3,
"benchmark_rows": 0
}
}
},
{
"day": 15,
"timestamp": "2026-09-16T22:16:11.325459Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-09-16T22:16:11.325459Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "KURA",
"role": "selected",
"price": 13.7338,
"base_price": 13.79,
"return_since_base_pct": -0.4075,
"session_return_pct": 1.0581,
"change_since_prior_pct": 20.1557,
"volume_ratio": 1.42,
"rsi": 86.86,
"vwap": 13.37,
"vwap_distance_pct": 2.721,
"position_52w_pct": 99.7,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:18:04Z",
"source": "yfinance_quote",
"name": "Kura Oncology, Inc.",
"episode_id": "n0:KURA:2026-08-25",
"ema_trend": "11.99 > 11.15 > 10.55",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:58.818200Z",
"facts": [
"KURA gained 11.21%, with a 1.42x volume ratio, an 85.7 volume percentile and +10.76% relative strength versus QQQ.",
"The sealed catalyst package includes a reported $1.24 million CEO stock purchase, 57% KOMZIFTI revenue growth and 35% growth in new patient starts.",
"The captured intraday view showed KURA above VWAP and up, with an intraday range position of 0.998."
],
"price_as_of": "2026-08-25T21:18:04Z",
"vwap_as_of": null
},
{
"symbol": "CRML",
"role": "alternative",
"price": 8.4469,
"base_price": 7.955,
"return_since_base_pct": 6.1835,
"session_return_pct": 4.2827,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.64,
"rsi": 61.49,
"vwap": 7.6,
"vwap_distance_pct": 11.1434,
"position_52w_pct": 24.71,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:20:04Z",
"source": "yfinance_quote",
"name": "Critical Metals Corp.",
"episode_id": "n0:CRML:2026-08-25",
"ema_trend": "6.8 > 6.75 > 7.63",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:50.354399Z",
"facts": [
"CRML gained 19.27% with +18.82% relative strength versus QQQ and a 1.64x volume ratio.",
"The rare-earth and European lithium merger narrative had no company announcement in the secondary news packet.",
"Short interest was 29.37% and the move was 1.98 ATR above the EMA reference."
],
"price_as_of": "2026-08-25T21:20:04Z",
"vwap_as_of": null
},
{
"symbol": "LEU",
"role": "alternative",
"price": 193.0,
"base_price": 185.37,
"return_since_base_pct": 4.1161,
"session_return_pct": -0.2017,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.29,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:17:47Z",
"source": "yfinance_quote",
"name": "Centrus Energy Corp.",
"episode_id": "narrative:LEU:d551ea7899e32218",
"selection_as_of": "2026-08-25T17:00:00Z",
"facts": [
"LEU was above VWAP and up, with a 0.963 intraday range position and a +5.44% relative-strength reading versus QQQ.",
"The sealed catalyst package connected X-Energy, Ohio and federal attention to domestic fuel and energy-security activity.",
"Volume ratio was only 0.29x, while the quoted options spread was 11.36%."
],
"price_as_of": "2026-08-25T21:17:47Z",
"vwap_as_of": null
},
{
"symbol": "GENB",
"role": "alternative",
"price": 20.11,
"base_price": 20.869,
"return_since_base_pct": -3.637,
"session_return_pct": -1.3248,
"change_since_prior_pct": 0.0,
"volume_ratio": 3.06,
"rsi": 80.02,
"vwap": 20.73,
"vwap_distance_pct": -2.9908,
"position_52w_pct": 91.84,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:12:46Z",
"source": "yfinance_quote",
"name": "Generate Biomedicines, Inc.",
"episode_id": "n0:GENB:2026-08-25",
"ema_trend": "17.05 > 15.86 > 15.0",
"vwap_state": "above",
"selection_as_of": "2026-08-25T15:15:23.027806Z",
"facts": [
"GENB gained 17.77% with a 3.06x volume ratio and +17.32% relative strength versus QQQ.",
"The sealed options snapshot was unavailable.",
"The catalyst was not a direct issuer-specific event in the corrected evidence."
],
"price_as_of": "2026-08-25T21:12:46Z",
"vwap_as_of": null
},
{
"symbol": "MRK",
"role": "alternative",
"price": 156.38,
"base_price": 154.8999,
"return_since_base_pct": 0.9555,
"session_return_pct": -0.0447,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.48,
"rsi": null,
"vwap": null,
"vwap_distance_pct": null,
"position_52w_pct": null,
"extended_hours_pct": null,
"as_of": "2026-08-25T21:20:21Z",
"source": "yfinance_quote",
"name": "Merck & Co., Inc.",
"episode_id": "narrative:MRK:5a78131dec6b3a0e",
"selection_as_of": "2026-08-25T17:00:19Z",
"facts": [
"MRK gained 2.80%, traded above VWAP and up, and showed a 0.938 intraday range position.",
"The sealed catalyst related to a Moderna cancer-vaccine and melanoma partnership.",
"RSI was 83.74, the move was 3.53 ATR above the EMA reference, and volume ratio was 0.48x."
],
"price_as_of": "2026-08-25T21:20:21Z",
"vwap_as_of": null
}
],
"benchmarks": [],
"coverage": {
"candidate_rows": 5,
"candidate_prices": 5,
"candidate_technical": 3,
"benchmark_rows": 0
}
}
}
],
"candidates": [
{
"symbol": "CRML",
"name": "Critical Metals Corp.",
"exchange": "NASDAQ",
"tradingview_url": "https://es.tradingview.com/chart/?symbol=NASDAQ%3ACRML&interval=60",
"score": 5,
"price": 7.955,
"change": 19.27,
"volume": 10344869,
"avg_volume_3m": 6315879,
"volume_ratio": 1.64,
"rsi": 61.49,
"ema_trend": "6.8 > 6.75 > 7.63",
"position_52w_pct": 24.71,
"vwap": 7.6,
"vwap_distance_pct": null,
"vwap_state": "above",
"facts": [
"CRML gained 19.27% with +18.82% relative strength versus QQQ and a 1.64x volume ratio.",
"The rare-earth and European lithium merger narrative had no company announcement in the secondary news packet.",
"Short interest was 29.37% and the move was 1.98 ATR above the EMA reference."
],
"role": "alternative",
"selected": false,
"reason": "CRML had the strongest one-day move among the leading mechanism candidates, but its current merger catalyst remained unverified in the sealed packet."
},
{
"symbol": "LEU",
"name": "Centrus Energy Corp.",
"exchange": "NYSE",
"tradingview_url": "https://es.tradingview.com/chart/?symbol=NYSE%3ALEU&interval=60",
"score": null,
"price": 185.37,
"change": null,
"volume": 202900,
"avg_volume_3m": 794630,
"volume_ratio": 0.29,
"rsi": null,
"ema_trend": null,
"position_52w_pct": null,
"vwap": null,
"vwap_distance_pct": null,
"vwap_state": null,
"facts": [
"LEU was above VWAP and up, with a 0.963 intraday range position and a +5.44% relative-strength reading versus QQQ.",
"The sealed catalyst package connected X-Energy, Ohio and federal attention to domestic fuel and energy-security activity.",
"Volume ratio was only 0.29x, while the quoted options spread was 11.36%."
],
"role": "alternative",
"selected": false,
"reason": "LEU offered the cleaner extension and options profile, but participation was too quiet for the strongest Daily prospective case."
},
{
"symbol": "GENB",
"name": "Generate Biomedicines, Inc.",
"exchange": "NASDAQ",
"tradingview_url": "https://es.tradingview.com/chart/?symbol=NASDAQ%3AGENB&interval=60",
"score": 6,
"price": 20.869,
"change": 17.77,
"volume": 2577509,
"avg_volume_3m": 841028,
"volume_ratio": 3.06,
"rsi": 80.02,
"ema_trend": "17.05 > 15.86 > 15.0",
"position_52w_pct": 91.84,
"vwap": 20.73,
"vwap_distance_pct": null,
"vwap_state": "above",
"facts": [
"GENB gained 17.77% with a 3.06x volume ratio and +17.32% relative strength versus QQQ.",
"The sealed options snapshot was unavailable.",
"The catalyst was not a direct issuer-specific event in the corrected evidence."
],
"role": "alternative",
"selected": false,
"reason": "GENB showed powerful relative strength and participation, but the catalyst was an indirect Nvidia, SpaceX and AI-biotech narrative."
},
{
"symbol": "MRK",
"name": "Merck & Co., Inc.",
"exchange": "NYSE",
"tradingview_url": "https://es.tradingview.com/chart/?symbol=NYSE%3AMRK&interval=60",
"score": null,
"price": 154.8999,
"change": null,
"volume": 4898303,
"avg_volume_3m": 10863287,
"volume_ratio": 0.48,
"rsi": null,
"ema_trend": null,
"position_52w_pct": null,
"vwap": null,
"vwap_distance_pct": null,
"vwap_state": null,
"facts": [
"MRK gained 2.80%, traded above VWAP and up, and showed a 0.938 intraday range position.",
"The sealed catalyst related to a Moderna cancer-vaccine and melanoma partnership.",
"RSI was 83.74, the move was 3.53 ATR above the EMA reference, and volume ratio was 0.48x."
],
"role": "alternative",
"selected": false,
"reason": "MRK had a coherent healthcare connection and solid structure, but its participation was quiet and its move was already stretched."
}
],
"news": [
{
"title": "Kura Oncology Shares Jump After CEO Buys $1.24 Million of Stock",
"url": "https://investorshub.advfn.com/market-news/article/35023/kura-oncology-shares-jump-after-ceo-buys-1-24-million-of-stock"
},
{
"title": "Citizens Reiterates Market Outperform on Kura Oncology, Maintains $24 Price Target",
"url": "https://finnhub.io/api/news?id=3a88d6dcb5063973a0ad5a00bd9c6c0e23aff0b1475270cbbb11b8b4fc29fe3f"
},
{
"title": "Kura Oncology (KURA) Q2 2026 Earnings Call Transcript",
"url": "https://www.fool.com/earnings/call-transcripts/2026/08/19/kura-oncology-kura-q2-2026-earnings-call-transcript/"
},
{
"title": "Kura Oncology (KURA) is a Great Momentum Stock: Should You Buy?",
"url": "https://finance.yahoo.com/markets/stocks/articles/kura-oncology-kura-great-momentum-160005181.html"
}
],
"transcript_url": null,
"initial_transcript_anchor": "transcript-entry-e4845f1ebcc37e888af83d5eaba6179f3ed08d1a5b0f83fde5e6d039a8410b5d",
"chart_url": null,
"secondary_chart_url": null,
"forecast_chart_url": null,
"methodology_url": "https://trydingday.com/methodology/",
"track_record_url": "https://trydingday.com/track-record/",
"market_timezone": "America/New_York"
}
}